
<html lang="en"     class="pb-page"  data-request-id="c2c62863-f364-452e-beee-38d0f4d20839"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;issue:issue:10.1021/jmcmar.2012.55.issue-23;wgroup:string:ACHS website Group;website:website:acspubs;article:article:10.1021/jm3013147;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Discovery of (5S,6S,9R)-5-Amino-6-(2,3-difluorophenyl)-6,7,8,9-tetrahydro-5H-cyclohepta[b]pyridin-9-yl 4-(2-oxo-2,3-dihydro-1H-imidazo[4,5-b]pyridin-1-yl)piperidine-1-carboxylate (BMS-927711): An Oral Calcitonin Gene-Related Peptide (CGRP) Antagonist in Clinical Trials for Treating Migraine" /></meta><meta name="dc.Creator" content="Guanglin  Luo" /></meta><meta name="dc.Creator" content="Ling  Chen" /></meta><meta name="dc.Creator" content="Charles M.  Conway" /></meta><meta name="dc.Creator" content="Rex  Denton" /></meta><meta name="dc.Creator" content="Deborah  Keavy" /></meta><meta name="dc.Creator" content="Laura  Signor" /></meta><meta name="dc.Creator" content="Walter  Kostich" /></meta><meta name="dc.Creator" content="Kimberley A.  Lentz" /></meta><meta name="dc.Creator" content="Kenneth S.  Santone" /></meta><meta name="dc.Creator" content="Richard  Schartman" /></meta><meta name="dc.Creator" content="Marc  Browning" /></meta><meta name="dc.Creator" content="Gary  Tong" /></meta><meta name="dc.Creator" content="John G.  Houston" /></meta><meta name="dc.Creator" content="Gene M.  Dubowchik" /></meta><meta name="dc.Creator" content="John E.  Macor" /></meta><meta name="dc.Description" content="Calcitonin gene-related peptide (CGRP) receptor antagonists have demonstrated clinical efficacy in the treatment of acute migraine. Herein, we describe the design, synthesis, and preclinical charac..." /></meta><meta name="Description" content="Calcitonin gene-related peptide (CGRP) receptor antagonists have demonstrated clinical efficacy in the treatment of acute migraine. Herein, we describe the design, synthesis, and preclinical charac..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="November 15, 2012" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm3013147" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2012 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm3013147" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm3013147" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm3013147" /></link>
        
    
    

<title>Discovery of (5S,6S,9R)-5-Amino-6-(2,3-difluorophenyl)-6,7,8,9-tetrahydro-5H-cyclohepta[b]pyridin-9-yl 4-(2-oxo-2,3-dihydro-1H-imidazo[4,5-b]pyridin-1-yl)piperidine-1-carboxylate (BMS-927711): An Oral Calcitonin Gene-Related Peptide (CGRP) Antagonist in Clinical Trials for Treating Migraine | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm3013147" /></meta><meta property="og:title" content="Discovery of (5S,6S,9R)-5-Amino-6-(2,3-difluorophenyl)-6,7,8,9-tetrahydro-5H-cyclohepta[b]pyridin-9-yl 4-(2-oxo-2,3-dihydro-1H-imidazo[4,5-b]pyridin-1-yl)piperidine-1-carboxylate (BMS-927711): An Oral Calcitonin Gene-Related Peptide (CGRP) Antagonist in Clinical Trials for Treating Migraine" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-23/jm3013147/production/images/large/jm-2012-013147_0008.jpeg" /></meta><meta property="og:description" content="Calcitonin gene-related peptide (CGRP) receptor antagonists have demonstrated clinical efficacy in the treatment of acute migraine. Herein, we describe the design, synthesis, and preclinical characterization of a highly potent, oral CGRP receptor antagonist BMS-927711 (8). Compound 8 has good oral bioavailability in rat and cynomolgus monkey, attractive overall preclinical properties, and shows dose-dependent activity in a primate model of CGRP-induced facial blood flow. Compound 8 is presently in phase II clinical trials." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm3013147"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm3013147">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm3013147&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm3013147&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm3013147&amp;href=/doi/10.1021/jm3013147" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2012</span><span class="cit-fg-volume">, 55</span><span class="cit-fg-issue">, 23</span><span class="cit-fg-pageRange">, 10644-10651</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/55/23" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm3012992" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm3013163" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Discovery of (5<i>S</i>,6<i>S</i>,9<i>R</i>)-5-Amino-6-(2,3-difluorophenyl)-6,7,8,9-tetrahydro-5<i>H</i>-cyclohepta[<i>b</i>]pyridin-9-yl 4-(2-oxo-2,3-dihydro-1<i>H</i>-imidazo[4,5-<i>b</i>]pyridin-1-yl)piperidine-1-carboxylate (BMS-927711): An Oral Calcitonin Gene-Related Peptide (CGRP) Antagonist in Clinical Trials for Treating Migraine</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Guanglin++Luo">Guanglin Luo</a></span><span class="author-xref-symbol "><sup>*</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ling++Chen">Ling Chen</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Charles+M.++Conway">Charles M. Conway</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Rex++Denton">Rex Denton</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Deborah++Keavy">Deborah Keavy</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Laura++Signor">Laura Signor</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Walter++Kostich">Walter Kostich</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kimberley+A.++Lentz">Kimberley A. Lentz</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kenneth+S.++Santone">Kenneth S. Santone</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Richard++Schartman">Richard Schartman</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Marc++Browning">Marc Browning</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Gary++Tong">Gary Tong</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=John+G.++Houston">John G. Houston</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Gene+M.++Dubowchik">Gene M. Dubowchik</a></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=John+E.++Macor">John E. Macor</a></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-text">Molecular Sciences and Candidate Optimization, Disease Sciences and Biologics, Bristol-Myers Squibb Research & Development, 5 Research Parkway, Wallingford, Connecticut 06492, United States</span></div><div class="corresp-info"><strong>*</strong>Phone: 203-677-6640. Fax: 203-677-7702. E-mail: <a href="/cdn-cgi/l/email-protection#d3b4a6b2bdb4bfbabdfdbfa6bc93b1bea0fdb0bcbe"><span class="__cf_email__" data-cfemail="baddcfdbd4ddd6d3d494d6cfd5fad8d7c994d9d5d7">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm3013147&amp;href=/doi/10.1021%2Fjm3013147" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2012</span></span><span class="cit-volume">, 55</span><span class="cit-issue">, 23</span><span class="cit-pageRange">, 10644–10651</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">November 2, 2012</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>12 September 2012</li><li><span class="item_label"><b>Published</b> online</span>15 November 2012</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 13 December 2012</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm3013147" title="DOI URL">https://doi.org/10.1021/jm3013147</a></div><div class="article_header-article-copyright"><strong>Copyright © 2012 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D10644%26pageCount%3D8%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DGuanglin%2BLuo%252C%2BLing%2BChen%252C%2BCharles%2BM.%2BConway%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D55%26issueNum%3D23%26contentID%3Djm3013147%26title%3DDiscovery%2Bof%2B%25285S%252C6S%252C9R%2529-5-Amino-6-%25282%252C3-difluorophenyl%2529-6%252C7%252C8%252C9-tetrahydro-5H-cyclohepta%255Bb%255Dpyridin-9-yl%2B4-%25282-oxo-2%252C3-dihydro-1H-imidazo%255B4%252C5-b%255Dpyridin-1-yl%2529piperidine-1-carboxylate%2B%2528BMS-927711%2529%253A%2BAn%2BOral%2BCalcitonin%2BGene-Related%2BPeptide%2B%2528CGRP%2529%2BAntagonist%2Bin%2BClinical%2BTrials%2Bfor%2BTreating%2BMigraine%26numPages%3D8%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D10651%26publicationDate%3DDecember%2B2012">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm3013147"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2891</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">41</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm3013147" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Discovery of (5S,6S,9R)-5-Amino-6-(2,3-difluorophenyl)-6,7,8,9-tetrahydro-5H-cyclohepta[b]pyridin-9-yl 4-(2-oxo-2,3-dihydro-1H-imidazo[4,5-b]pyridin-1-yl)piperidine-1-carboxylate (BMS-927711): An Oral Calcitonin Gene-Related Peptide (CGRP) Antagonist in Clinical Trials for Treating Migraine&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Guanglin&quot;,&quot;last_name&quot;:&quot;Luo&quot;},{&quot;first_name&quot;:&quot;Ling&quot;,&quot;last_name&quot;:&quot;Chen&quot;},{&quot;first_name&quot;:&quot;Charles&quot;,&quot;last_name&quot;:&quot;M. Conway&quot;},{&quot;first_name&quot;:&quot;Rex&quot;,&quot;last_name&quot;:&quot;Denton&quot;},{&quot;first_name&quot;:&quot;Deborah&quot;,&quot;last_name&quot;:&quot;Keavy&quot;},{&quot;first_name&quot;:&quot;Laura&quot;,&quot;last_name&quot;:&quot;Signor&quot;},{&quot;first_name&quot;:&quot;Walter&quot;,&quot;last_name&quot;:&quot;Kostich&quot;},{&quot;first_name&quot;:&quot;Kimberley&quot;,&quot;last_name&quot;:&quot;A. Lentz&quot;},{&quot;first_name&quot;:&quot;Kenneth&quot;,&quot;last_name&quot;:&quot;S. Santone&quot;},{&quot;first_name&quot;:&quot;Richard&quot;,&quot;last_name&quot;:&quot;Schartman&quot;},{&quot;first_name&quot;:&quot;Marc&quot;,&quot;last_name&quot;:&quot;Browning&quot;},{&quot;first_name&quot;:&quot;Gary&quot;,&quot;last_name&quot;:&quot;Tong&quot;},{&quot;first_name&quot;:&quot;John&quot;,&quot;last_name&quot;:&quot;G. Houston&quot;},{&quot;first_name&quot;:&quot;Gene&quot;,&quot;last_name&quot;:&quot;M. Dubowchik&quot;},{&quot;first_name&quot;:&quot;John&quot;,&quot;last_name&quot;:&quot;E. Macor&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2012&quot;,&quot;month&quot;:&quot;11&quot;,&quot;day&quot;:&quot;15&quot;,&quot;issue&quot;:&quot;23&quot;,&quot;volume&quot;:&quot;55&quot;,&quot;pages&quot;:&quot;10644-10651&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm3013147&quot;},&quot;abstract&quot;:&quot;Calcitonin gene-related peptide (CGRP) receptor antagonists have demonstrated clinical efficacy in the treatment of acute migraine. Herein, we describe the design, synthesis, and preclinical characterization of a highly potent, oral CGRP receptor antagonist BMS-927711 (8). Compound 8 has good oral bioavailability in rat and cynomolgus monkey, attractive overall preclinical properties, and shows dose-dependent activity in a primate model of CGRP-induced facial blood flow. Compound 8 is presently in phase II clinical trials.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm3013147&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm3013147" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm3013147&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm3013147" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm3013147&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm3013147" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm3013147&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm3013147&amp;href=/doi/10.1021/jm3013147" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm3013147" /></input><a href="/doi/pdf/10.1021/jm3013147" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (671 KB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm3013147&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm3013147%26sid%3Dliteratum%253Aachs%26pmid%3D23153230%26genre%3Darticle%26aulast%3DLuo%26date%3D2012%26atitle%3DDiscovery%2Bof%2B%25285S%252C6S%252C9R%2529-5-Amino-6-%25282%252C3-difluorophenyl%2529-6%252C7%252C8%252C9-tetrahydro-5H-cyclohepta%255Bb%255Dpyridin-9-yl%2B4-%25282-oxo-2%252C3-dihydro-1H-imidazo%255B4%252C5-b%255Dpyridin-1-yl%2529piperidine-1-carboxylate%2B%2528BMS-927711%2529%253A%2BAn%2BOral%2BCalcitonin%2BGene-Related%2BPeptide%2B%2528CGRP%2529%2BAntagonist%2Bin%2BClinical%2BTrials%2Bfor%2BTreating%2BMigraine%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D55%26issue%3D23%26spage%3D10644%26epage%3D10651%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=290758" title="Anatomy">Anatomy</a>,</li><li><a href="/action/doSearch?ConceptID=291650" title="Alcohols">Alcohols</a>,</li><li><a href="/action/doSearch?ConceptID=291171" title="Antagonists">Antagonists</a>,</li><li><a href="/action/doSearch?ConceptID=292398" title="Stereochemistry">Stereochemistry</a>,</li><li><a href="/action/doSearch?ConceptID=292186" title="Receptors">Receptors</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/55/23" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-23/jmcmar.2012.55.issue-23/production/jmcmar.2012.55.issue-23.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-23/jm3013147/production/images/medium/jm-2012-013147_0008.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-23/jm3013147/production/images/large/jm-2012-013147_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3013147&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Calcitonin gene-related peptide (CGRP) receptor antagonists have demonstrated clinical efficacy in the treatment of acute migraine. Herein, we describe the design, synthesis, and preclinical characterization of a highly potent, oral CGRP receptor antagonist BMS-927711 (<b>8</b>). Compound <b>8</b> has good oral bioavailability in rat and cynomolgus monkey, attractive overall preclinical properties, and shows dose-dependent activity in a primate model of CGRP-induced facial blood flow. Compound <b>8</b> is presently in phase II clinical trials.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_72320" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_72320" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Migraine is a painful, incapacitating disease, that affects a large portion (12%) of the adult population and imposes a substantial economic burden on society (estimated to be $13 billion per year).<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> It is characterized by recurrent unilateral headaches often accompanied by nausea, vomiting, photophobia, and phonophobia. Much remains to be learned about the underlying pathophysiology of migraine. One prominent hypothesis is that migraine headache is initiated with the dilation of cranial blood vessels.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> Additional contemporary work has focused on neural processes and the potential roles of peripheral<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> and possibly central sensitization<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> in the neurobiology of headache. The current standard of care is the triptan class of 5-HT<sub>1B/1D</sub> receptor agonists, which are believed to act by constriction of the cranial blood vessels.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> However, because they cause nonselective smooth muscle vasoconstriction, they are associated with a number of unpleasant, and potentially dangerous, cardiovascular side effects, and the triptans have labeled contraindications against use in patients with heart disease and hypertension.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> A novel class of drugs for migraine treatment that are devoid of direct vasoconstriction would offer a significant therapeutic advantage over the current standard of care.</div><div class="NLM_p">Calcitonin gene-related peptide CGRP is a 37 amino acid peptide that is widely distributed in the nervous system.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> It is an extremely potent vasodilator that has been directly implicated in the pathogenesis of migraine.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> Studies have shown that plasma levels of CGRP are elevated during migraine attacks, and these levels are normalized by sumatriptan in connection with the relief of headache.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> CGRP receptors are G-coupled cell surface receptors composed of the calcitonin receptor-like receptor (CLR), receptor activity modifying protein 1 (RAMP1), and the receptor component protein (RCP).<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a></div><div class="NLM_p">CGRP receptor antagonists are a new therapeutic target for the treatment of migraine. Proof of mechanism in the clinic was first demonstrated with intravenous administration of olcegepant (BIBN4096BS) (<b>1</b>, Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>), where alleviation of pain in migraneurs was significantly superior over placebo.<a onclick="showRef(event, 'ref8 ref9'); return false;" href="javascript:void(0);" class="ref ref8 ref9">(8, 9)</a> Importantly, cardiovascular side effects associated with sumatriptan were not observed with the CGRP receptor antagonist <b>1</b>. More recently, an oral CGRP receptor antagonist, telcagepant (MK-0974)<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> (<b>2</b>, Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>), showed efficacy in multiple phase II and phase III trials but was discontinued following a larger study.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> Two later oral CGRP receptor antagonists, MK-3207<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> and BI-44370<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> (<b>3</b> and <b>4</b>, Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>), were efficacious in various phase II trials, but are not currently in clinical development.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-23/jm3013147/production/images/medium/jm-2012-013147_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-23/jm3013147/production/images/large/jm-2012-013147_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Selected CGRP receptor antagonists.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-23/jm3013147/production/images/large/jm-2012-013147_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3013147&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">A recent publication from our laboratory disclosed the potent, oral CGRP receptor antagonist, BMS-846372, which contained a cyclohepta[<i>b</i>]pyridine core (<b>5</b>, Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>) and was an attractive preclinical lead.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> However, the compound was highly crystalline with very low aqueous solubility (<2 μg/mL), and this created a significant challenge for further clinical development. Formation of useful salts of the core pyridine (p<i>K</i><sub>a</sub> ∼ 4) was not feasible because strong acids led to hydrolysis of the carbamate. A limited number of phosphate-related prodrugs were attempted, but they were not progressable.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> We realized that one way to increase the aqueous solubility of an organic molecule was to add hydrophilic groups. We hypothesized that the addition of small, polar groups such as OH or NH<sub>2</sub> would provide “helpful polarity,” improving the solubility while maintaining the attractive properties of <b>5</b>. In this vein, two target alcohols, <b>6</b> and <b>7</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>), were prepared to test this hypothesis. These more polar analogues of <b>5</b> (<b>6</b> and <b>7</b>) maintained their potency as CGRP receptor antagonists, and this encouraged us to make the primary amine analogue <b>8</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>). A primary amine would also allow salt formation that might not facilitate decomposition of the carbamate linker. Accordingly, herein we describe the discovery of a potent, aqueous soluble, orally active CGRP receptor antagonist BMS-927711 (<b>8</b>) (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>), which is presently in phase II clinical trials.</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-23/jm3013147/production/images/medium/jm-2012-013147_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-23/jm3013147/production/images/large/jm-2012-013147_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Proposed target CGRP receptor antagonists <b>6</b>, <b>7</b>, and <b>8</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-23/jm3013147/production/images/large/jm-2012-013147_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3013147&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_24525" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_24525" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">We recently reported a stereoselective synthesis of <b>5</b>,<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> in which ketone <b>9</b> (Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>) was prepared as a key intermediate. It was also useful for the formation of our present targets, compounds <b>6</b>, <b>7</b>, and <b>8</b>. The syntheses of the desired alcohols, <b>6</b> and <b>7</b> are shown in Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>. Careful deprotection of <b>9</b> by TBAF afforded the rather unstable hydroxyl ketone intermediate <b>10</b> in 62% yield. Carbamate formation with <b>11</b> under previously reported conditions<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> using NaHMDS as the base at low temperature afforded the intermediate ketone <b>12</b> in 29% yield. Reduction of the ketone <b>12</b> by NaBH<sub>4</sub> afforded three alcohols, <b>6</b>, <b>7</b>, and <b>13</b>, after careful purifications using preparative HPLC and flash column chromatography.</div><figure id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-23/jm3013147/production/images/medium/jm-2012-013147_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-23/jm3013147/production/images/large/jm-2012-013147_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Alcohols <b>6</b> and <b>7</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-23/jm3013147/production/images/large/jm-2012-013147_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3013147&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) THF, TBAF, −15 °C, 1 h (62%); (b) DMF, NaHMDS, −15 to −5 °C, 1.5 h (29%); (c) MeOH, NaBH<sub>4</sub>, rt, 30 min, <b>6</b> (14%), <b>7</b> (12%), <b>13</b> (6%).</p></p></figure><div class="NLM_p">To assign relative stereochemistry, ketone mixture <b>9</b> was directly reduced by NaBH<sub>4</sub> to the diastereomeric mixture <b>14</b> (Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>). Treatment of <b>14</b> with TBAF at room temperature left <b>16</b> untouched while removing the TIPS protecting group from the major and minor diastereomers, <b>15</b> and <b>17</b>. All three components were easily separable at this stage. The major diastereomer, <b>15</b>, was obtained in 65% yield. An X-ray structure of <b>15</b> was obtained and identified its relative stereochemistry (as shown in Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>).<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> The protected diasteromer <b>16</b> was further treated with TBAF at elevated temperature to afford the diol <b>18</b>. An X-ray structure of <b>18</b> was also obtained, showing its relative stereochemistry (as shown in Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>).<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> The relative stereochemistry of diol <b>17</b> was not determined.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a></div><figure id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-23/jm3013147/production/images/medium/jm-2012-013147_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-23/jm3013147/production/images/large/jm-2012-013147_0005.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Absolute Stereochemistry of Diols <b>15</b> and <b>18</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-23/jm3013147/production/images/large/jm-2012-013147_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3013147&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) MeOH, NaBH<sub>4</sub>, rt, 1 h (96%); (b) THF, TBAF, rt, 2 h, <b>15</b> (65%), <b>16</b> (17%), <b>17</b> (12%); (c) THF, TBAF (2.5 equiv), 50 °C, 18 h, (94%).</p></p></figure><div class="NLM_p">On the basis of the stereochemical information and product distribution ratio (compounds <b>6</b> and <b>15</b> were major products from both NaBH<sub>4</sub> reductions) obtained from <b>15</b> and <b>18</b>, the absolute stereochemistry of compound <b>6</b> was assigned as shown in Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>. To further confirm the stereochemistry of <b>6</b>, a stereoselective synthesis of compound <b>6</b> was carried out (Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a>). Enantiomerically pure <b>19</b> was available from ketone <b>9</b> through dynamic resolution and diastereoselective reduction.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> Protection of alcohol <b>19</b> as the acetate afforded <b>20</b>, which after TBAF deprotection, afforded the desired alcohol <b>21</b>. When <b>21</b> was subjected to the coupling conditions described in Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>, compound <b>22</b> was obtained. Under the basic conditions, partial hydrolysis of <b>22</b> occurred to generate the final product <b>6</b>. After separation, treatment of <b>22</b> with K<sub>2</sub>CO<sub>3</sub> in MeOH resulted in complete conversion to compound <b>6</b>, which was identical in every respect with that generated in Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>.</div><figure id="sch3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-23/jm3013147/production/images/medium/jm-2012-013147_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-23/jm3013147/production/images/large/jm-2012-013147_0006.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. The Stereospecific Synthesis of <b>6</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-23/jm3013147/production/images/large/jm-2012-013147_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3013147&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) CH<sub>2</sub>Cl<sub>2</sub>, Ac<sub>2</sub>O, Et<sub>3</sub>N, DMAP, rt, 2 h; (b) THF, TBAF, rt, 2h (87% for 2 steps); (c) <b>11</b>, DMF, NaHMDS, −15 to 0 °C, 2 h (30% + 13% of <b>6</b>); (d) MeOH, K<sub>2</sub>CO<sub>3</sub>, rt, 1 h (56%).</p></p></figure><div class="NLM_p">With the absolute stereochemistry of the more active alcohol <b>6</b> established (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>), we prepared the primary amine analogue with the same configuration. The stereospecific synthesis of <b>8</b> was achieved as shown in Scheme <a class="ref internalNav" href="#sch4" aria-label="4">4</a>.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> On the basis of the stereochemistry of alcohol <b>19</b>, a double inversion strategy was used to preserve the absolute configuration of <b>6</b>. Thus, alcohol <b>19</b> was first converted to the chloride <b>23</b> with inversion of the chiral center. The second inversion was achieved by treating <b>23</b> with NaN<sub>3</sub> to obtain <b>24</b>. After TIPS removal, the alcohol <b>25</b>was coupled with <b>11</b>, as described in Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>, to give the azide <b>26</b>. This was converted to the amine <b>8</b> by treatment with Me<sub>3</sub>P (Scheme <a class="ref internalNav" href="#sch4" aria-label="4">4</a>).</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. In Vitro Data for hCGRP Receptor Antagonists</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="center" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="center" /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">hCGRP <i>K</i><sup>i</sup> (nM)</th><th class="colsep0 rowsep0" align="center" char=".">cAMP EC<sub>50</sub> (nM)</th><th class="colsep0 rowsep0" align="center" char=".">human <i>f</i><sub>u</sub> (%)</th><th class="colsep0 rowsep0" align="center" char=".">protein adjusted <i>K</i><sub>i</sub> (nM)<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center">aq soln (crystalline) (μg/mL)</th><th class="colsep0 rowsep0" align="center" char=".">HMetStab <i>T</i><sub>1/2</sub> (min)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5</b><a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a></td><td class="colsep0 rowsep0" align="center">0.070 (±0.021)</td><td class="colsep0 rowsep0" align="char" char=".">0.22</td><td class="colsep0 rowsep0" align="char" char=".">2.3</td><td class="colsep0 rowsep0" align="char" char=".">3.0</td><td class="colsep0 rowsep0" align="center"><2</td><td class="colsep0 rowsep0" align="char" char=".">24</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6</b></td><td class="colsep0 rowsep0" align="center">0.081 (±0.034)</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char=".">4.1</td><td class="colsep0 rowsep0" align="char" char=".">2.0</td><td class="colsep0 rowsep0" align="center">66<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="char" char=".">70</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7</b></td><td class="colsep0 rowsep0" align="center">4.3 (±0.7)</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8</b></td><td class="colsep0 rowsep0" align="center">0.027 (±0.009)</td><td class="colsep0 rowsep0" align="char" char=".">0.14</td><td class="colsep0 rowsep0" align="char" char=".">6.9</td><td class="colsep0 rowsep0" align="char" char=".">0.39</td><td class="colsep0 rowsep0" align="center">50</td><td class="colsep0 rowsep0" align="char" char=".">83</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13</b></td><td class="colsep0 rowsep0" align="center">0.67 (±0.01)</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>26</b></td><td class="colsep0 rowsep0" align="center">0.066 (±0.018)</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="char" char="."> </td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>a</sup><p class="last">Protein adjusted <i>K</i><sub>i</sub> was defined as <i>K</i><sub>i</sub>/human <i>f</i><sub>u</sub>.</p></div><div class="footnote" id="t1fn2"><sup>b</sup><p class="last">Amorphous.</p></div></div></div><figure id="sch4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-23/jm3013147/production/images/medium/jm-2012-013147_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-23/jm3013147/production/images/large/jm-2012-013147_0007.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. The Stereospecific Synthesis of <b>8</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-23/jm3013147/production/images/large/jm-2012-013147_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3013147&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) NCS, Ph<sub>3</sub>P, THF, rt, 5 h (83%); (b) NaN<sub>3</sub>, DMF, 50 °C, 15 h; (c) TBAF, THF, rt, 1.5 h; (d) <b>11</b>, DMF, NaHMDS, −15 °C to rt, 4 h (73% for 3 steps); (e) PMe<sub>3</sub>, THF, H<sub>2</sub>O, rt, 5 h (85%).</p></p></figure></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i8">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_05360" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_05360" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Binding affinities for the human CGRP receptor were determined by inhibition of <sup>125</sup>I-CGRP binding to SK-N-MC cell membranes, which endogenously express receptor.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> Alcohol <b>6</b> demonstrated potent CGRP receptor binding (<i>K</i><sub>i</sub> = 0.081 ± 0.034 nM (<i>n</i> = 8), Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>), comparable to previously reported antagonist <b>5</b><a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> (<i>K</i><sub>i</sub> = 0.070 ± 0.021 nM). In addition, the presence of the hydroxyl group in <b>6</b> improved aqueous solubility (66 μg/mL), reduced human plasma protein binding (<i>f</i><sub>u</sub> = 4.1%), and improved human microsomal stability (HLM <i>T</i><sub>1/2</sub> = 70 min.) relative to <b>5</b>. The diastereomeric alcohols <b>13</b> and <b>7</b> (<i>K</i><sub>i</sub> = 0.67 and 4.3 nM, respectively) were successively less potent than <b>5</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>).</div><div class="NLM_p">The corresponding primary amine <b>8</b> demonstrated even better in vitro properties relative to <b>5</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). Because of its higher human plasma free fraction and more potent CGRP receptor binding, the protein-adjusted <i>K</i><sub>i</sub> for <b>8</b> was improved by 8-fold in comparison with <b>5</b>. There was also a further improvement in HLM stability (<i>T</i><sub>1/2</sub> = 83 min). Functional receptor antagonism for <b>8</b> was determined by measuring inhibition of CGRP-stimulated cAMP production in SK-N-MC cells. Compound <b>8</b> was shown to be a full, competitive antagonist with IC<sub>50</sub> = 0.14 ± 0.01 nM (<i>n</i> = 2). Despite the additional polarity of the primary amine, permeability of <b>8</b> in the parallel artificial membrane permeability assay (PAMPA) was excellent (190 and 320 nm/s at pH 5.5 and 7.4, respectively). The solubility of crystalline <b>8</b> was very good (50 μg/mL) and a good portent of a straightforward pharmaceutics development.</div><div class="NLM_p">A novel noninvasive marmoset recovery model for in vivo efficacy assessment of CGRP receptor antagonists was developed in our laboratories, which utilizes laser Doppler facial blood flow as a surrogate for intracranial artery diameter.<a onclick="showRef(event, 'ref15 ref21'); return false;" href="javascript:void(0);" class="ref ref15 ref21">(15, 21)</a> Briefly, marmosets were anesthetized and facial blood flow was increased by four intravenous (IV) administrations of hαCGRP (10 μg/kg) delivered at 45 min intervals (−30, 15, 60, and 105 min). The effect of antagonist, delivered subcutaneously (SC) at 0 min, on the hαCGRP-induced changes in facial blood flow was measured by laser Doppler flowmetry. In this model, compound <b>8</b> inhibited hαCGRP-induced increases in marmoset facial blood flow upon subcutaneous (SC) dosing.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> Compared to predose hCGRP control (−30 min), strong (>50%) inhibition of CGRP-induced effects on facial blood flow were observed with <b>8</b> dosed sc at 7 mg/kg at 15, 60, and 105 min postdose (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>). Comparing activity versus exposure 15 min postdose, plasma levels of approximately 400 nM were associated with strong in vivo efficacy (>65% inhibition). In comparison, plasma levels of <b>5</b> above 1000 nM were needed for similar efficacy in this model.<a onclick="showRef(event, 'ref15 ref21'); return false;" href="javascript:void(0);" class="ref ref15 ref21">(15, 21)</a> Peak inhibition for <b>8</b> was very strong at 75–80% at 60 and 105 min postdose, with corresponding plasma levels just below 800 nM (Figure <a data-tab="pane-pcw-Figures" href="#fig2a" id="" class=" internalNav">3</a>).<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a></div><figure id="fig2a" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-23/jm3013147/production/images/medium/jm-2012-013147_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-23/jm3013147/production/images/large/jm-2012-013147_0003.jpeg" id="GRAPHIC-d1677e1115-autogenerated" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Marmoset facial blood flow at 7 mg/kg, SC: 30 min represents the increased facial blood flow caused for hCGRP (10 μg/kg IV); 7 mg/kg <b>8</b> (SC) delivered at time = 0 min. At 15, 60, and 105 min, hCGRP challenge (10 μg/kg IV) was administered and reduction of facial blood flow and plasma levels of <b>8</b> were measured.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-23/jm3013147/production/images/large/jm-2012-013147_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3013147&amp;id=fig2a"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Compound <b>8</b> exhibited good oral bioavailability in the rat (<i>F</i><sub>PO</sub> = 45%) and cynomolgus monkey (<i>F</i><sub>PO</sub> = 67% as a solution). When dosed as a free base suspension of crystalline material, the oral bioavailability of <b>8</b> in the monkey remained good at 48%.</div><div class="NLM_p">Against a panel of eight recombinant hCYP isoforms, <b>8</b> showed low levels of inhibition: IC<sub>50</sub> ≥ 20 μM for all except CYP3A4 (IC<sub>50</sub> = 17 μM). In addition, <b>8</b> showed no significant potential for off-target liabilities in a panel of 45 receptor and ion channel binding and enzyme activity assays. No cardiovascular liability was identified in vitro. At 10 and 30 μM, <b>8</b> caused less than 30% inhibition of the hERG potassium channel alpha subunit expressed in HEK-293 cells, and no significant effect was seen on L-type sodium or calcium channels expressed in these cells. The compound was not mutagenic in an exploratory Ames study.</div><div class="NLM_p last">On the basis of favorable prenomination and pre-IND toxicological studies, <b>8</b> was chosen for clinical development. Initial phase I human PK results have been in good agreement with preclinical human PK projections, giving exposures at a 75 mg dose that are expected to prove efficacious. No significant adverse effects were encountered up to 600 mg. Compound <b>8</b> is presently in phase II studies, and the results of those studies will be reported in due course.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i9">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_47058" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_47058" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">Compound <b>8</b> is a highly potent CGRP receptor antagonist, with very good metabolic stability, acceptable CYP inhibition profile, good animal PK, and a favorable predictive toxicological profile. The presence of a primary amino group greatly improved aqueous solubility without compromising bilayer permeability, resulting in enhanced ADME properties. More detailed pharmacological and clinical results for <b>8</b> will be reported in due course.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i10">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_01087" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_01087" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> General Procedures</h3><div class="NLM_p last">All commercially available reagents and solvents were used without further purification unless otherwise stated. All reactions were carried out under an inert atmosphere of dry nitrogen in oven- or flame-dried glassware unless otherwise stated. Flash column chromatography was performed using 40–60 μm Silica Gel 60 (EMD Chemicals, Inc.) as the stationary phase or prepacked columns from ISCO Inco., Biotage, or Thomson Instrument Co. <sup>1</sup>H NMR spectra were recorded on a Bruker 400 or 500 MHz machine with tetramethylsilane or residual protiated solvent used as a reference. <sup>13</sup>C NMR were recorded on a Bruker DRX-500 instrument operating at 125 MHz with residual <sup>12</sup>C solvent used as a reference. Low resolution mass spectra were recorded using a Waters Micromass ZQ with electrospray ionization. High resolution mass spectra were recorded using a Waters Micromass LCT time-of-flight mass spectrometer with electrospray ionization. The purity of all compounds was determined by either liquid chromatography–mass spectrometry (LCMS) or analytical HPLC and was confirmed to be greater than 95% purity.</div></div><div id="sec5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> (5<i>S</i>,6<i>S</i>,9<i>R</i>)-6-(2,3-Difluorophenyl)-5-hydroxy-6,7,8,9-tetrahydro-5<i>H</i>-cyclohepta[<i>b</i>]pyridin-9-yl 4-(2-Oxo-2,3-dihydro-1<i>H</i>-imidazo[4,5-<i>b</i>]pyridin-1-yl)piperidine-1-carboxylate (<b>6</b>), (5<i>R</i>,6<i>S</i>,9<i>R</i>)-6-(2,3-Difluorophenyl)-5-hydroxy-6,7,8,9-tetrahydro-5<i>H</i>-cyclohepta[<i>b</i>]pyridin-9-yl 4-(2-Oxo-2,3-dihydro-1<i>H</i>-imidazo[4,5-<i>b</i>]pyridin-1-yl)piperidine-1-carboxylate (<b>7</b>), and (5<i>S</i>,6<i>R</i>,9<i>R</i>)-6-(2,3-Difluorophenyl)-5-hydroxy-6,7,8,9-tetrahydro-5<i>H</i>-cyclohepta[<i>b</i>]pyridin-9-yl 4-(2-Oxo-2,3-dihydro-1<i>H</i>-imidazo[4,5-<i>b</i>]pyridin-1-yl)piperidine-1-carboxylate (<b>13</b>)</h3><div class="NLM_p last">In a 100 mL round-bottom flask was dissolved <b>12</b> (44.4 mg, 0.083 mmol) in MeOH (1 mL) to give a colorless solution. NaBH<sub>4</sub> (6.30 mg, 0.166 mmol) was added, and the mixture was stirred at rt for 30 min. LCMS indicated complete conversion, showing three peaks, all with the desired MW (M + H = 536). The mixture was concentrated and directly purified by prep-HPLC (0.1% TFA–MeOH–water system) to afford three components. They were individually purified by flash column chromotagraphy using 0–10% MeOH/CH<sub>2</sub>Cl<sub>2</sub> to afford the products <b>6</b> (6.7 mg, 14%), <b>7</b> (5.5 mg, 12%), and <b>13</b> (3.0 mg, 6%) as white solids. The relative stereochemistry was not strictly assigned at this stage. Product <b>6</b>: <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i>) δ ppm 10.21 (br s, 1 H), 8.52 (d, <i>J</i> = 3.53 Hz, 1 H), 7.97–8.16 (m, 2 H), 7.47 (br s, 1 H), 7.27–7.37 (m, 1 H), 6.90–7.22 (m, 4 H), 5.97 (d, <i>J</i> = 10.32 Hz, 1 H), 5.32 (d, <i>J</i> = 10.4 Hz, 1 H), 4.26–4.74 (m, 3 H), 2.55–3.29 (m, 3 H), 2.18–2.49 (m, 4 H), 2.07–2.17 (m, 1 H), 1.59–2.02 (m, 4 H); <sup>19</sup>F NMR (376 MHz, chloroform-<i>d</i>) δ ppm −137.26 to −136.84 (m, 1 F), −142.46 to −142.13 (m, 1 F). Product <b>7</b>: <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i>) δ ppm 10.04 (br s, 1 H), 8.60 (dd, <i>J</i> = 4.78, 1.26 Hz, 1 H), 8.05 (br s, 1 H), 7.66 (d, <i>J</i> = 6.55 Hz, 1 H), 7.31 (dd, <i>J</i> = 7.43, 4.91 Hz, 3 H), 7.03–7.17 (m, 2 H), 6.91–7.03 (m, 1 H), 6.25 (d, <i>J</i> = 5.79 Hz, 1 H), 4.80 (d, <i>J</i> = 8.56 Hz, 1 H), 4.18–4.66 (m, 3 H), 3.38–3.58 (m, 2 H), 3.02 (d, <i>J</i> = 6.29 Hz, 2 H), 2.68 (d, <i>J</i> = 13.60 Hz, 2 H), 2.05–2.45 (m, 3 H), 1.93 (br s, 3 H); <sup>19</sup>F NMR (376 MHz, chloroform-<i>d</i>) δ ppm −138.28 (m, 1 F), 143.94 (m, 1 F). Product <b>13</b>: <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i>) δ ppm 9.47 (br s, 1 H), 8.50 (dd, <i>J</i> = 4.78, 1.26 Hz, 1 H), 8.03 (dd, <i>J</i> = 5.16, 1.13 Hz, 1 H), 7.35–7.55 (m, 3 H), 7.04–7.15 (m, 3 H), 7.00 (dd, <i>J</i> = 7.55, 5.29 Hz, 1 H), 6.58 (br s, 1 H) 4.85 (s, 1 H), 4.61 (br s, 3 H), 3.36 (br s, 1 H), 2.55–3.15 (m, 3 H), 2.35 (br s, 1 H), 1.83–2.04 (m, 3 H), 1.57–1.80 (m, 4 H); <sup>19</sup>F NMR (376 MHz, chloroform-<i>d</i>) δ ppm −138.49 (br s, 1 F), −144.30 (m, 1 F).</div></div><div id="sec5_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> (5<i>S</i>,6<i>S</i>,9<i>R</i>)-6-(2,3-Difluorophenyl)-5-hydroxy-6,7,8,9-tetrahydro-5<i>H</i>-cyclohepta[<i>b</i>]pyridin-9-yl 4-(2-oxo-2,3-dihydro-1<i>H</i>-imidazo[4,5-<i>b</i>]pyridin-1-yl)piperidine-1-carboxylate (<b>6</b>)</h3><div class="NLM_p last">In a 250 mL round-bottom flask was dissolved <b>22</b> (51 mg, 0.088 mmol) (acetate-protected product from above) in MeOH (1 mL) to give a colorless solution. K<sub>2</sub>CO<sub>3</sub> (122 mg, 0.883 mmol) was added, and the mixture was stirred at rt for 1 h. LCMS indicated complete conversion. MeOH was removed in vacuo. The residue was partitioned between water and EtOAc. The phases were separated. The organic layer was washed with brine, dried, and concentrated to a white solid. Purification by flash column chromotagraphy using 0–10% MeOH/CH<sub>2</sub>Cl<sub>2</sub> afforded the desired product (28 mg, 56%) as a light-yellow solid. <sup>1</sup>H and <sup>19</sup>F NMRs were obtained and matched that of the previous product <b>6</b>.</div></div><div id="sec5_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> (5<i>S</i>,6<i>S</i>,9<i>R</i>)-5-Amino-6-(2,3-difluorophenyl)-6,7,8,9-tetrahydro-5<i>H</i>-cyclohepta[<i>b</i>]pyridin-9-yl 4-(2-Oxo-2,3-dihydro-1<i>H</i>-imidazo[4,5-<i>b</i>]pyridin-1-yl)piperidine-1-carboxylate (<b>8</b>)</h3><div class="NLM_p last">In a 100 mL round-bottom flask was dissolved <b>26</b> (620 mg, 1.106 mmol) in THF (5 mL) to give a colorless solution. Trimethylphosphine (3.32 mL, 3.32 mmol, 1.0 M in toluene) was added. The mixture was stirred at rt. After 2 h, LCMS indicated complete conversion. Water (0.080 mL, 4.42 mmol) was added, and the mixture was stirred for another 3 h. LCMS showed complete conversion to the desired product. Volatile components were removed in vacuo, and the residue was directly purified by flash column chromotagraphy using 0–10% MeOH in CH<sub>2</sub>Cl<sub>2</sub> to afford the product (510 mg, 85%) as a white solid, which was recrystallized from EtOH: MS (ESI) [M + H<sup>+</sup>] = 535.23. <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i>) δ ppm 10.39 (br s, 1 H), 8.52 (d, <i>J</i> = 3.78 Hz, 1 H), 8.09 (d, <i>J</i> = 5.04 Hz, 2 H), 7.46 (br s, 1 H), 7.26–7.38 (m, 1 H), 7.06–7.20 (m, 3 H), 6.94–7.05 (m, 1 H), 6.06–6.23 (m, 1 H), 4.31–4.78 (m, 4 H), 4.05 (spt, <i>J</i> = 6.13 Hz, 1 H), 2.57–3.25 (m, 3 H), 2.17–2.38 (m, 3 H), 1.42–2.04 (m, 6 H); <sup>19</sup>F NMR (376 MHz, chloroform-<i>d</i>) δ ppm −136.90 (br s, 1 F), −142.48 to −142.21 (m, 1 F); [α]<sub>D</sub><sup>23</sup> = −86.36° (<i>c</i> = 5.71 mg/mL, methanol). Elemental Analysis: Calcd for C<sub>28</sub>H<sub>28</sub>N<sub>6</sub>·0.01EtOH: C 62.90, H 5.29, N 15.70. Observed: C 63.03, H 5.26, N 15.62.</div></div><div id="sec5_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> (9<i>R</i>)-6-(2,3-Difluorophenyl)-9-hydroxy-6,7,8,9-tetrahydro-5<i>H</i>-cyclohepta[<i>b</i>]pyridin-5-one (<b>10</b>)</h3><div class="NLM_p last">In a 250 mL round-bottom flask was dissolved <b>9</b> (0.218 g, 0.49 mmol) in THF (5 mL) to give a colorless solution. After cooling to −15 °C (ice/MeOH bath) under nitrogen, TBAF (0.490 mL, 0.490 mmol) was added, and the resulting bright-yellow solution was stirred at −15 °C for 1 h. The reaction was quenched with NaHCO<sub>3</sub> solution and diluted with EtOAc. The phases were separated, and the aqueous layer was extracted with EtOAc. The combined organic layers were washed with brine, dried, and concentrated to give a tan oil. Purification by flash column chromotagraphy using EtOAc/hexane afforded a mixture of two diastereomers (87 mg, 62%). Major component: <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i>) δ ppm 8.53 (dd, <i>J</i> = 4.91, 1.64 Hz, 1 H), 7.85 (dd, <i>J</i> = 7.68, 1.64 Hz, 1 H), 7.34 (dd, <i>J</i> = 7.68, 4.91 Hz, 1 H), 7.00–7.16 (m, 3 H), 5.32 (s, 1 H), 4.94–5.04 (m, 1 H), 4.48 (dd, <i>J</i> = 11.83, 3.02 Hz, 1 H), 2.14–2.48 (m, 4 H); <sup>19</sup>F NMR (376 MHz, chloroform-<i>d</i>) δ ppm −138.24 to −138.07 (m, 1 F), −140.70 to −140.50 (m, 1 F).</div></div><div id="sec5_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> (9<i>R</i>)-6-(2,3-Difluorophenyl)-5-oxo-6,7,8,9-tetrahydro-5<i>H</i>-cyclohepta[<i>b</i>]pyridin-9-yl 4-(2-Oxo-2,3-dihydro-1<i>H</i>-imidazo[4,5-<i>b</i>]pyridin-1-yl)piperidine-1-carboxylate (<b>12</b>)</h3><div class="NLM_p last">In an oven-dried 100 mL round-bottom flask was added <b>10</b> (112 mg, 0.389 mmol) (azeotroped with dry benzene) and <b>11</b><a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> (224 mg, 0.583 mmol) in DMF (3 mL) to give a light-yellow suspension under nitrogen. After cooling to −15 °C (ice/MeOH bath), NaHMDS (1.55 mL, 1.55 mmol, 1.0 M in THF) was added dropwise. The resulting yellow solution was stirred under nitrogen at −15 °C for 1 h. After gradually warming to −5 °C over 30 min, the reaction was quenched with NaHCO<sub>3</sub> solution and diluted with EtOAc. The phases were separated, and the aqueous layer was extracted with EtOAc twice. The combined organic layers were washed with brine, dried with Na<sub>2</sub>SO<sub>4</sub>, and concentrated to give a yellow oil. Purification by flash column chromotagraphy using 0–10% MeOH/CH<sub>2</sub>Cl<sub>2</sub> afforded the product (60 mg, 29%) as a white solid. Major component: <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i>) δ ppm 11.35 (br s, 1 H), 8.76 (br s, 1 H), 8.00–8.17 (m, 1 H), 7.88–8.00 (m, 1 H), 7.29–7.55 (m, 2 H), 6.82–7.19 (m, 4 H), 6.20 (br s, 1 H), 4.58 (br s, 1 H), 4.24–4.51 (m, 2 H), 4.12 (q, <i>J</i> = 7.22 Hz, 1 H), 2.75–3.17 (m, 2 H), 2.02–2.68 (m, 6 H), 1.89 (br s, 2 H).</div></div><div id="sec5_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> (9<i>R</i>)-6-(2,3-Difluorophenyl)-9-(triisopropylsilyloxy)-6,7,8,9-tetrahydro-5<i>H</i>-cyclohepta[<i>b</i>]pyridin-5-ol (<b>14</b>)</h3><div class="NLM_p last">In a 100 mL round-bottom flask was dissolved ketone <b>9</b> (510 mg, 1.144 mmol) (mainly trans with a trans/cis ratio of ∼6/1) in MeOH (5 mL) to give a colorless solution. NaBH<sub>4</sub> (87 mg, 2.289 mmol) was added, and the mixture was stirred at rt for 1 h. LCMS indicated complete conversion. MeOH was removed in vacuo, and the residue was partitioned between water and EtOAc. The phases were separated. The organic layer was washed with brine, dried, and concentrated to <b>14</b> (492 mg, 96%) as a light-yellow oil. The crude product was carried onto the next reaction without further purification and characterization.</div></div><div id="sec5_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> (5<i>S</i>,6<i>S</i>,9<i>R</i>)-6-(2,3-Difluorophenyl)-6,7,8,9-tetrahydro-5<i>H</i>-cyclohepta[<i>b</i>]pyridine-5,9-diol (<b>15</b>), (5<i>R</i>,6<i>S</i>,9<i>R</i>)-6-(2,3-Difluorophenyl)-9-((triisopropylsilyl)oxy)-6,7,8,9-tetrahydro-5<i>H</i>-cyclohepta[<i>b</i>]pyridin-5-ol (<b>16</b>), and (5<i>S</i>,6<i>R</i>,9<i>R</i>)-6-(2,3-Difluorophenyl)-6,7,8,9-tetrahydro-5<i>H</i>-cyclohepta[<i>b</i>]pyridine-5,9-diol (<b>17</b>)</h3><div class="NLM_p last">In a 100 mL round-bottom flask was dissolved <b>14</b> (224.3 mg, 0.501 mmol) in THF (4 mL) to give a colorless solution. TBAF (0.752 mL, 0.752 mmol) was added, and the mixture was stirred at rt for 2 h. LCMS indicated complete conversion of the major component while the minor one did not change. THF was removed in vacuo, and the residue was partitioned between water and EtOAc. The phases were separated, and the aqueous layer was extracted with EtOAc. The combined organic layer was washed with brine, dried with Na<sub>2</sub>SO<sub>4</sub>, and concentrated to give a tan oil. Flash column chromotagraphy using 0–50% EtOAc/hexane afforded intermediate <b>16</b> unchanged (38 mg, 17%) as a white crystalline solid and intermediate <b>15</b> (95 mg, 65%) as a colorless oil that solidified upon standing. Further elution up to 100% EtOAc afforded <b>17</b> (17.3 mg, 12%) as a colorless oil. Intermediate <b>15</b> was further crystallized, and single crystals were obtained. Its relative stereochemistry was proven by X-ray studies. <b>15</b>: MS (ESI) [M + H<sup>+</sup>] = 292.26; <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i>) δ ppm 8.45 (dd, <i>J</i> = 4.78, 1.26 Hz, 1 H), 8.10 (d, <i>J</i> = 7.81 Hz, 1 H), 7.24–7.36 (m, 1 H), 6.97–7.18 (m, 3 H), 5.77–6.44 (m, 1 H), 5.08 (d, <i>J</i> = 10.07 Hz, 1 H), 4.70–4.84 (m, 1 H), 2.93–3.08 (m, 1 H), 2.55 (br s, 1 H), 2.17–2.38 (m, 2 H), 2.04–2.13 (m, 1 H), 1.39–1.58 (m, 1 H); <sup>19</sup>F NMR (376 MHz, chloroform-<i>d</i>) δ ppm −137.35 to −136.88 (m, 1 F), −142.50 to −142.13 (m, 1 F); <sup>13</sup>C NMR (101 MHz, chloroform-<i>d</i>) δ ppm 157.58 (s, 1 C), 150.05–152.35 (dd, J = 12.5 and 199 Hz, 1 C), 147.63–149.87 (dd, J = 13.0 and 197 Hz, 1 C), 145.43 (s, 1 C), 136.62 (s, 1 C), 133.15 (s, 1 C), 132.69 (d, <i>J</i> = 11.56 Hz, 1 C), 124.36–124.79 (m, 1 C), 123.71 (br s, 1 C), 122.74 (s, 1 C), 115.75 (d, <i>J</i> = 16.96 Hz, 1 C), 71.37 (s, 1 C), 71.12 (s, 1 C), 46.21 (br s, 1 C), 35.70 (s, 1 C), 32.83 (s, 1 C). <b>16</b>: MS (ESI) [M + H<sup>+</sup>] = 448.43; <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i>) δ ppm 8.34–8.48 (m, 1 H), 7.62 (d, <i>J</i> = 7.55 Hz, 1 H), 7.15 (dd, <i>J</i> = 7.81, 4.78 Hz, 1 H), 6.89–7.05 (m, 1 H), 6.67–6.82 (m, 1 H), 6.24 (br s, 1 H), 5.81 (br s, 1 H), 5.38 (d, <i>J</i> = 4.78 Hz, 1 H), 3.93 (br s, 1 H), 2.59 (br s, 1 H), 2.31 (d, <i>J</i> = 4.53 Hz, 1 H), 2.13–2.25 (m, 1 H), 2.01–2.12 (m, <i>J</i> = 14.20, 7.07, 7.07, 3.65 Hz, 1 H), 1.85–2.01 (m, 1 H), 1.10–1.23 (m, 3 H), 1.02–1.08 (m, 9 H), 0.93–1.00 (m, 9 H). <b>17</b>: <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i>) δ ppm 8.11 (dd, <i>J</i> = 5.04, 1.51 Hz, 1 H), 7.55 (dd, <i>J</i> = 7.55, 1.51 Hz, 1 H), 7.43–7.51 (m, 1 H), 7.28 (s, 1 H), 6.99–7.16 (m, 3 H), 5.92 (br s, 1 H), 5.12 (d, <i>J</i> = 6.04 Hz, 1 H), 4.63 (br s, 1 H), 3.40 (d, <i>J</i> = 12.09 Hz, 1 H), 2.76–2.98 (m, 1 H), 2.33–2.54 (m, 1 H), 1.90–2.03 (m, 1 H), 1.76–1.90 (m, 1 H); <sup>19</sup>F NMR (376 MHz, chloroform-<i>d</i>) δ ppm −138.96 to −138.49 (m, 1 F), −145.03 to −144.50 (m, 1 F).</div></div><div id="sec5_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> ((5<i>R</i>,6<i>S</i>,9<i>R</i>)-6-(2,3-Difluorophenyl)-6,7,8,9-tetrahydro-5<i>H</i>-cyclohepta[<i>b</i>]pyridine-5,9-diol (<b>18</b>)</h3><div class="NLM_p last">In a 100 mL round-bottom flask was dissolved <b>16</b> in THF (2 mL) to give a colorless solution. TBAF (0.407 mL, 0.407 mmol) was added, and the mixture was heated at 50 °C for 18h. LCMS showed complete conversion. The mixture was diluted with EtOAc and water. The phases were separated and the aqueous layer was extracted with EtOAc. The combined organic layers were washed with brine, dried with Na<sub>2</sub>SO<sub>4</sub>, and concentrated to give a tan oil. Flash column chromotagraphy using 0–50% EtOAc/hexane afforded the desired product (56 mg, 94%) as a white crystalline solid. Intermediate <b>18</b> was further crystallized, and single crystals were obtained. Its relative stereochemistry was proven by X-ray studies. MS (ESI) [M + H<sup>+</sup>] = 292.26; <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i>) δ ppm 8.37 (dd, <i>J</i> = 5.04, 1.51 Hz, 1 H), 7.52 (dd, <i>J</i> = 7.55, 1.51 Hz, 1 H), 7.37–7.49 (m, 1 H), 7.19 (dd, <i>J</i> = 7.30, 5.04 Hz, 1 H), 7.00–7.15 (m, 2 H), 5.96 (br s, 1 H), 5.23 (dd, <i>J</i> = 11.58, 2.27 Hz, 1 H), 4.78 (s, 1 H), 3.22–3.32 (m, 1 H), 3.10 (br s, 1 H), 2.74–2.89 (m, 1 H), 2.29 (dddd, <i>J</i> = 13.60, 5.16, 2.77, 2.64 Hz, 1 H), 1.77–1.91 (m, 1 H), 1.47–1.67 (m, 1 H); <sup>19</sup>F NMR (376 MHz, chloroform-<i>d</i>) δ ppm −138.73 to −138.11 (m, 1 F), −144.45 to −144.03 (m, 1 F); <sup>13</sup>C NMR (101 MHz, chloroform-<i>d</i>) δ ppm 160.75 (s, 1 C), 149.14–151.82 (dd, J = 14.0 and 246 Hz, 1 C), 146.49–149.15 (dd, J = 12.0 and 244 Hz, 1 C), 146.14 (s, 1 C), 136.75 (s, 1 C), 135.45 (s, 1 C), 134.93 (d, <i>J</i> = 10.79 Hz, 1 C), 123.79–124.30 (m, 1 C), 123.38 (s, 1 C), 122.20 (s, 1 C), 115.24 (d, <i>J</i> = 16.96 Hz, 1 C), 77.94 (s, 1 C), 70.62 (s, 1 C), 40.42 (s, 1 C), 36.62 (s, 1 C), 26.81 (s, 1 C).</div></div><div id="sec5_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> (5<i>S</i>,6<i>S</i>,9<i>R</i>)-6-(2,3-Difluorophenyl)-9-(triisopropylsilyloxy)-6,7,8,9-tetrahydro-5<i>H</i>-cyclohepta[<i>b</i>]pyridin-5-yl acetate (<b>20</b>)</h3><div class="NLM_p last">In a 250 mL round-bottom flask was dissolved <b>19</b> (1.0 g, 2.243 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (20 mL) to give a colorless solution. Acetic anhydride (0.423 mL, 4.49 mmol) and triethylamine (0.938 mL, 6.73 mmol) were added, followed by DMAP (0.055 g, 0.449 mmol). The mixture was stirred at rt under nitrogen. After 2 h, LCMS showed complete conversion. The mixture was quenched with NaHCO<sub>3</sub> solution and diluted with EtOAc. The phases were separated. The organic layer was washed with brine, dried, and concentrated to give a colorless oil (100%), which was immediately carried onto the next reaction without further purification and characterization. MS ESI) [M + H<sup>+</sup>] = 490.26.</div></div><div id="sec5_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> (5<i>S</i>,6<i>S</i>,9<i>R</i>)-6-(2,3-Difluorophenyl)-9-hydroxy-6,7,8,9-tetrahydro-5<i>H</i>-cyclohepta[<i>b</i>]pyridin-5-yl Acetate (<b>21</b>)</h3><div class="NLM_p last">In a 100 mL round-bottom flask was dissolved <b>20</b> (1.1 g, 2.243 mmol) (azeotroped with dry benzene) in THF (20 mL) to give a colorless solution. TBAF (2.69 mL, 2.69 mmol) was added, and the resulting light-yellow solution was stirred at rt for 2 h. LCMS indicated complete conversion. THF was removed in vacuo, and the residue was diluted with water and EtOAc. The phases were separated. The organic layer was washed with brine, dried, and concentrated to give a colorless oil. Purification by flash column chromotagraphy using 0–70% EtOAc/hexane afforded the desired product (648 mg, 87% for 2 steps) as a colorless oil. MS (ESI) [M + H<sup>+</sup>] = 334.21; <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i>) δ ppm 8.47 (dd, <i>J</i> = 4.78, 1.51 Hz, 1 H), 7.69 (d, <i>J</i> = 7.30 Hz, 1 H), 7.28 (dd, <i>J</i> = 7.81, 5.04 Hz, 1 H), 6.94–7.10 (m, 3 H), 6.20 (d, <i>J</i> = 10.32 Hz, 1 H), 5.95 (br s, 1 H), 4.95 (dd, <i>J</i> = 11.21, 1.64 Hz, 1 H), 3.16–3.31 (m, 1 H), 2.27–2.41 (m, 2 H), 2.06–2.19 (m, 1 H), 1.80 (s, 3 H), 1.48–1.63 (m, 1 H); <sup>13</sup>C NMR (101 MHz, chloroform-<i>d</i>) δ ppm 168.96 (s, 1 C), 157.96 (s, 1 C), 149.66–151.75 (d, J = 12.6 and 199 Hz, 1 C), 147.21–149.29 (d, J = 13 and 198 Hz, 1 C), 146.00 (s, 1 C), 133.43 (s, 1 C), 132.23 (d, <i>J</i> = 11.56 Hz, 1 C), 131.99 (s, 1 C), 123.90–124.24 (m, 1 C), 122.89 (br s, 1 C), 122.66 (s, 1 C), 115.36 (d, <i>J</i> = 16.95 Hz, 1 C), 72.77 (s, 1 C), 71.14 (s, 1 C), 42.12 (br s, 1 C), 35.66 (s, 1 C), 32.68 (s, 1 C), 20.28 (s, 1 C); <sup>19</sup>F NMR (376 MHz, chloroform-<i>d</i>) δ ppm −138.20 to −137.93 (m, 1 F), −143.38 to −143.16 (m, 1 F).</div></div><div id="sec5_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> (5<i>S</i>,6<i>S</i>,9<i>R</i>)-5-Acetoxy-6-(2,3-difluorophenyl)-6,7,8,9-tetrahydro-5<i>H</i>-cyclohepta[<i>b</i>]pyridin-9-yl 4-(2-Oxo-2,3-dihydro-1<i>H</i>-imidazo[4,5-<i>b</i>]pyridin-1-yl)piperidine-1-carboxylate (<b>22</b>)</h3><div class="NLM_p last">In an oven-dried 100 mL round-bottom flask was added <b>21</b> (96.7 mg, 0.290 mmol) (azeotroped with dry benzene) and 4-nitrophenyl 4-(2-oxo-2,3-dihydro-1<i>H</i>-imidazo[4,5-<i>b</i>]pyridin-1-yl)piperidine-1-carboxylate (167 mg, 0.435 mmol) in DMF (3 mL) to give a light-yellow suspension under nitrogen. After cooling to −15 °C (ice/MeOH bath), NaHMDS (0.870 mL, 0.870 mmol) was added dropwise. The resulting dark-red solution was stirred under nitrogen at −15 to 0 °C for 1 h. LCMS showed the desired product along with possible hydrolyzed product. After another 1 h at rt, complete hydrolysis was not achieved. The reaction was quenched with NaHCO<sub>3</sub> solution and volatile components removed in vacuo. The mixture was diluted with EtOAc. The phases were separated, and the aqueous layer was extracted with EtOAc twice. The combined organic layers were washed with brine, dried with Na<sub>2</sub>SO<sub>4</sub>, and concentrated to give a yellow oil. Purification by flash column chromotagraphy using 0–10% MeOH/CH<sub>2</sub>Cl<sub>2</sub> afforded the acetate-protected product (51 mg, 30%) as well as the final product alcohol <b>6</b> (20 mg, 13%).</div></div><div id="sec5_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> (5<i>R</i>,6<i>S</i>,9<i>R</i>)-5-Chloro-6-(2,3-difluorophenyl)-9-(triisopropylsilyloxy)-6,7,8,9-tetrahydro-5<i>H</i>-cyclohepta[<i>b</i>]pyridine (<b>23</b>)</h3><div class="NLM_p last">In an oven-dried 250 mL round-bottom flask was added <i>N</i>-chlorosuccinimide (0.751 g, 5.62 mmol) in THF (15 mL) to give a colorless suspension. Ph<sub>3</sub>P (1.475 g, 5.62 mmol) was added. After stirring under nitrogen for 5 min, <b>19</b> (1.0 g, 2.250 mmol) was added in one portion to the gray suspension. The resulting reddish suspension was stirred at rt. The solids gradually dissolved to give a tan solution. After 5 h, LCMS indicated complete conversion. THF was removed in vacuo. The remaining red oil was directly purified by flash column chromotagraphy (240 g silica column) using 10–100% EtOAc/hexane and then using 10% MeOH (with 2.0 M NH<sub>4</sub>OH) in CH<sub>2</sub>Cl<sub>2</sub>. The product fractions were combined and repurified by flash column chromotagraphy using 0–50% EtOAc/hexane to afford the desired product as a colorless oil (869 mg, 83%). MS (ESI) [M + H<sup>+</sup>] = 466.22; <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i>) δ ppm 8.55 (d, <i>J</i> = 3.53 Hz, 1 H), 7.63 (br s, 1 H), 7.20 (dd, <i>J</i> = 7.68, 4.91 Hz, 1 H), 7.01–7.15 (m, 1 H), 6.90–7.01 (m, 1 H), 6.66–6.90 (m, 1 H), 5.55–5.85 (m, 1 H), 5.40–5.56 (m, 1 H), 3.96–4.33 (m, 1 H), 2.33 (br s, 3 H), 2.09–2.20 (m, 1 H), 1.14–1.23 (m, 3 H), 1.04–1.14 (m, 9 H), 1.01 (d, <i>J</i> = 7.30 Hz, 9 H).</div></div><div id="sec5_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> (5<i>S</i>,6<i>S</i>,9<i>R</i>)-5-Azido-6-(2,3-difluorophenyl)-9-(triisopropylsilyloxy)-6,7,8,9-tetrahydro-5<i>H</i>-cyclohepta[<i>b</i>]pyridine (<b>24</b>)</h3><div class="NLM_p last">In a 100 mL round-bottom flask was dissolved <b>23</b> (566 mg, 1.214 mmol) in DMF (5 mL) to give a colorless solution. Sodium azide (474 mg, 7.29 mmol) was added, and the mixture was stirred at rt under nitrogen for 2.5 h. LCMS indicated only very little reaction. The mixture was heated at 50 °C overnight. After 15 h, LCMS indicated complete conversion with some elimination product. The mixture was diluted with water and EtOAc. The phases were separated. The organic layer was washed with brine, dried, and concentrated to a colorless oil. The crude product was carried onto the next reaction without further purification and characterization. Smaller scale purification afforded an analytical sample: MS (ESI) [M + H<sup>+</sup>] = 473.27; <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i>) δ ppm 8.52–8.63 (m, 1 H), 7.75 (d, <i>J</i> = 7.81 Hz, 1 H), 7.23–7.36 (m, 1 H), 6.95–7.17 (m, 2 H), 6.89 (br s, 1 H), 5.28 (d, <i>J</i> = 4.03 Hz, 1 H), 4.90 (d, <i>J</i> = 9.07 Hz, 1 H), 3.79 (t, <i>J</i> = 9.44 Hz, 1 H), 1.86–2.23 (m, 4 H), 1.16–1.30 (m, 3 H), 0.98–1.15 (m, 18 H); <sup>19</sup>F NMR (376 MHz, chloroform-<i>d</i>) δ ppm −137.68 to −137.36 (m, 1 F), −141.78 to −141.54 (m, 1 F).</div></div><div id="sec5_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> (5<i>S</i>,6<i>S</i>,9<i>R</i>)-5-Azido-6-(2,3-difluorophenyl)-6,7,8,9-tetrahydro-5<i>H</i>-cyclohepta[<i>b</i>]pyridin-9-ol (<b>25</b>)</h3><div class="NLM_p last">In a 100 mL round-bottom flask was dissolved <b>24</b> (0.732 g, 1.549 mmol) (crude) in THF (8 mL) to give a colorless solution. TBAF (1.859 mL, 1.859 mmol) was added, and the resulting light-yellow solution was stirred at rt for 1.5 h. LCMS indicated complete conversion. THF was removed in vacuo, and the residue was diluted with water and EtOAc. The phases were separated. The organic layer was washed with brine, dried, and concentrated to a light-yellow oil. Purification by flash column chromatography using 0–60% EtOAc/hexane afforded the desired product (crude weight 480 mg) as a colorless oil. Smaller scale purification afforded an analytical sample: MS (ESI) [M + H<sup>+</sup>] = 317.22; <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i>) δ ppm 8.51 (dd, <i>J</i> = 4.91, 1.38 Hz, 1 H), 7.99 (d, <i>J</i> = 7.30 Hz, 1 H), 7.35 (dd, <i>J</i> = 7.81, 5.04 Hz, 1 H), 7.06–7.20 (m, 2 H), 6.94–7.05 (m, 1 H), 5.91 (br s, 1 H), 5.03 (d, <i>J</i> = 10.32 Hz, 1 H), 4.92 (dd, <i>J</i> = 11.21, 2.39 Hz, 1 H), 2.84–3.02 (m, 1 H), 2.37–2.49 (m, 1 H), 2.25–2.36 (m, 1 H), 2.07–2.17 (m, <i>J</i> = 14.38, 4.94, 3.05, 3.05 Hz, 1 H), 1.40–1.64 (m, 1 H); <sup>13</sup>C NMR (101 MHz, chloroform-<i>d</i>) δ ppm 158.48 (s, 1 C), 152.19–149.87 (dd, <i>J</i> = 13.10 and 221 Hz, 1 C), 149.72–147.42 (dd, <i>J</i> = 13.87 and 219 Hz, 1 C), 146.16 (s, 1 C), 133.67 (s, 1 C), 133.23 (s, 1 C), 132.66 (d, <i>J</i> = 10.79 Hz, 1 C), 124.43 (dd, <i>J</i> = 6.94, 3.85 Hz, 1 C), 123.84 (br s, 1 C), 122.89 (s, 1 C), 115.98 (d, <i>J</i> = 17.73 Hz, 1 C), 70.94 (s, 1 C), 65.67 (s, 1 C), 45.43 (br s, 1 C), 35.71 (s, 1 C), 33.45 (s, 1 C); <sup>19</sup>F NMR (376 MHz, chloroform-<i>d</i>) δ ppm −137.55 to −137.20 (m, 1 F), −142.28 to −141.89 (m, 1 F).</div></div><div id="sec5_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> (5<i>S</i>,6<i>S</i>,9<i>R</i>)-5-Azido-6-(2,3-difluorophenyl)-6,7,8,9-tetrahydro-5<i>H</i>-cyclohepta[<i>b</i>]pyridin-9-yl 4-(2-Oxo-2,3-dihydro-1<i>H</i>-imidazo[4,5-<i>b</i>]pyridin-1-yl)piperidine-1-carboxylate (<b>26</b>)</h3><div class="NLM_p last">In a 100 mL round-bottom flask was added <b>25</b> (0.490 g, 1.549 mmol) (azeotroped with dry benzene) and 4-nitrophenyl 4-(2-oxo-2,3-dihydro-1<i>H</i>-imidazo[4,5-<i>b</i>]pyridin-1-yl)piperidine-1-carboxylate (0.713 g, 1.859 mmol) in DMF (8 mL) to give a light-yellow suspension under nitrogen. After cooling to −15 °C (ice/MeOH bath), NaHMDS (4.18 mL, 4.18 mmol) was added dropwise. The resulting tan solution was stirred under nitrogen at −10 to 0 °C for 2 h and at rt for 2 h. LCMS showed complete conversion. The reaction was quenched with NaHCO<sub>3</sub> solution. The mixture was diluted with EtOAc. The phases were separated, and the aqueous layer was extracted with EtOAc. The combined organic layers were washed with water, brine, dried with Na<sub>2</sub>SO<sub>4</sub>, and concentrated to give a tan oil. Purification by flash column chromotagraphy using 0–8% MeOH/CH<sub>2</sub>Cl<sub>2</sub> afforded the desired product (632 mg, 73% for 3 steps) as a light-yellow foam. MS (ESI) [M + H<sup>+</sup>] = 561.27; <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i>) δ ppm 11.50 (br s, 1 H), 8.58 (d, <i>J</i> = 3.78 Hz, 1 H), 8.11 (d, <i>J</i> = 5.04 Hz, 1 H), 7.91 (d, <i>J</i> = 7.30 Hz, 1 H), 7.33 (br s, 2 H), 7.07–7.19 (m, 2 H), 6.92–7.06 (m, 2 H), 6.10 (d, <i>J</i> = 9.32 Hz, 1 H), 5.23 (d, <i>J</i> = 10.07 Hz, 1 H), 4.26–4.84 (m, 3 H), 2.46–3.34 (m, 4 H), 2.20–2.43 (m, 3 H), 2.01–2.13 (m, 1 H), 1.94 (d, <i>J</i> = 12.34 Hz, 3 H); <sup>19</sup>F NMR (376 MHz, chloroform-<i>d</i>) δ ppm −137.30 to −137.01 (m, 1 F), −142.32 to −142.03 (m, 1 F).</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i27"><a href="/doi/suppl/10.1021/jm3013147">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_18702" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_18702" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">X-ray structures of intermediates <b>15</b> and <b>18</b> and biology experimental. This material is available free of charge via the Internet at <a href="http://pubs.acs.org" class="extLink">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm3013147/suppl_file/jm3013147_si_001.pdf">jm3013147_si_001.pdf (312.84 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/jm3013147" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_15007" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_15007" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Guanglin Luo</span> - <span class="hlFld-Affiliation affiliation">Molecular Sciences and Candidate Optimization, Disease Sciences
and Biologics, Bristol-Myers Squibb Research & Development, 5
Research Parkway, Wallingford, Connecticut 06492, United States</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#244351454a43484d4a0a48514b644649570a474b49"><span class="__cf_email__" data-cfemail="442331252a23282d2a6a28312b042629376a272b29">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ling Chen</span> - <span class="hlFld-Affiliation affiliation">Molecular Sciences and Candidate Optimization, Disease Sciences
and Biologics, Bristol-Myers Squibb Research & Development, 5
Research Parkway, Wallingford, Connecticut 06492, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Charles M. Conway</span> - <span class="hlFld-Affiliation affiliation">Molecular Sciences and Candidate Optimization, Disease Sciences
and Biologics, Bristol-Myers Squibb Research & Development, 5
Research Parkway, Wallingford, Connecticut 06492, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Rex Denton</span> - <span class="hlFld-Affiliation affiliation">Molecular Sciences and Candidate Optimization, Disease Sciences
and Biologics, Bristol-Myers Squibb Research & Development, 5
Research Parkway, Wallingford, Connecticut 06492, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Deborah Keavy</span> - <span class="hlFld-Affiliation affiliation">Molecular Sciences and Candidate Optimization, Disease Sciences
and Biologics, Bristol-Myers Squibb Research & Development, 5
Research Parkway, Wallingford, Connecticut 06492, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Laura Signor</span> - <span class="hlFld-Affiliation affiliation">Molecular Sciences and Candidate Optimization, Disease Sciences
and Biologics, Bristol-Myers Squibb Research & Development, 5
Research Parkway, Wallingford, Connecticut 06492, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Walter Kostich</span> - <span class="hlFld-Affiliation affiliation">Molecular Sciences and Candidate Optimization, Disease Sciences
and Biologics, Bristol-Myers Squibb Research & Development, 5
Research Parkway, Wallingford, Connecticut 06492, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kimberley A. Lentz</span> - <span class="hlFld-Affiliation affiliation">Molecular Sciences and Candidate Optimization, Disease Sciences
and Biologics, Bristol-Myers Squibb Research & Development, 5
Research Parkway, Wallingford, Connecticut 06492, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kenneth S. Santone</span> - <span class="hlFld-Affiliation affiliation">Molecular Sciences and Candidate Optimization, Disease Sciences
and Biologics, Bristol-Myers Squibb Research & Development, 5
Research Parkway, Wallingford, Connecticut 06492, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Richard Schartman</span> - <span class="hlFld-Affiliation affiliation">Molecular Sciences and Candidate Optimization, Disease Sciences
and Biologics, Bristol-Myers Squibb Research & Development, 5
Research Parkway, Wallingford, Connecticut 06492, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Marc Browning</span> - <span class="hlFld-Affiliation affiliation">Molecular Sciences and Candidate Optimization, Disease Sciences
and Biologics, Bristol-Myers Squibb Research & Development, 5
Research Parkway, Wallingford, Connecticut 06492, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Gary Tong</span> - <span class="hlFld-Affiliation affiliation">Molecular Sciences and Candidate Optimization, Disease Sciences
and Biologics, Bristol-Myers Squibb Research & Development, 5
Research Parkway, Wallingford, Connecticut 06492, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">John G. Houston</span> - <span class="hlFld-Affiliation affiliation">Molecular Sciences and Candidate Optimization, Disease Sciences
and Biologics, Bristol-Myers Squibb Research & Development, 5
Research Parkway, Wallingford, Connecticut 06492, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Gene M. Dubowchik</span> - <span class="hlFld-Affiliation affiliation">Molecular Sciences and Candidate Optimization, Disease Sciences
and Biologics, Bristol-Myers Squibb Research & Development, 5
Research Parkway, Wallingford, Connecticut 06492, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">John E. Macor</span> - <span class="hlFld-Affiliation affiliation">Molecular Sciences and Candidate Optimization, Disease Sciences
and Biologics, Bristol-Myers Squibb Research & Development, 5
Research Parkway, Wallingford, Connecticut 06492, United States</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d1677e2369-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i28">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_40310" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_40310" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">A generous supply of alcohol <b>19</b> from our Process group is greatly appreciated. We thank Alicia Ng and Dr. Qi Gao for the X-ray structures of diols <b>15</b> and <b>18</b> and the members of Discovery Analytical Sciences for detailed characterizations.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i29" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i29"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i30" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i30"> Abbreviations Used</h2><tr><td class="NLM_term">CGRP</td><td class="NLM_def"><p class="first last">calcitonin gene-related peptide</p></td></tr><tr><td class="NLM_term">CLP</td><td class="NLM_def"><p class="first last">calcitonin receptor-like receptor</p></td></tr><tr><td class="NLM_term">RAMP1</td><td class="NLM_def"><p class="first last">receptor activity modifying protein 1</p></td></tr><tr><td class="NLM_term">RCP</td><td class="NLM_def"><p class="first last">receptor component protein</p></td></tr><tr><td class="NLM_term">TBAF</td><td class="NLM_def"><p class="first last">tetrabutylammonium fluoride</p></td></tr><tr><td class="NLM_term">PAMPA</td><td class="NLM_def"><p class="first last">parallel artificial membrane permeability assay</p></td></tr><tr><td class="NLM_term">IV</td><td class="NLM_def"><p class="first last">intravenous</p></td></tr><tr><td class="NLM_term"><i>F</i><sub>po</sub></td><td class="NLM_def"><p class="first last">oral bioavailability</p></td></tr><tr><td class="NLM_term">SC</td><td class="NLM_def"><p class="first last">subcutaneous</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i31">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_04005" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_04005" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 22 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Hu, X. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Markson, L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lipton, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stewart., W. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berger, M. L.</span><span> </span><span class="NLM_article-title">Burden of Migraine in the United States: Disability and Economic Costs</span> <span class="citation_source-journal">Arch. Intern. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">159</span><span class="NLM_x">, </span> <span class="NLM_fpage">813</span><span class="NLM_x">–</span> <span class="NLM_lpage">818</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm3013147&amp;key=10.1001%2Farchinte.159.8.813" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm3013147&amp;key=10219926" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm3013147&amp;key=1%3ACAS%3A280%3ADyaK1M3jsFegsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=159&publication_year=1999&pages=813-818&author=X.+H.+Huauthor=L.+E.+Marksonauthor=R.+B.+Liptonauthor=W.+F.+Stewart.author=M.+L.+Berger&title=Burden+of+Migraine+in+the+United+States%3A+Disability+and+Economic+Costs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Burden of migraine in the United States: disability and economic costs</span></div><div class="casAuthors">Hu X H; Markson L E; Lipton R B; Stewart W F; Berger M L</div><div class="citationInfo"><span class="NLM_cas:title">Archives of internal medicine</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">159</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">813-8</span>
        ISSN:<span class="NLM_cas:issn">0003-9926</span>.
    </div><div class="casAbstract">BACKGROUND:  Migraine is a common disabling disease but its economic burden has not been adequately quantified.  OBJECTIVE:  To estimate the burden of migraine in the United States with respect to disability and economic costs.  METHODS:  The following data sources were used: published data, the Baltimore County Migraine Study, MEDSTAT's MarketScan medical claims data set, and statistics from the Census Bureau and the Bureau of Labor Statistics.  Disability was expressed as bedridden days.  Charges for migraine-related treatment were used as direct cost inputs.  The human capital approach was used in the estimation of indirect costs.  RESULTS:  Migraineurs required 3.8 bed rest days for men and 5.6 days for women each year, resulting in a total of 112 million bedridden days.  Migraine costs American employers about $13 billion a year because of missed workdays and impaired work function; close to $8 billion was directly due to missed workdays.  Patients of both sexes aged 30 to 49 years incurred higher indirect costs compared with younger or older employed patients.  Annual direct medical costs for migraine care were about $1 billion and about $100 was spent per diagnosed patient.  Physician office visits accounted for about 60% of all costs; in contrast, emergency department visits contributed less than 1% of the direct costs.  CONCLUSIONS:  The economic burden of migraine predominantly falls on patients and their employers in the form of bedridden days and lost productivity.  Various screening and treatment regimens should be evaluated to identify opportunities to reduce the disease burden.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTrOdrohggHIzUE-swuRqsHfW6udTcc2eYINBrXfrOk_rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK1M3jsFegsA%253D%253D&md5=0def3c32ae10cac85a007cb62c6343c6</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1001%2Farchinte.159.8.813&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1001%252Farchinte.159.8.813%26sid%3Dliteratum%253Aachs%26aulast%3DHu%26aufirst%3DX.%2BH.%26aulast%3DMarkson%26aufirst%3DL.%2BE.%26aulast%3DLipton%26aufirst%3DR.%2BB.%26aulast%3DStewart.%26aufirst%3DW.%2BF.%26aulast%3DBerger%26aufirst%3DM.%2BL.%26atitle%3DBurden%2520of%2520Migraine%2520in%2520the%2520United%2520States%253A%2520Disability%2520and%2520Economic%2520Costs%26jtitle%3DArch.%2520Intern.%2520Med.%26date%3D1999%26volume%3D159%26spage%3D813%26epage%3D818" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Graham, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolff, H. G.</span><span> </span><span class="NLM_article-title">Mechanism of migraine headache and the action of ergotamine tartrate</span> <span class="citation_source-journal">Arch. Neurol. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1938</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">737</span><span class="NLM_x">–</span> <span class="NLM_lpage">763</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm3013147&amp;key=10.1001%2Farchneurpsyc.1938.02270040093005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm3013147&amp;key=1%3ACAS%3A528%3ADyaA1cXkvVCjtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=1938&pages=737-763&author=J.+P.+Grahamauthor=H.+G.+Wolff&title=Mechanism+of+migraine+headache+and+the+action+of+ergotamine+tartrate"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanism of migraine headache and action of ergotamine tartrate</span></div><div class="casAuthors">Graham, J. R.; Wolff, H. G.</div><div class="citationInfo"><span class="NLM_cas:title">Archives of Neurology and Psychiatry</span>
        (<span class="NLM_cas:date">1938</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">737-63</span>CODEN:
                <span class="NLM_cas:coden">ANPSAI</span>;
        ISSN:<span class="NLM_cas:issn">0096-6754</span>.
    </div><div class="casAbstract">See C. A. 32, 3824.6.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqM0aZpru8Z2rVg90H21EOLACvtfcHk0lhjHnkAwd72SA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaA1cXkvVCjtQ%253D%253D&md5=e30731ad6d779369a228cc783d930089</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1001%2Farchneurpsyc.1938.02270040093005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1001%252Farchneurpsyc.1938.02270040093005%26sid%3Dliteratum%253Aachs%26aulast%3DGraham%26aufirst%3DJ.%2BP.%26aulast%3DWolff%26aufirst%3DH.%2BG.%26atitle%3DMechanism%2520of%2520migraine%2520headache%2520and%2520the%2520action%2520of%2520ergotamine%2520tartrate%26jtitle%3DArch.%2520Neurol.%2520Psychiatry%26date%3D1938%26volume%3D39%26spage%3D737%26epage%3D763" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Olesen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burstein, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ashina, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tfelt-Hansen, P.</span><span> </span><span class="NLM_article-title">Origin of pain in migraine: evidence for peripheral sensitisation</span> <span class="citation_source-journal">Lancet Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">679</span><span class="NLM_x">–</span> <span class="NLM_lpage">690</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm3013147&amp;key=10.1016%2FS1474-4422%2809%2970090-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm3013147&amp;key=19539239" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm3013147&amp;key=1%3ACAS%3A280%3ADC%252BD1Mvjt1ynsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2009&pages=679-690&author=J.+Olesenauthor=R.+Bursteinauthor=M.+Ashinaauthor=P.+Tfelt-Hansen&title=Origin+of+pain+in+migraine%3A+evidence+for+peripheral+sensitisation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Origin of pain in migraine: evidence for peripheral sensitisation</span></div><div class="casAuthors">Olesen Jes; Burstein Rami; Ashina Messoud; Tfelt-Hansen Peer</div><div class="citationInfo"><span class="NLM_cas:title">The Lancet. Neurology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">679-90</span>
        ISSN:<span class="NLM_cas:issn">1474-4422</span>.
    </div><div class="casAbstract">Migraine is the most common neurological disorder, and much has been learned about its mechanisms in recent years.  However, the origin of painful impulses in the trigeminal nerve is still uncertain.  Despite the attention paid recently to the role of central sensitisation in migraine pathophysiology, in our view, neuronal hyperexcitability depends on activation of peripheral nociceptors.  Although the onset of a migraine attack might take place in deep-brain structures, some evidence indicates that the headache phase depends on nociceptive input from perivascular sensory nerve terminals.  The input from arteries is probably more important than the input from veins.  Several studies provide evidence for input from extracranial, dural, and pial arteries but, likewise, there is also evidence against all three of these locations.  On balance, afferents are most probably excited in all three territories or the importance of individual territories varies from patient to patient.  We suggest that migraine can be explained to patients as a disorder of the brain, and that the headache originates in the sensory fibres that convey pain signals from intracranial and extracranial blood vessels.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcThAEQji8-P8_h3YQQtAhNufW6udTcc2eaOXet3cRhYUbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1Mvjt1ynsQ%253D%253D&md5=a3bddb8ef7e49bdbcad68339552e00eb</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2FS1474-4422%2809%2970090-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1474-4422%252809%252970090-0%26sid%3Dliteratum%253Aachs%26aulast%3DOlesen%26aufirst%3DJ.%26aulast%3DBurstein%26aufirst%3DR.%26aulast%3DAshina%26aufirst%3DM.%26aulast%3DTfelt-Hansen%26aufirst%3DP.%26atitle%3DOrigin%2520of%2520pain%2520in%2520migraine%253A%2520evidence%2520for%2520peripheral%2520sensitisation%26jtitle%3DLancet%2520Neurol.%26date%3D2009%26volume%3D8%26spage%3D679%26epage%3D690" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Goadsby, P. J</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Charbit, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andreou, A. P</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akerman, S</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holland, P. R.</span><span> </span><span class="NLM_article-title">Neurobiology of migraine</span> <span class="citation_source-journal">Neuroscience</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">161</span><span class="NLM_x">, </span> <span class="NLM_fpage">327</span><span class="NLM_x">–</span> <span class="NLM_lpage">341</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=161&publication_year=2009&pages=327-341&author=P.+J+Goadsbyauthor=A.+R.+Charbitauthor=A.+P+Andreouauthor=S+Akermanauthor=P.+R.+Holland&title=Neurobiology+of+migraine"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGoadsby%26aufirst%3DP.%2BJ%26aulast%3DCharbit%26aufirst%3DA.%2BR.%26aulast%3DAndreou%26aufirst%3DA.%2BP%26aulast%3DAkerman%26aufirst%3DS%26aulast%3DHolland%26aufirst%3DP.%2BR.%26atitle%3DNeurobiology%2520of%2520migraine%26jtitle%3DNeuroscience%26date%3D2009%26volume%3D161%26spage%3D327%26epage%3D341" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">van Rossum, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanisch, U. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quirion, R.</span><span> </span><span class="NLM_article-title">Neuroanatomical localization, pharmacological characterization and functions of CGRP, related peptides and their receptors</span> <span class="citation_source-journal">Neurosci. Biobehav. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">649</span><span class="NLM_x">–</span> <span class="NLM_lpage">678</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=1997&pages=649-678&author=D.+van+Rossumauthor=U.+K.+Hanischauthor=R.+Quirion&title=Neuroanatomical+localization%2C+pharmacological+characterization+and+functions+of+CGRP%2C+related+peptides+and+their+receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3Dvan%2BRossum%26aufirst%3DD.%26aulast%3DHanisch%26aufirst%3DU.%2BK.%26aulast%3DQuirion%26aufirst%3DR.%26atitle%3DNeuroanatomical%2520localization%252C%2520pharmacological%2520characterization%2520and%2520functions%2520of%2520CGRP%252C%2520related%2520peptides%2520and%2520their%2520receptors%26jtitle%3DNeurosci.%2520Biobehav.%2520Rev.%26date%3D1997%26volume%3D21%26spage%3D649%26epage%3D678" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Goadsby, P. J.</span><span> </span><span class="NLM_article-title">Calcitonin gene-related peptide antagonists as treatments of migraine and other primary headaches</span> <span class="citation_source-journal">Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">65</span><span class="NLM_x">, </span> <span class="NLM_fpage">2557</span><span class="NLM_x">–</span> <span class="NLM_lpage">2567</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2005&pages=2557-2567&author=P.+J.+Goadsby&title=Calcitonin+gene-related+peptide+antagonists+as+treatments+of+migraine+and+other+primary+headaches"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGoadsby%26aufirst%3DP.%2BJ.%26atitle%3DCalcitonin%2520gene-related%2520peptide%2520antagonists%2520as%2520treatments%2520of%2520migraine%2520and%2520other%2520primary%2520headaches%26jtitle%3DDrugs%26date%3D2005%26volume%3D65%26spage%3D2557%26epage%3D2567" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit6b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Edvinsson, L.</span><span> </span><span class="NLM_article-title">Blockade of CGRP receptors in the intracranial vasculature: a new target in the treatment of headache</span> <span class="citation_source-journal">Cephalalgia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">611</span><span class="NLM_x">–</span> <span class="NLM_lpage">622</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2004&pages=611-622&author=L.+Edvinsson&title=Blockade+of+CGRP+receptors+in+the+intracranial+vasculature%3A+a+new+target+in+the+treatment+of+headache"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEdvinsson%26aufirst%3DL.%26atitle%3DBlockade%2520of%2520CGRP%2520receptors%2520in%2520the%2520intracranial%2520vasculature%253A%2520a%2520new%2520target%2520in%2520the%2520treatment%2520of%2520headache%26jtitle%3DCephalalgia%26date%3D2004%26volume%3D24%26spage%3D611%26epage%3D622" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit6c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Williamson, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hargreaves, R. J.</span><span> </span><span class="NLM_article-title">Neurogenic inflammation in the context of migraine</span> <span class="citation_source-journal">Microsc. Res. Tech.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">167</span><span class="NLM_x">–</span> <span class="NLM_lpage">178</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6c&amp;dbid=16&amp;doi=10.1021%2Fjm3013147&amp;key=10.1002%2Fjemt.1081" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6c&amp;dbid=8&amp;doi=10.1021%2Fjm3013147&amp;key=11301492" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6c&amp;dbid=32&amp;doi=10.1021%2Fjm3013147&amp;key=1%3ACAS%3A528%3ADC%252BD3MXjvVKrur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2001&pages=167-178&author=D.+J.+Williamsonauthor=R.+J.+Hargreaves&title=Neurogenic+inflammation+in+the+context+of+migraine"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6cR"><div class="casContent"><span class="casTitleNuber">6c</span><div class="casTitle"><span class="NLM_cas:atitle">Neurogenic inflammation in the context of migraine</span></div><div class="casAuthors">Williamson, David J.; Hargreaves, Richard J.</div><div class="citationInfo"><span class="NLM_cas:title">Microscopy Research and Technique</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">167-178</span>CODEN:
                <span class="NLM_cas:coden">MRTEEO</span>;
        ISSN:<span class="NLM_cas:issn">1059-910X</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">A review with refs.  Despite considerable research into the pathogenesis of idiopathic headaches, such as migraine, the pathophysiol. mechanisms underlying them remain poorly understood.  Although it is well established that the trigeminal nerve becomes activated during migraine, the consequences of this activation remain controversial.  One theory, based on preclin. observations, is that activation of trigeminal sensory fibers leads to a painful neurogenic inflammation within the meningeal (dural) vasculature mediated by neuropeptide release from trigeminal sensory fibers and characterized by plasma protein extravasation, vasodilation, and mast cell degranulation.  Effective antimigraine agents such as ergots, triptans, opioids, and valproate inhibit preclin. neurogenic dural extravasation, suggesting that this activity may be a predictor of potential clin. efficacy of novel agents.  However, several clin. trials with other agents that inhibit this process preclinically have failed to show efficacy in the acute treatment of migraine in man.  Alternatively, it has been proposed that painful neurogenic vasodilation of meningeal blood vessels could be a key component of the inflammatory process during migraine headache.  This view is supported by the observation that jugular plasma levels of the potent vasodilator, calcitonin gene-related peptide (CGRP) are elevated during the headache and normalized by successful sumatriptan treatment.  Preclinically, activation of trigeminal sensory fibers evokes a CGRP-mediated neurogenic dural vasodilation, which is blocked by dihydroergotamine, triptans, and opioids but unaffected by NK1 receptor antagonists that failed in clin. trials.  These observations suggest that CGRP release with assocd. neurogenic dural vasodilation may be important in the generation of migraine pain, a theory that would ultimately be tested by the clin. testing of a CGRP receptor antagonist.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoEGuy5ewVpVbVg90H21EOLACvtfcHk0liYy_-dn0z8Og"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXjvVKrur0%253D&md5=a2639c17392a170b3a9499bdfbdd2247</span></div><a href="/servlet/linkout?suffix=cit6c&amp;dbid=16384&amp;doi=10.1002%2Fjemt.1081&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjemt.1081%26sid%3Dliteratum%253Aachs%26aulast%3DWilliamson%26aufirst%3DD.%2BJ.%26aulast%3DHargreaves%26aufirst%3DR.%2BJ.%26atitle%3DNeurogenic%2520inflammation%2520in%2520the%2520context%2520of%2520migraine%26jtitle%3DMicrosc.%2520Res.%2520Tech.%26date%3D2001%26volume%3D53%26spage%3D167%26epage%3D178" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Recober, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Russo, A. F.</span><span> </span><span class="NLM_article-title">Calcitonin gene-related peptide: an update on the biology</span> <span class="citation_source-journal">Curr. Opin. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">241</span><span class="NLM_x">–</span> <span class="NLM_lpage">246</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm3013147&amp;key=10.1097%2FWCO.0b013e32832b2427" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm3013147&amp;key=19434786" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm3013147&amp;key=1%3ACAS%3A528%3ADC%252BD1MXlsVeqsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2009&pages=241-246&author=A.+Recoberauthor=A.+F.+Russo&title=Calcitonin+gene-related+peptide%3A+an+update+on+the+biology"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Calcitonin gene-related peptide: an update on the biology</span></div><div class="casAuthors">Recober, Ana; Russo, Andrew F.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Neurology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">241-246</span>CODEN:
                <span class="NLM_cas:coden">CONEEX</span>;
        ISSN:<span class="NLM_cas:issn">1350-7540</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Purpose of review: This review includes the most relevant and recent studies on the biol. of calcitonin gene-related peptide (CGRP) as it pertains to primary headaches and particularly to migraine.  Especial attention was given to those published within the last year.  Recent findings: The development of CGRP receptor antagonists is discussed in detail, as well as recent advances in our understanding of CGRP actions in migraine.  Finally, other important functions of CGRP outside of the nervous system are briefly discussed.  Summary: The advent of CGRP receptor antagonists as a novel therapy for migraine attacks may represent a new era in the acute management of migraine.  More than a simple addn. to the currently available treatments, this group of drugs may become an outstanding option for patients with cardiovascular disease, given the lack of assocd. vasoconstriction.  Furthermore, nonpeptide CGRP receptor antagonists, CGRP antibodies and CGRP-binding RNA-Spiegelmer are valuable research tools that will further advance our understanding of migraine pathophysiol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo2sEn4kbfdM7Vg90H21EOLACvtfcHk0liYy_-dn0z8Og"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXlsVeqsLs%253D&md5=a202b91719ad347b88efd0d1371e61f2</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1097%2FWCO.0b013e32832b2427&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FWCO.0b013e32832b2427%26sid%3Dliteratum%253Aachs%26aulast%3DRecober%26aufirst%3DA.%26aulast%3DRusso%26aufirst%3DA.%2BF.%26atitle%3DCalcitonin%2520gene-related%2520peptide%253A%2520an%2520update%2520on%2520the%2520biology%26jtitle%3DCurr.%2520Opin.%2520Neurol.%26date%3D2009%26volume%3D22%26spage%3D241%26epage%3D246" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Olesen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diener, H. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Husstedt, I. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goadsby, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hall, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meier, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pollentier, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lesko, L. M.</span><span> </span><span class="NLM_article-title">Calcitonin gene related peptide receptor antagonist BIBN 4096 BS for the acute treatment of migraine</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">350</span><span class="NLM_x">, </span> <span class="NLM_fpage">1104</span><span class="NLM_x">–</span> <span class="NLM_lpage">1110</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm3013147&amp;key=10.1056%2FNEJMoa030505" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm3013147&amp;key=15014183" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm3013147&amp;key=1%3ACAS%3A528%3ADC%252BD2cXitV2qur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=350&publication_year=2004&pages=1104-1110&author=J.+Olesenauthor=H.+C.+Dienerauthor=I.+W.+Husstedtauthor=P.+J.+Goadsbyauthor=D.+Hallauthor=U.+Meierauthor=S.+Pollentierauthor=L.+M.+Lesko&title=Calcitonin+gene+related+peptide+receptor+antagonist+BIBN+4096+BS+for+the+acute+treatment+of+migraine"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Calcitonin gene-related peptide receptor antagonist BIBN 4096 BS for the acute treatment of migraine</span></div><div class="casAuthors">Olesen, Jes; Diener, Hans-Christoph; Husstedt, Ingo W.; Goadsby, Peter J.; Hall, David; Meier, Ulrich; Pollentier, Stephane; Lesko, Lynna M.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">350</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1104-1110</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">BACKGROUND: Calcitonin gene-related peptide (CGRP) may have a causative role in migraine.  We therefore hypothesized that a CGRP-receptor antagonist might be effective in the treatment of migraine attacks.  METHODS: In an international, multicenter, double-blind, randomized clin. trial of BIBN 4096 BS, a highly specific and potent nonpeptide CGRP-receptor antagonist, 126 patients with migraine received one of the following: placebo or 0.25, 0.5, 1, 2.5, 5, or 10 mg of BIBN 4096 BS i.v. over a period of 10 min.  A group-sequential adaptive treatment-assignment design was used to minimize the no. of patients exposed.  RESULTS: The 2.5-mg dose was selected, with a response rite of 66 %, as compared with 27 % for placebo (P = 0.001).  The BIBN 4096 BS group as a whole had a response rate of 60 %.  Significant superiority over placebo was also obsd. with respect to most secondary end points: the pain-free rate at 2 h; the rate of sustained response over a period of 24 h; the rate of recurrence of headache; improvement in nausea, photophobia, phonophobia, and functional capacity; and the time to meaningful relief.  An effect was apparent after 30 min and increased over the next few hours.  The overall rate of adverse events was 25 % after the 2.5-mg dose of the drug and 20 % for the BIBN 4096 BS group as a whole, as compared with 12 % for placebo.  The most frequent side effect was paresthesia.  There were no serious adverse events.  CONCLUSIONS: The CGRP antagonist BIBN 4096 BS was effective in treating acute attacks of migraine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpsmM0pM13jFLVg90H21EOLACvtfcHk0liYy_-dn0z8Og"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXitV2qur0%253D&md5=5eaed0182c6d0232507467ef7120515b</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa030505&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa030505%26sid%3Dliteratum%253Aachs%26aulast%3DOlesen%26aufirst%3DJ.%26aulast%3DDiener%26aufirst%3DH.%2BC.%26aulast%3DHusstedt%26aufirst%3DI.%2BW.%26aulast%3DGoadsby%26aufirst%3DP.%2BJ.%26aulast%3DHall%26aufirst%3DD.%26aulast%3DMeier%26aufirst%3DU.%26aulast%3DPollentier%26aufirst%3DS.%26aulast%3DLesko%26aufirst%3DL.%2BM.%26atitle%3DCalcitonin%2520gene%2520related%2520peptide%2520receptor%2520antagonist%2520BIBN%25204096%2520BS%2520for%2520the%2520acute%2520treatment%2520of%2520migraine%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2004%26volume%3D350%26spage%3D1104%26epage%3D1110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="note"><p class="first last">IDDB, Thomson Scientific reports that development of BIBN4096BS has been discontinued.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Paone, D. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaw, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, D. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burgey, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deng, J. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kane, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koblan, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salvatore, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mosser, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnston, V. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, B. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller-Stein, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hershey, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graham, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vacca, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, T. M.</span><span> </span><span class="NLM_article-title">Potent, Orally Bioavailable Calcitonin Gene-Related Peptide Receptor Antagonists for the Treatment of Migraine: Discovery of <i>N</i>-[(3<i>R</i>,6<i>S</i>)-6-(2,3-Difluorophenyl)-2-oxo-1- (2,2,2-trifluoroethyl)azepan-3-yl]-4-(2-oxo-2,3-dihydro-1<i>H</i>-imidazo[4,5-<i>b</i>]pyridin- 1-yl)piperidine-1-carboxamide (MK-0974)</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">5564</span><span class="NLM_x">–</span> <span class="NLM_lpage">5567</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm070668p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=5564-5567&author=D.+V.+Paoneauthor=A.+W.+Shawauthor=D.+N.+Nguyenauthor=C.+S.+Burgeyauthor=J.+Z.+Dengauthor=S.+A.+Kaneauthor=K.+S.+Koblanauthor=C.+A.+Salvatoreauthor=S.+D.+Mosserauthor=V.+K.+Johnstonauthor=B.+K.+Wongauthor=C.+M.+Miller-Steinauthor=J.+C.+Hersheyauthor=S.+L.+Grahamauthor=J.+P.+Vaccaauthor=T.+M.+Williams&title=Potent%2C+Orally+Bioavailable+Calcitonin+Gene-Related+Peptide+Receptor+Antagonists+for+the+Treatment+of+Migraine%3A+Discovery+of+N-%5B%283R%2C6S%29-6-%282%2C3-Difluorophenyl%29-2-oxo-1-+%282%2C2%2C2-trifluoroethyl%29azepan-3-yl%5D-4-%282-oxo-2%2C3-dihydro-1H-imidazo%5B4%2C5-b%5Dpyridin-+1-yl%29piperidine-1-carboxamide+%28MK-0974%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1021%2Fjm070668p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm070668p%26sid%3Dliteratum%253Aachs%26aulast%3DPaone%26aufirst%3DD.%2BV.%26aulast%3DShaw%26aufirst%3DA.%2BW.%26aulast%3DNguyen%26aufirst%3DD.%2BN.%26aulast%3DBurgey%26aufirst%3DC.%2BS.%26aulast%3DDeng%26aufirst%3DJ.%2BZ.%26aulast%3DKane%26aufirst%3DS.%2BA.%26aulast%3DKoblan%26aufirst%3DK.%2BS.%26aulast%3DSalvatore%26aufirst%3DC.%2BA.%26aulast%3DMosser%26aufirst%3DS.%2BD.%26aulast%3DJohnston%26aufirst%3DV.%2BK.%26aulast%3DWong%26aufirst%3DB.%2BK.%26aulast%3DMiller-Stein%26aufirst%3DC.%2BM.%26aulast%3DHershey%26aufirst%3DJ.%2BC.%26aulast%3DGraham%26aufirst%3DS.%2BL.%26aulast%3DVacca%26aufirst%3DJ.%2BP.%26aulast%3DWilliams%26aufirst%3DT.%2BM.%26atitle%3DPotent%252C%2520Orally%2520Bioavailable%2520Calcitonin%2520Gene-Related%2520Peptide%2520Receptor%2520Antagonists%2520for%2520the%2520Treatment%2520of%2520Migraine%253A%2520Discovery%2520of%2520N-%255B%25283R%252C6S%2529-6-%25282%252C3-Difluorophenyl%2529-2-oxo-1-%2520%25282%252C2%252C2-trifluoroethyl%2529azepan-3-yl%255D-4-%25282-oxo-2%252C3-dihydro-1H-imidazo%255B4%252C5-b%255Dpyridin-%25201-yl%2529piperidine-1-carboxamide%2520%2528MK-0974%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D5564%26epage%3D5567" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Hewitt, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lipton, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brandes, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ceesay, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gottwald, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schaefer, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lines, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ho, T. W.</span><span> </span><span class="NLM_article-title">Randomized Controlled Study of Telcagepant Plus Ibuprofen or Acetaminophen in Migraine</span> <span class="citation_source-journal">Headache</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">533</span><span class="NLM_x">–</span> <span class="NLM_lpage">543</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2011&pages=533-543&author=D.+J.+Hewittauthor=V.+Martinauthor=R.+B.+Liptonauthor=J.+Brandesauthor=P.+Ceesayauthor=R.+Gottwaldauthor=E.+Schaeferauthor=C.+Linesauthor=T.+W.+Ho&title=Randomized+Controlled+Study+of+Telcagepant+Plus+Ibuprofen+or+Acetaminophen+in+Migraine"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHewitt%26aufirst%3DD.%2BJ.%26aulast%3DMartin%26aufirst%3DV.%26aulast%3DLipton%26aufirst%3DR.%2BB.%26aulast%3DBrandes%26aufirst%3DJ.%26aulast%3DCeesay%26aufirst%3DP.%26aulast%3DGottwald%26aufirst%3DR.%26aulast%3DSchaefer%26aufirst%3DE.%26aulast%3DLines%26aufirst%3DC.%26aulast%3DHo%26aufirst%3DT.%2BW.%26atitle%3DRandomized%2520Controlled%2520Study%2520of%2520Telcagepant%2520Plus%2520Ibuprofen%2520or%2520Acetaminophen%2520in%2520Migraine%26jtitle%3DHeadache%26date%3D2011%26volume%3D51%26spage%3D533%26epage%3D543" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit11b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Tfelt-Hansen, P.</span><span> </span><span class="NLM_article-title">Excellent Tolerability but Relatively Low Initial Clinical Efficacy of Telcagepant in Migraine Headache</span> <span class="citation_source-journal">Headache</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">118</span><span class="NLM_x">–</span> <span class="NLM_lpage">123</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2011&pages=118-123&author=P.+Tfelt-Hansen&title=Excellent+Tolerability+but+Relatively+Low+Initial+Clinical+Efficacy+of+Telcagepant+in+Migraine+Headache"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTfelt-Hansen%26aufirst%3DP.%26atitle%3DExcellent%2520Tolerability%2520but%2520Relatively%2520Low%2520Initial%2520Clinical%2520Efficacy%2520of%2520Telcagepant%2520in%2520Migraine%2520Headache%26jtitle%3DHeadache%26date%3D2011%26volume%3D51%26spage%3D118%26epage%3D123" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit11c"><span><span class="NLM_label">(c) </span><div class="note"><p class="first last">Merck recently discontinued the development of telcagepant.</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Merck+recently+discontinued+the+development+of+telcagepant."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Bell, I. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallicchio, S. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quigley, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Craig, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stump, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">C. Blair Zartman, C. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fay, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, C.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lynch, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moore, E. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mosser, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prueksaritanont, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Regan, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roller, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salvatore, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kane, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vacca, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selnick, H. G.</span><span> </span><span class="NLM_article-title">Discovery of MK-3207: A Highly Potent, Orally Bioavailable CGRP Receptor Antagonist</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">24</span><span class="NLM_x">–</span> <span class="NLM_lpage">29</span></span><div class="citationLinks">[<a href="/doi/10.1021/ml900016y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm3013147&amp;key=1%3ACAS%3A528%3ADC%252BC3cXksFegsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2010&pages=24-29&author=I.+M.+Bellauthor=S.+N.+Gallicchioauthor=M.+R.+Woodauthor=A.+G.+Quigleyauthor=A.+Craigauthor=C.+A.+Stumpauthor=C.+B.+C.+Blair+Zartmanauthor=J.+F.+Fayauthor=C.-C.+Liauthor=J.+J.+Lynchauthor=E.+L.+Mooreauthor=S.+D.+Mosserauthor=T.+Prueksaritanontauthor=C.+P.+Reganauthor=S.+Rollerauthor=C.+A.+Salvatoreauthor=S.+A.+Kaneauthor=J.+P.+Vaccaauthor=H.+G.+Selnick&title=Discovery+of+MK-3207%3A+A+Highly+Potent%2C+Orally+Bioavailable+CGRP+Receptor+Antagonist"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of MK-3207: A Highly Potent, Orally Bioavailable CGRP Receptor Antagonist</span></div><div class="casAuthors">Bell, Ian M.; Gallicchio, Steven N.; Wood, Michael R.; Quigley, Amy G.; Stump, Craig A.; Zartman, C. Blair; Fay, John F.; Li, Chi-Chung; Lynch, Joseph J.; Moore, Eric L.; Mosser, Scott D.; Prueksaritanont, Thomayant; Regan, Christopher P.; Roller, Shane; Salvatore, Christopher A.; Kane, Stefanie A.; Vacca, Joseph P.; Selnick, Harold G.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">24-29</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Incorporation of polar functionality into a series of highly potent calcitonin gene-related peptide (CGRP) receptor antagonists was explored in an effort to improve pharmacokinetics.  This strategy identified piperazinone analogs that possessed improved soly. at acidic pH and increased oral bioavailability in monkeys.  Further optimization led to the discovery of the clin. candidate 2-[(8R)-8-(3,5-difluorophenyl)-10-oxo-6,9-diazaspiro[4.5]dec-9-yl]-N-[(2R)-2'-oxo-1,1',2',3-tetrahydrospiro[indene-2,3'-pyrrolo[2,3-b]pyridin]-5-yl]acetamide (MK-3207) (4), the most potent orally active CGRP receptor antagonist described to date.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoIThxRCo8aD7Vg90H21EOLACvtfcHk0li9Y2wNNvx73A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXksFegsQ%253D%253D&md5=2060a1762781cce87db2263731e9d85a</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1021%2Fml900016y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml900016y%26sid%3Dliteratum%253Aachs%26aulast%3DBell%26aufirst%3DI.%2BM.%26aulast%3DGallicchio%26aufirst%3DS.%2BN.%26aulast%3DWood%26aufirst%3DM.%2BR.%26aulast%3DQuigley%26aufirst%3DA.%2BG.%26aulast%3DCraig%26aufirst%3DA.%26aulast%3DStump%26aufirst%3DC.%2BA.%26aulast%3DC.%2BBlair%2BZartman%26aufirst%3DC.%2BB.%26aulast%3DFay%26aufirst%3DJ.%2BF.%26aulast%3DLi%26aufirst%3DC.-C.%26aulast%3DLynch%26aufirst%3DJ.%2BJ.%26aulast%3DMoore%26aufirst%3DE.%2BL.%26aulast%3DMosser%26aufirst%3DS.%2BD.%26aulast%3DPrueksaritanont%26aufirst%3DT.%26aulast%3DRegan%26aufirst%3DC.%2BP.%26aulast%3DRoller%26aufirst%3DS.%26aulast%3DSalvatore%26aufirst%3DC.%2BA.%26aulast%3DKane%26aufirst%3DS.%2BA.%26aulast%3DVacca%26aufirst%3DJ.%2BP.%26aulast%3DSelnick%26aufirst%3DH.%2BG.%26atitle%3DDiscovery%2520of%2520MK-3207%253A%2520A%2520Highly%2520Potent%252C%2520Orally%2520Bioavailable%2520CGRP%2520Receptor%2520Antagonist%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D1%26spage%3D24%26epage%3D29" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Diener, H.-C</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barbanti, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dahlöf, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reuter, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Habeck, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Podhorna, J.</span><span> </span><span class="NLM_article-title">BI 44370 TA, an oral CGRP antagonist for the treatment of acute migraine attacks: results from a phase II study</span> <span class="citation_source-journal">Cephalalgia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">573</span><span class="NLM_x">–</span> <span class="NLM_lpage">584</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2011&pages=573-584&author=H.-C+Dienerauthor=P.+Barbantiauthor=C.+Dahl%C3%B6fauthor=U.+Reuterauthor=J.+Habeckauthor=J.+Podhorna&title=BI+44370+TA%2C+an+oral+CGRP+antagonist+for+the+treatment+of+acute+migraine+attacks%3A+results+from+a+phase+II+study"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDiener%26aufirst%3DH.-C%26aulast%3DBarbanti%26aufirst%3DP.%26aulast%3DDahl%25C3%25B6f%26aufirst%3DC.%26aulast%3DReuter%26aufirst%3DU.%26aulast%3DHabeck%26aufirst%3DJ.%26aulast%3DPodhorna%26aufirst%3DJ.%26atitle%3DBI%252044370%2520TA%252C%2520an%2520oral%2520CGRP%2520antagonist%2520for%2520the%2520treatment%2520of%2520acute%2520migraine%2520attacks%253A%2520results%2520from%2520a%2520phase%2520II%2520study%26jtitle%3DCephalalgia%26date%3D2011%26volume%3D31%26spage%3D573%26epage%3D584" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="note"><p class="first last">Merck publicly anounced the discontinuation of MK-3207 due to toxicity, while there was no further public news about BI 44370.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Luo, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conway, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keavy, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denton, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kostich, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mercer, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schartman, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Signor, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lentz, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Browning, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macor, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dubowchik, G. M.</span><span> </span><span class="NLM_article-title">Discovery of BMS-846372, a Potent and Orally Active Human CGRP Receptor Antagonist for the Treatment of Migraine</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">337</span><span class="NLM_x">–</span> <span class="NLM_lpage">341</span></span><div class="citationLinks">[<a href="/doi/10.1021/ml300021s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm3013147&amp;key=1%3ACAS%3A528%3ADC%252BC38XivVCmtL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=337-341&author=G.+Luoauthor=L.+Chenauthor=C.+M.+Conwayauthor=D.+Keavyauthor=R.+Dentonauthor=W.+Kostichauthor=S.+Mercerauthor=R.+Schartmanauthor=L.+Signorauthor=K.+Lentzauthor=M.+Browningauthor=J.+E.+Macorauthor=G.+M.+Dubowchik&title=Discovery+of+BMS-846372%2C+a+Potent+and+Orally+Active+Human+CGRP+Receptor+Antagonist+for+the+Treatment+of+Migraine"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of BMS-846372, a Potent and Orally Active Human CGRP Receptor Antagonist for the Treatment of Migraine</span></div><div class="casAuthors">Luo, Guanglin; Chen, Ling; Conway, Charles M.; Denton, Rex; Keavy, Deborah; Gulianello, Michael; Huang, Yanling; Kostich, Walter; Lentz, Kimberley A.; Mercer, Stephen E.; Schartman, Richard; Signor, Laura; Browning, Marc; Macor, John E.; Dubowchik, Gene M.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">337-341</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Calcitonin gene-related peptide (CGRP) receptor antagonists have been clin. shown to be effective in the treatment of migraine, but identification of potent and orally bioavailable compds. has been challenging.  Herein, we describe the conceptualization, synthesis, and preclin. characterization of a potent, orally active CGRP receptor antagonist 5 (BMS-846372, I).  Compd. 5 has good oral bioavailability in rat, dog, and cynomolgus monkeys and overall attractive preclin. properties including strong (>50% inhibition) exposure-dependent in vivo efficacy in a marmoset migraine model.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTLc4IaUEHT7Vg90H21EOLACvtfcHk0lhOmJdTG7kmIQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XivVCmtL4%253D&md5=23c9624b0835dd459bdf4348fc66f623</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1021%2Fml300021s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml300021s%26sid%3Dliteratum%253Aachs%26aulast%3DLuo%26aufirst%3DG.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DConway%26aufirst%3DC.%2BM.%26aulast%3DKeavy%26aufirst%3DD.%26aulast%3DDenton%26aufirst%3DR.%26aulast%3DKostich%26aufirst%3DW.%26aulast%3DMercer%26aufirst%3DS.%26aulast%3DSchartman%26aufirst%3DR.%26aulast%3DSignor%26aufirst%3DL.%26aulast%3DLentz%26aufirst%3DK.%26aulast%3DBrowning%26aufirst%3DM.%26aulast%3DMacor%26aufirst%3DJ.%2BE.%26aulast%3DDubowchik%26aufirst%3DG.%2BM.%26atitle%3DDiscovery%2520of%2520BMS-846372%252C%2520a%2520Potent%2520and%2520Orally%2520Active%2520Human%2520CGRP%2520Receptor%2520Antagonist%2520for%2520the%2520Treatment%2520of%2520Migraine%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D3%26spage%3D337%26epage%3D341" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Luo, G.; Conway, C. M.; Everlof, G.; Lentz, K. A.; Schartman, R.; Macor, J. E.; Dubowchik, G. M.</span><div class="note"><p class="first last">Unpublished results</p></div>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Luo%2C+G.%3B+Conway%2C+C.+M.%3B+Everlof%2C+G.%3B+Lentz%2C+K.+A.%3B+Schartman%2C+R.%3B+Macor%2C+J.+E.%3B+Dubowchik%2C+G.+M.Unpublished+results."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dunpublished%26sid%3Dliteratum%253Aachs%26aulast%3DLuo%26aufirst%3DG." title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Leahy, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fan, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Desai, L. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanson, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sugiyama, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosner, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cuniere, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, Q.</span><span> </span><span class="NLM_article-title">Efficient and Scalable Enantioselective Synthesis of a CGRP antagonist</span> <span class="citation_source-journal">Org. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">4938</span><span class="NLM_x">–</span> <span class="NLM_lpage">4941</span></span><div class="citationLinks">[<a href="/doi/10.1021/ol302262q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm3013147&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhtlaju7bE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2012&pages=4938-4941&author=D.+K.+Leahyauthor=Y.+Fanauthor=L.+V.+Desaiauthor=C.+Chanauthor=J.+Zhuauthor=G.+Luoauthor=L.+Chenauthor=R.+L.+Hansonauthor=M.+Sugiyamaauthor=T.+Rosnerauthor=N.+Cuniereauthor=Z.+Guoauthor=Q.+Gao&title=Efficient+and+Scalable+Enantioselective+Synthesis+of+a+CGRP+antagonist"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Efficient and Scalable Enantioselective Synthesis of a CGRP Antagonist</span></div><div class="casAuthors">Leahy, David K.; Fan, Yu; Desai, Lopa V.; Chan, Collin; Zhu, Jason; Luo, Guanglin; Chen, Ling; Hanson, Ronald L.; Sugiyama, Masano; Rosner, Thorsten; Cuniere, Nicolas; Guo, Zhiwei; Hsiao, Yi; Gao, Qi</div><div class="citationInfo"><span class="NLM_cas:title">Organic Letters</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">4938-4941</span>CODEN:
                <span class="NLM_cas:coden">ORLEF7</span>;
        ISSN:<span class="NLM_cas:issn">1523-7052</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">An enantioselective synthesis of the CGRP antagonist BMS-846372, amenable to large scale prepn., is presented.  This new synthesis showcases a chemo- and enantioselective redn. of a cyclohepta[b]pyridine-5,9-dione as well as a Pd-catalyzed alpha-arylation reaction to form the key carbon-carbon bond and set the abs. and relative stereochem.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGod3XsfrjjvsrVg90H21EOLACvtfcHk0lhOmJdTG7kmIQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhtlaju7bE&md5=e3e51b78cfb9dc615d414fcdf99267f5</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1021%2Fol302262q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol302262q%26sid%3Dliteratum%253Aachs%26aulast%3DLeahy%26aufirst%3DD.%2BK.%26aulast%3DFan%26aufirst%3DY.%26aulast%3DDesai%26aufirst%3DL.%2BV.%26aulast%3DChan%26aufirst%3DC.%26aulast%3DZhu%26aufirst%3DJ.%26aulast%3DLuo%26aufirst%3DG.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DHanson%26aufirst%3DR.%2BL.%26aulast%3DSugiyama%26aufirst%3DM.%26aulast%3DRosner%26aufirst%3DT.%26aulast%3DCuniere%26aufirst%3DN.%26aulast%3DGuo%26aufirst%3DZ.%26aulast%3DGao%26aufirst%3DQ.%26atitle%3DEfficient%2520and%2520Scalable%2520Enantioselective%2520Synthesis%2520of%2520a%2520CGRP%2520antagonist%26jtitle%3DOrg.%2520Lett.%26date%3D2012%26volume%3D14%26spage%3D4938%26epage%3D4941" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Luo, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Civiello, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pin, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kostich, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelley, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conway, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macor, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dubowchik, G. M.</span><span> </span><span class="NLM_article-title">Calcitonin Gene-related Peptide (CGRP) Receptor Antagonists: Pyridine as a Replacement for a Core Amide Group</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">2917</span><span class="NLM_x">–</span> <span class="NLM_lpage">2921</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Fjm3013147&amp;key=10.1016%2Fj.bmcl.2012.02.065" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Fjm3013147&amp;key=22429470" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Fjm3013147&amp;key=1%3ACAS%3A528%3ADC%252BC38XktFSju7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=2917-2921&author=G.+Luoauthor=L.+Chenauthor=R.+Civielloauthor=S.+S.+Pinauthor=C.+Xuauthor=W.+Kostichauthor=M.+Kelleyauthor=C.+M.+Conwayauthor=J.+E.+Macorauthor=G.+M.+Dubowchik&title=Calcitonin+Gene-related+Peptide+%28CGRP%29+Receptor+Antagonists%3A+Pyridine+as+a+Replacement+for+a+Core+Amide+Group"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Calcitonin gene-related peptide (CGRP) receptor antagonists: Pyridine as a replacement for a core amide group</span></div><div class="casAuthors">Luo, Guanglin; Chen, Ling; Civiello, Rita; Pin, Sokhom S.; Xu, Cen; Kostich, Walter; Kelley, Michelle; Conway, Charles M.; Macor, John E.; Dubowchik, Gene M.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2917-2921</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">In our continuing efforts to identify CGRP receptor antagonists that can be dosed orally for the treatment of migraine headache, we have investigated a pyridine bioisosteric replacement of a polar amide portion of a previous lead compd., BMS-694153.  Pyridine derivs. were discovered and their SAR was studied.  Some of them showed excellent binding potency.  However, oral bioavailability was low, even for compds. with good Caco-2 cell permeability.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq0OTIfcyLurbVg90H21EOLACvtfcHk0lgV3T2NMHzAAA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XktFSju7o%253D&md5=d3746bdccb98d8b3a03e162f01c620bd</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2012.02.065&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2012.02.065%26sid%3Dliteratum%253Aachs%26aulast%3DLuo%26aufirst%3DG.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DCiviello%26aufirst%3DR.%26aulast%3DPin%26aufirst%3DS.%2BS.%26aulast%3DXu%26aufirst%3DC.%26aulast%3DKostich%26aufirst%3DW.%26aulast%3DKelley%26aufirst%3DM.%26aulast%3DConway%26aufirst%3DC.%2BM.%26aulast%3DMacor%26aufirst%3DJ.%2BE.%26aulast%3DDubowchik%26aufirst%3DG.%2BM.%26atitle%3DCalcitonin%2520Gene-related%2520Peptide%2520%2528CGRP%2529%2520Receptor%2520Antagonists%253A%2520Pyridine%2520as%2520a%2520Replacement%2520for%2520a%2520Core%2520Amide%2520Group%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D2917%26epage%3D2921" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="note"><p class="first last">See <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a> for details.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><div class="note"><p class="first last">The relative stereochemistry of <b>17</b> and <b>13</b> were not rigorously established. The absolute stereochemistry of <b>8</b> was established through extensive X-ray analysis of <b>8</b> and intermediate <b>23</b></p></div>: <span class="NLM_contrib-group">Qi, G. </span><div class="note"><p class="first last">Unpublished results</p></div>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=The+relative+stereochemistry+of+17+and+13+were+not+rigorously+established.+The+absolute+stereochemistry+of+8+was+established+through+extensive+X-ray+analysis+of+8+and+intermediate+23%3A+Qi%2C+G.+Unpublished+results."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dunpublished%26sid%3Dliteratum%253Aachs%26aulast%3DQi%26aufirst%3DG." title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><div class="note"><p class="first last">Compound <b>8</b> had marmoset CGRP receptor <i>K</i><sub>i</sub> of 0.0921 ± 1.5 nM (<i>n</i> = 2). For the description of all biologic assays, see also:</p></div><span class="NLM_contrib-group">Degnan, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaturvedula, P. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conway, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cook, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denton, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macci, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathias, N. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moench, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pin, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ren, S. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schartman, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Signor, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thalody, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Widmann, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macor, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dubowchik, G. M.</span><span> </span><span class="NLM_article-title">Discovery of (<i>R</i>)-4-(8-Fluoro-2-oxo-1,2-dihydroquinazolin-3(4<i>H</i>)-yl)-<i>N</i>-(3-(7-methyl-1<i>H</i>-indazol-5-yl)-1-oxo-1-(4-(piperidin-1-yl)piperidin-1-yl)propan-2-yl)piperidine-1-carboxamide (BMS-694153): A Potent Antagonist of the Human Calcitonin Gene-Related Peptide Receptor for Migraine with Rapid and Efficient Intranasal Exposure</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">4858</span><span class="NLM_x">–</span> <span class="NLM_lpage">4861</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm800546t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=4858-4861&author=A.+P.+Degnanauthor=P.+V.+Chaturvedulaauthor=C.+M.+Conwayauthor=D.+Cookauthor=C.+D.+Davisauthor=R.+Dentonauthor=X.+Hanauthor=R.+Macciauthor=N.+R.+Mathiasauthor=P.+Moenchauthor=S.+S.+Pinauthor=S.+X.+Renauthor=R.+Schartmanauthor=L.+Signorauthor=G.+Thalodyauthor=K.+A.+Widmannauthor=C.+Xuauthor=J.+E.+Macorauthor=G.+M.+Dubowchik&title=Discovery+of+%28R%29-4-%288-Fluoro-2-oxo-1%2C2-dihydroquinazolin-3%284H%29-yl%29-N-%283-%287-methyl-1H-indazol-5-yl%29-1-oxo-1-%284-%28piperidin-1-yl%29piperidin-1-yl%29propan-2-yl%29piperidine-1-carboxamide+%28BMS-694153%29%3A+A+Potent+Antagonist+of+the+Human+Calcitonin+Gene-Related+Peptide+Receptor+for+Migraine+with+Rapid+and+Efficient+Intranasal+Exposure"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Fjm800546t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm800546t%26sid%3Dliteratum%253Aachs%26aulast%3DDegnan%26aufirst%3DA.%2BP.%26aulast%3DChaturvedula%26aufirst%3DP.%2BV.%26aulast%3DConway%26aufirst%3DC.%2BM.%26aulast%3DCook%26aufirst%3DD.%26aulast%3DDavis%26aufirst%3DC.%2BD.%26aulast%3DDenton%26aufirst%3DR.%26aulast%3DHan%26aufirst%3DX.%26aulast%3DMacci%26aufirst%3DR.%26aulast%3DMathias%26aufirst%3DN.%2BR.%26aulast%3DMoench%26aufirst%3DP.%26aulast%3DPin%26aufirst%3DS.%2BS.%26aulast%3DRen%26aufirst%3DS.%2BX.%26aulast%3DSchartman%26aufirst%3DR.%26aulast%3DSignor%26aufirst%3DL.%26aulast%3DThalody%26aufirst%3DG.%26aulast%3DWidmann%26aufirst%3DK.%2BA.%26aulast%3DXu%26aufirst%3DC.%26aulast%3DMacor%26aufirst%3DJ.%2BE.%26aulast%3DDubowchik%26aufirst%3DG.%2BM.%26atitle%3DDiscovery%2520of%2520%2528R%2529-4-%25288-Fluoro-2-oxo-1%252C2-dihydroquinazolin-3%25284H%2529-yl%2529-N-%25283-%25287-methyl-1H-indazol-5-yl%2529-1-oxo-1-%25284-%2528piperidin-1-yl%2529piperidin-1-yl%2529propan-2-yl%2529piperidine-1-carboxamide%2520%2528BMS-694153%2529%253A%2520A%2520Potent%2520Antagonist%2520of%2520the%2520Human%2520Calcitonin%2520Gene-Related%2520Peptide%2520Receptor%2520for%2520Migraine%2520with%2520Rapid%2520and%2520Efficient%2520Intranasal%2520Exposure%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D4858%26epage%3D4861" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Conway, C. M.; Dubowchik, G. M.; Cook, D. A.; Signor, L. J.; Thalody, G.; Kostich, W. A.; Gulianello, M.; Huang, Y.; Denton, R.; Lentz, K. A.; Schartman, R.; Johnson, B. M.; Browning, M.; Luo, G.; Chen, L.; Macor, J. E.</span><div class="note"><p class="first last">Unpublished results</p></div>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Conway%2C+C.+M.%3B+Dubowchik%2C+G.+M.%3B+Cook%2C+D.+A.%3B+Signor%2C+L.+J.%3B+Thalody%2C+G.%3B+Kostich%2C+W.+A.%3B+Gulianello%2C+M.%3B+Huang%2C+Y.%3B+Denton%2C+R.%3B+Lentz%2C+K.+A.%3B+Schartman%2C+R.%3B+Johnson%2C+B.+M.%3B+Browning%2C+M.%3B+Luo%2C+G.%3B+Chen%2C+L.%3B+Macor%2C+J.+E.Unpublished+results."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dunpublished%26sid%3Dliteratum%253Aachs%26aulast%3DConway%26aufirst%3DC.%2BM." title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6a','cit6b','cit6c'],'ref7':['cit7'],'ref8':['cit8'],'ref9':[],'ref10':['cit10'],'ref11':['cit11a','cit11b','cit11c'],'ref12':['cit12'],'ref13':['cit13'],'ref14':[],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':[],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 41 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Paul D. Leeson, A. Patricia Bento, Anna Gaulton, Anne Hersey, Emma J. Manners, Chris J. Radoux, <span class="NLM_string-name hlFld-ContribAuthor">Andrew R. Leach</span>. </span><span class="cited-content_cbyCitation_article-title">Target-Based Evaluation of “Drug-Like” Properties and Ligand Efficiencies. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (11)
                                     , 7210-7230. <a href="https://doi.org/10.1021/acs.jmedchem.1c00416" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.1c00416</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.1c00416&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.1c00416%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DTarget-Based%252BEvaluation%252Bof%252B%2525E2%252580%25259CDrug-Like%2525E2%252580%25259D%252BProperties%252Band%252BLigand%252BEfficiencies%26aulast%3DLeeson%26aufirst%3DPaul%2BD.%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D08032021%26date%3D13052021%26volume%3D64%26issue%3D11%26spage%3D7210%26epage%3D7230" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Sarah J. Bucknell, Mark A. Ator, Alastair J. H. Brown, Jason Brown, Andrew D. Cansfield, Julie E. Cansfield, John A. Christopher, Miles Congreve, Gabriella Cseke, Francesca Deflorian, Christopher R. Jones, Jonathan S. Mason, M. Alistair O’Brien, Gregory R. Ott, Mark Pickworth, <span class="NLM_string-name hlFld-ContribAuthor">Stacey M. Southall</span>. </span><span class="cited-content_cbyCitation_article-title">Structure-Based Drug Discovery of N-((R)-3-(7-Methyl-1H-indazol-5-yl)-1-oxo-1-(((S)-1-oxo-3-(piperidin-4-yl)-1-(4-(pyridin-4-yl)piperazin-1-yl)propan-2-yl)amino)propan-2-yl)-2′-oxo-1′,2′-dihydrospiro[piperidine-4,4′-pyrido[2,3-d][1,3]oxazine]-1-carboxamide (HTL22562): A Calcitonin Gene-Related Peptide Receptor Antagonist for Acute Treatment of Migraine. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (14)
                                     , 7906-7920. <a href="https://doi.org/10.1021/acs.jmedchem.0c01003" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01003</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01003%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DStructure-Based%252BDrug%252BDiscovery%252Bof%252BN-%252528%252528R%252529-3-%2525287-Methyl-1H-indazol-5-yl%252529-1-oxo-1-%252528%252528%252528S%252529-1-oxo-3-%252528piperidin-4-yl%252529-1-%2525284-%252528pyridin-4-yl%252529piperazin-1-yl%252529propan-2-yl%252529amino%252529propan-2-yl%252529-2%2525E2%252580%2525B2-oxo-1%2525E2%252580%2525B2%25252C2%2525E2%252580%2525B2-dihydrospiro%25255Bpiperidine-4%25252C4%2525E2%252580%2525B2-pyrido%25255B2%25252C3-d%25255D%25255B1%25252C3%25255Doxazine%25255D-1-carboxamide%252B%252528HTL22562%252529%25253A%252BA%252BCalcitonin%252BGene-Related%252BPeptide%252BReceptor%252BAntagonist%252Bfor%252BAcute%252BTreatment%252Bof%252BMigraine%26aulast%3DBucknell%26aufirst%3DSarah%2BJ.%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D12062020%26date%3D08072020%26date%3D19062020%26volume%3D63%26issue%3D14%26spage%3D7906%26epage%3D7920" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Gene M. Dubowchik, Charles M. Conway, <span class="NLM_string-name hlFld-ContribAuthor">Alison W. Xin</span>. </span><span class="cited-content_cbyCitation_article-title">Blocking the CGRP Pathway for Acute and Preventive Treatment of Migraine: The Evolution of Success. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (13)
                                     , 6600-6623. <a href="https://doi.org/10.1021/acs.jmedchem.9b01810" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b01810</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b01810&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b01810%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DBlocking%252Bthe%252BCGRP%252BPathway%252Bfor%252BAcute%252Band%252BPreventive%252BTreatment%252Bof%252BMigraine%25253A%252BThe%252BEvolution%252Bof%252BSuccess%26aulast%3DDubowchik%26aufirst%3DGene%2BM.%26date%3D2020%26date%3D2020%26date%3D2019%26date%3D05112019%26date%3D20022020%26date%3D14022020%26volume%3D63%26issue%3D13%26spage%3D6600%26epage%3D6623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Guanglin  Luo</span>, <span class="hlFld-ContribAuthor ">Ling  Chen</span>, <span class="hlFld-ContribAuthor ">Charles M.  Conway</span>, <span class="hlFld-ContribAuthor ">Walter  Kostich</span>, <span class="hlFld-ContribAuthor ">Benjamin M.  Johnson</span>, <span class="hlFld-ContribAuthor ">Alicia  Ng</span>, <span class="hlFld-ContribAuthor ">John E.  Macor</span>, and <span class="hlFld-ContribAuthor ">Gene M.  Dubowchik</span>  . </span><span class="cited-content_cbyCitation_article-title">Asymmetric Synthesis of the Major Metabolite of a Calcitonin Gene-Related Peptide Receptor Antagonist and Mechanism of Epoxide Hydrogenolysis. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2017,</strong> <em>82 </em>
                                    (7)
                                     , 3710-3720. <a href="https://doi.org/10.1021/acs.joc.7b00052" title="DOI URL">https://doi.org/10.1021/acs.joc.7b00052</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.7b00052&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.7b00052%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DAsymmetric%252BSynthesis%252Bof%252Bthe%252BMajor%252BMetabolite%252Bof%252Ba%252BCalcitonin%252BGene-Related%252BPeptide%252BReceptor%252BAntagonist%252Band%252BMechanism%252Bof%252BEpoxide%252BHydrogenolysis%26aulast%3DLuo%26aufirst%3DGuanglin%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D25012017%26date%3D28032017%26date%3D07042017%26date%3D17032017%26volume%3D82%26issue%3D7%26spage%3D3710%26epage%3D3720" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Guanglin  Luo</span>, <span class="hlFld-ContribAuthor ">Ling  Chen</span>, <span class="hlFld-ContribAuthor ">Charles M.  Conway</span>, <span class="hlFld-ContribAuthor ">Walter  Kostich</span>, <span class="hlFld-ContribAuthor ">John E.  Macor</span>, and <span class="hlFld-ContribAuthor ">Gene M.  Dubowchik</span>  . </span><span class="cited-content_cbyCitation_article-title">Asymmetric Synthesis of Heterocyclic Analogues of a CGRP Receptor Antagonist for Treating Migraine. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2015,</strong> <em>17 </em>
                                    (24)
                                     , 5982-5985. <a href="https://doi.org/10.1021/acs.orglett.5b02921" title="DOI URL">https://doi.org/10.1021/acs.orglett.5b02921</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.5b02921&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.5b02921%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DAsymmetric%252BSynthesis%252Bof%252BHeterocyclic%252BAnalogues%252Bof%252Ba%252BCGRP%252BReceptor%252BAntagonist%252Bfor%252BTreating%252BMigraine%26aulast%3DLuo%26aufirst%3DGuanglin%26date%3D2015%26date%3D2015%26date%3D2015%26date%3D08102015%26date%3D09122015%26date%3D18122015%26volume%3D17%26issue%3D24%26spage%3D5982%26epage%3D5985" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ian M.  Bell</span>  . </span><span class="cited-content_cbyCitation_article-title">Calcitonin Gene-Related Peptide Receptor Antagonists: New Therapeutic Agents for Migraine. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>57 </em>
                                    (19)
                                     , 7838-7858. <a href="https://doi.org/10.1021/jm500364u" title="DOI URL">https://doi.org/10.1021/jm500364u</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm500364u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm500364u%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DCalcitonin%252BGene-Related%252BPeptide%252BReceptor%252BAntagonists%25253A%252BNew%252BTherapeutic%252BAgents%252Bfor%252BMigraine%26aulast%3DBell%26aufirst%3DIan%2BM.%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D07032014%26date%3D24062014%26date%3D09102014%26volume%3D57%26issue%3D19%26spage%3D7838%26epage%3D7858" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dehua  Yang</span>, <span class="hlFld-ContribAuthor ">Qingtong  Zhou</span>, <span class="hlFld-ContribAuthor ">Viktorija  Labroska</span>, <span class="hlFld-ContribAuthor ">Shanshan  Qin</span>, <span class="hlFld-ContribAuthor ">Sanaz  Darbalaei</span>, <span class="hlFld-ContribAuthor ">Yiran  Wu</span>, <span class="hlFld-ContribAuthor ">Elita  Yuliantie</span>, <span class="hlFld-ContribAuthor ">Linshan  Xie</span>, <span class="hlFld-ContribAuthor ">Houchao  Tao</span>, <span class="hlFld-ContribAuthor ">Jianjun  Cheng</span>, <span class="hlFld-ContribAuthor ">Qing  Liu</span>, <span class="hlFld-ContribAuthor ">Suwen  Zhao</span>, <span class="hlFld-ContribAuthor ">Wenqing  Shui</span>, <span class="hlFld-ContribAuthor ">Yi  Jiang</span>, <span class="hlFld-ContribAuthor ">Ming-Wei  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">G protein-coupled receptors: structure- and function-based drug discovery. </span><span class="cited-content_cbyCitation_journal-name">Signal Transduction and Targeted Therapy</span><span> <strong>2021,</strong> <em>6 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s41392-020-00435-w" title="DOI URL">https://doi.org/10.1038/s41392-020-00435-w</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41392-020-00435-w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41392-020-00435-w%26sid%3Dliteratum%253Aachs%26jtitle%3DSignal%2520Transduction%2520and%2520Targeted%2520Therapy%26atitle%3DG%252Bprotein-coupled%252Breceptors%25253A%252Bstructure-%252Band%252Bfunction-based%252Bdrug%252Bdiscovery%26aulast%3DYang%26aufirst%3DDehua%26date%3D2021%26date%3D2021%26volume%3D6%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Guanglin  Luo</span>, <span class="hlFld-ContribAuthor ">Xiang-Jun  Jiang</span>, <span class="hlFld-ContribAuthor ">Ling  Chen</span>, <span class="hlFld-ContribAuthor ">Charles M.  Conway</span>, <span class="hlFld-ContribAuthor ">Michael  Gulianello</span>, <span class="hlFld-ContribAuthor ">Walter  Kostich</span>, <span class="hlFld-ContribAuthor ">Deborah  Keavy</span>, <span class="hlFld-ContribAuthor ">Laura J.  Signor</span>, <span class="hlFld-ContribAuthor ">Ping  Chen</span>, <span class="hlFld-ContribAuthor ">Carl  Davis</span>, <span class="hlFld-ContribAuthor ">Valerie J.  Whiterock</span>, <span class="hlFld-ContribAuthor ">Richard  Schartman</span>, <span class="hlFld-ContribAuthor ">Kimberly A.  Widmann</span>, <span class="hlFld-ContribAuthor ">John E.  Macor</span>, <span class="hlFld-ContribAuthor ">Gene M.  Dubowchik</span>. </span><span class="cited-content_cbyCitation_article-title">Calcitonin gene-related peptide (CGRP) receptor antagonists: Heterocyclic modification of a novel azepinone lead. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2021,</strong> <em>43 </em>, 128077. <a href="https://doi.org/10.1016/j.bmcl.2021.128077" title="DOI URL">https://doi.org/10.1016/j.bmcl.2021.128077</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2021.128077&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2021.128077%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DCalcitonin%252Bgene-related%252Bpeptide%252B%252528CGRP%252529%252Breceptor%252Bantagonists%25253A%252BHeterocyclic%252Bmodification%252Bof%252Ba%252Bnovel%252Bazepinone%252Blead%26aulast%3DLuo%26aufirst%3DGuanglin%26date%3D2021%26volume%3D43%26spage%3D128077" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Michael L.  Garelja</span>, <span class="hlFld-ContribAuthor ">Christopher S.  Walker</span>, <span class="hlFld-ContribAuthor ">Debbie L.  Hay</span>. </span><span class="cited-content_cbyCitation_article-title">CGRP receptor antagonists for migraine. Are they also AMY
              1
              receptor antagonists?. </span><span class="cited-content_cbyCitation_journal-name">British Journal of Pharmacology</span><span> <strong>2021,</strong> <em>176 </em><a href="https://doi.org/10.1111/bph.15585" title="DOI URL">https://doi.org/10.1111/bph.15585</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/bph.15585&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fbph.15585%26sid%3Dliteratum%253Aachs%26jtitle%3DBritish%2520Journal%2520of%2520Pharmacology%26atitle%3DCGRP%252Breceptor%252Bantagonists%252Bfor%252Bmigraine.%252BAre%252Bthey%252Balso%252BAMY%252B1%252Breceptor%252Bantagonists%25253F%26aulast%3DGarelja%26aufirst%3DMichael%2BL.%26date%3D2021%26date%3D2021%26volume%3D176" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tessa  de Vries</span>, <span class="hlFld-ContribAuthor ">Linda  Al-Hassany</span>, <span class="hlFld-ContribAuthor ">Antoinette  MaassenVanDenBrink</span>. </span><span class="cited-content_cbyCitation_article-title">Evaluating rimegepant for the treatment of migraine. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Pharmacotherapy</span><span> <strong>2021,</strong> <em>22 </em>
                                    (8)
                                     , 973-979. <a href="https://doi.org/10.1080/14656566.2021.1895749" title="DOI URL">https://doi.org/10.1080/14656566.2021.1895749</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/14656566.2021.1895749&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F14656566.2021.1895749%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Pharmacotherapy%26atitle%3DEvaluating%252Brimegepant%252Bfor%252Bthe%252Btreatment%252Bof%252Bmigraine%26aulast%3Dde%2BVries%26aufirst%3DTessa%26date%3D2021%26date%3D2021%26volume%3D22%26issue%3D8%26spage%3D973%26epage%3D979" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alicia Potter  DeFalco</span>, <span class="hlFld-ContribAuthor ">Rachel  Lazim</span>, <span class="hlFld-ContribAuthor ">Nathan E.  Cope</span>. </span><span class="cited-content_cbyCitation_article-title">Rimegepant Orally Disintegrating Tablet for Acute Migraine Treatment: A Review. </span><span class="cited-content_cbyCitation_journal-name">Annals of Pharmacotherapy</span><span> <strong>2021,</strong> <em>55 </em>
                                    (5)
                                     , 650-657. <a href="https://doi.org/10.1177/1060028020954800" title="DOI URL">https://doi.org/10.1177/1060028020954800</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1177/1060028020954800&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1177%2F1060028020954800%26sid%3Dliteratum%253Aachs%26jtitle%3DAnnals%2520of%2520Pharmacotherapy%26atitle%3DRimegepant%252BOrally%252BDisintegrating%252BTablet%252Bfor%252BAcute%252BMigraine%252BTreatment%25253A%252BA%252BReview%26aulast%3DDeFalco%26aufirst%3DAlicia%2BPotter%26date%3D2021%26date%3D2020%26volume%3D55%26issue%3D5%26spage%3D650%26epage%3D657" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Golden L  Peters</span>, <span class="hlFld-ContribAuthor ">Erin K  Hennessey</span>. </span><span class="cited-content_cbyCitation_article-title">Rimegepant: acute treatment for migraine headaches. </span><span class="cited-content_cbyCitation_journal-name">Pain Management</span><span> <strong>2021,</strong> <em>11 </em>
                                    (3)
                                     , 259-266. <a href="https://doi.org/10.2217/pmt-2020-0090" title="DOI URL">https://doi.org/10.2217/pmt-2020-0090</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2217/pmt-2020-0090&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2217%2Fpmt-2020-0090%26sid%3Dliteratum%253Aachs%26jtitle%3DPain%2520Management%26atitle%3DRimegepant%25253A%252Bacute%252Btreatment%252Bfor%252Bmigraine%252Bheadaches%26aulast%3DPeters%26aufirst%3DGolden%2BL%26date%3D2021%26volume%3D11%26issue%3D3%26spage%3D259%26epage%3D266" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yingjie  Yu</span>, <span class="hlFld-ContribAuthor ">Aiyao  Liu</span>, <span class="hlFld-ContribAuthor ">Gagan  Dhawan</span>, <span class="hlFld-ContribAuthor ">Haibo  Mei</span>, <span class="hlFld-ContribAuthor ">Wei  Zhang</span>, <span class="hlFld-ContribAuthor ">Kunisuke  Izawa</span>, <span class="hlFld-ContribAuthor ">Vadim A.  Soloshonok</span>, <span class="hlFld-ContribAuthor ">Jianlin  Han</span>. </span><span class="cited-content_cbyCitation_article-title">Fluorine-containing pharmaceuticals approved by the FDA in 2020: Synthesis and biological activity. </span><span class="cited-content_cbyCitation_journal-name">Chinese Chemical Letters</span><span> <strong>2021,</strong> <em>198 </em><a href="https://doi.org/10.1016/j.cclet.2021.05.042" title="DOI URL">https://doi.org/10.1016/j.cclet.2021.05.042</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.cclet.2021.05.042&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.cclet.2021.05.042%26sid%3Dliteratum%253Aachs%26jtitle%3DChinese%2520Chemical%2520Letters%26atitle%3DFluorine-containing%252Bpharmaceuticals%252Bapproved%252Bby%252Bthe%252BFDA%252Bin%252B2020%25253A%252BSynthesis%252Band%252Bbiological%252Bactivity%26aulast%3DYu%26aufirst%3DYingjie%26date%3D2021%26volume%3D198" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shuo  Yuan</span>, <span class="hlFld-ContribAuthor ">Yong-Qiang  Luo</span>, <span class="hlFld-ContribAuthor ">Jia-Hui  Zuo</span>, <span class="hlFld-ContribAuthor ">Hui  Liu</span>, <span class="hlFld-ContribAuthor ">Fang  Li</span>, <span class="hlFld-ContribAuthor ">Bin  Yu</span>. </span><span class="cited-content_cbyCitation_article-title">New drug approvals for 2020: Synthesis and clinical applications. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>215 </em>, 113284. <a href="https://doi.org/10.1016/j.ejmech.2021.113284" title="DOI URL">https://doi.org/10.1016/j.ejmech.2021.113284</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2021.113284&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2021.113284%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DNew%252Bdrug%252Bapprovals%252Bfor%252B2020%25253A%252BSynthesis%252Band%252Bclinical%252Bapplications%26aulast%3DYuan%26aufirst%3DShuo%26date%3D2021%26volume%3D215%26spage%3D113284" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Daniel  Truong</span>, <span class="hlFld-ContribAuthor ">Brittany L.  Howard</span>, <span class="hlFld-ContribAuthor ">Philip E.  Thompson</span>. </span><span class="cited-content_cbyCitation_article-title">Regioselection in the synthesis of 4-benzyltetral-1-ones and the new 4-arylbenzosuber-1-ones. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron</span><span> <strong>2021,</strong> <em>85 </em>, 132034. <a href="https://doi.org/10.1016/j.tet.2021.132034" title="DOI URL">https://doi.org/10.1016/j.tet.2021.132034</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tet.2021.132034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tet.2021.132034%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%26atitle%3DRegioselection%252Bin%252Bthe%252Bsynthesis%252Bof%252B4-benzyltetral-1-ones%252Band%252Bthe%252Bnew%252B4-arylbenzosuber-1-ones%26aulast%3DTruong%26aufirst%3DDaniel%26date%3D2021%26volume%3D85%26spage%3D132034" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Stephen E.  Mercer</span>, <span class="hlFld-ContribAuthor ">Prasad V.  Chaturvedula</span>, <span class="hlFld-ContribAuthor ">Charles M.  Conway</span>, <span class="hlFld-ContribAuthor ">Deborah A.  Cook</span>, <span class="hlFld-ContribAuthor ">Carl D.  Davis</span>, <span class="hlFld-ContribAuthor ">Sokhom S.  Pin</span>, <span class="hlFld-ContribAuthor ">Robert  Macci</span>, <span class="hlFld-ContribAuthor ">Richard  Schartman</span>, <span class="hlFld-ContribAuthor ">Laura J.  Signor</span>, <span class="hlFld-ContribAuthor ">Kimberly A.  Widmann</span>, <span class="hlFld-ContribAuthor ">Valerie J.  Whiterock</span>, <span class="hlFld-ContribAuthor ">Ping  Chen</span>, <span class="hlFld-ContribAuthor ">Cen  Xu</span>, <span class="hlFld-ContribAuthor ">John J.  Herbst</span>, <span class="hlFld-ContribAuthor ">Walter A.  Kostich</span>, <span class="hlFld-ContribAuthor ">George  Thalody</span>, <span class="hlFld-ContribAuthor ">John E.  Macor</span>, <span class="hlFld-ContribAuthor ">Gene M.  Dubowchik</span>. </span><span class="cited-content_cbyCitation_article-title">Azepino-indazoles as calcitonin gene-related peptide (CGRP) receptor antagonists. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2021,</strong> <em>31 </em>, 127624. <a href="https://doi.org/10.1016/j.bmcl.2020.127624" title="DOI URL">https://doi.org/10.1016/j.bmcl.2020.127624</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2020.127624&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2020.127624%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DAzepino-indazoles%252Bas%252Bcalcitonin%252Bgene-related%252Bpeptide%252B%252528CGRP%252529%252Breceptor%252Bantagonists%26aulast%3DMercer%26aufirst%3DStephen%2BE.%26date%3D2021%26volume%3D31%26spage%3D127624" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">David Moreno  Ajona</span>, <span class="hlFld-ContribAuthor ">María Dolores Villar  Martínez</span>, <span class="hlFld-ContribAuthor ">Calvin  Chan</span>, <span class="hlFld-ContribAuthor ">Peter J.  Goadsby</span>. </span><span class="cited-content_cbyCitation_article-title">Migraine. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2021,</strong>,<a href="https://doi.org/10.1016/B978-0-12-820472-6.00083-9" title="DOI URL">https://doi.org/10.1016/B978-0-12-820472-6.00083-9</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-820472-6.00083-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-820472-6.00083-9%26sid%3Dliteratum%253Aachs%26atitle%3DMigraine%26aulast%3DAjona%26aufirst%3DDavid%2BMoreno%26date%3D2021%26pub%3DElsevier%26atitle%3DReference%252BModule%252Bin%252BBiomedical%252BSciences%26date%3D2021%26volume%3D122" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Inge A.  Mulder</span>, <span class="hlFld-ContribAuthor ">Mei  Li</span>, <span class="hlFld-ContribAuthor ">Tessa  Vries</span>, <span class="hlFld-ContribAuthor ">Tao  Qin</span>, <span class="hlFld-ContribAuthor ">Takeshi  Yanagisawa</span>, <span class="hlFld-ContribAuthor ">Kazutaka  Sugimoto</span>, <span class="hlFld-ContribAuthor ">Antoon  Bogaerdt</span>, <span class="hlFld-ContribAuthor ">A. H. Jan  Danser</span>, <span class="hlFld-ContribAuthor ">Marieke J. H.  Wermer</span>, <span class="hlFld-ContribAuthor ">Arn M. J. M.  Maagdenberg</span>, <span class="hlFld-ContribAuthor ">Antoinette  MaassenVanDenBrink</span>, <span class="hlFld-ContribAuthor ">Michel D.  Ferrari</span>, <span class="hlFld-ContribAuthor ">Cenk  Ayata</span>. </span><span class="cited-content_cbyCitation_article-title">Anti‐migraine Calcitonin Gene–Related Peptide Receptor Antagonists Worsen Cerebral Ischemic Outcome in Mice. </span><span class="cited-content_cbyCitation_journal-name">Annals of Neurology</span><span> <strong>2020,</strong> <em>88 </em>
                                    (4)
                                     , 771-784. <a href="https://doi.org/10.1002/ana.25831" title="DOI URL">https://doi.org/10.1002/ana.25831</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ana.25831&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fana.25831%26sid%3Dliteratum%253Aachs%26jtitle%3DAnnals%2520of%2520Neurology%26atitle%3DAnti%2525E2%252580%252590migraine%252BCalcitonin%252BGene%2525E2%252580%252593Related%252BPeptide%252BReceptor%252BAntagonists%252BWorsen%252BCerebral%252BIschemic%252BOutcome%252Bin%252BMice%26aulast%3DMulder%26aufirst%3DInge%2BA.%26date%3D2020%26date%3D2020%26volume%3D88%26issue%3D4%26spage%3D771%26epage%3D784" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">David  Moreno-Ajona</span>, <span class="hlFld-ContribAuthor ">Abigail  Pérez-Rodríguez</span>, <span class="hlFld-ContribAuthor ">Peter J.  Goadsby</span>. </span><span class="cited-content_cbyCitation_article-title">Small-molecule CGRP receptor antagonists: A new approach to the acute and preventive treatment of migraine. </span><span class="cited-content_cbyCitation_journal-name">Medicine in Drug Discovery</span><span> <strong>2020,</strong> <em>7 </em>, 100053. <a href="https://doi.org/10.1016/j.medidd.2020.100053" title="DOI URL">https://doi.org/10.1016/j.medidd.2020.100053</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.medidd.2020.100053&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.medidd.2020.100053%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicine%2520in%2520Drug%2520Discovery%26atitle%3DSmall-molecule%252BCGRP%252Breceptor%252Bantagonists%25253A%252BA%252Bnew%252Bapproach%252Bto%252Bthe%252Bacute%252Band%252Bpreventive%252Btreatment%252Bof%252Bmigraine%26aulast%3DMoreno-Ajona%26aufirst%3DDavid%26date%3D2020%26volume%3D7%26spage%3D100053" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kylie S.  Pan</span>, <span class="hlFld-ContribAuthor ">Andrew  Siow</span>, <span class="hlFld-ContribAuthor ">Debbie L.  Hay</span>, <span class="hlFld-ContribAuthor ">Christopher S.  Walker</span>. </span><span class="cited-content_cbyCitation_article-title">Antagonism of CGRP Signaling by Rimegepant at Two Receptors. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Pharmacology</span><span> <strong>2020,</strong> <em>11 </em><a href="https://doi.org/10.3389/fphar.2020.01240" title="DOI URL">https://doi.org/10.3389/fphar.2020.01240</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fphar.2020.01240&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffphar.2020.01240%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Pharmacology%26atitle%3DAntagonism%252Bof%252BCGRP%252BSignaling%252Bby%252BRimegepant%252Bat%252BTwo%252BReceptors%26aulast%3DPan%26aufirst%3DKylie%2BS.%26date%3D2020%26date%3D2020%26volume%3D11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tessa  de Vries</span>, <span class="hlFld-ContribAuthor ">Carlos M.  Villalón</span>, <span class="hlFld-ContribAuthor ">Antoinette  MaassenVanDenBrink</span>. </span><span class="cited-content_cbyCitation_article-title">Pharmacological treatment of migraine: CGRP and 5-HT beyond the triptans. </span><span class="cited-content_cbyCitation_journal-name">Pharmacology & Therapeutics</span><span> <strong>2020,</strong> <em>211 </em>, 107528. <a href="https://doi.org/10.1016/j.pharmthera.2020.107528" title="DOI URL">https://doi.org/10.1016/j.pharmthera.2020.107528</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.pharmthera.2020.107528&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.pharmthera.2020.107528%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmacology%2520%2526%2520Therapeutics%26atitle%3DPharmacological%252Btreatment%252Bof%252Bmigraine%25253A%252BCGRP%252Band%252B5-HT%252Bbeyond%252Bthe%252Btriptans%26aulast%3Dde%2BVries%26aufirst%3DTessa%26date%3D2020%26volume%3D211%26spage%3D107528" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kathleen  Mullin</span>, <span class="hlFld-ContribAuthor ">David  Kudrow</span>, <span class="hlFld-ContribAuthor ">Robert  Croop</span>, <span class="hlFld-ContribAuthor ">Meghan  Lovegren</span>, <span class="hlFld-ContribAuthor ">Charles M.  Conway</span>, <span class="hlFld-ContribAuthor ">Vladimir  Coric</span>, <span class="hlFld-ContribAuthor ">Richard B.  Lipton</span>. </span><span class="cited-content_cbyCitation_article-title">Potential for treatment benefit of small molecule CGRP receptor antagonist plus monoclonal antibody in migraine therapy. </span><span class="cited-content_cbyCitation_journal-name">Neurology</span><span> <strong>2020,</strong> <em>94 </em>
                                    (20)
                                     , e2121-e2125. <a href="https://doi.org/10.1212/WNL.0000000000008944" title="DOI URL">https://doi.org/10.1212/WNL.0000000000008944</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1212/WNL.0000000000008944&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1212%2FWNL.0000000000008944%26sid%3Dliteratum%253Aachs%26jtitle%3DNeurology%26atitle%3DPotential%252Bfor%252Btreatment%252Bbenefit%252Bof%252Bsmall%252Bmolecule%252BCGRP%252Breceptor%252Bantagonist%252Bplus%252Bmonoclonal%252Bantibody%252Bin%252Bmigraine%252Btherapy%26aulast%3DMullin%26aufirst%3DKathleen%26date%3D2020%26date%3D2020%26volume%3D94%26issue%3D20%26spage%3De2121%26epage%3De2125" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Thien Phu  Do</span>, <span class="hlFld-ContribAuthor ">Song  Guo</span>, <span class="hlFld-ContribAuthor ">Messoud  Ashina</span>. </span><span class="cited-content_cbyCitation_article-title">Therapeutic novelties in migraine: new drugs, new hope?. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Headache and Pain</span><span> <strong>2019,</strong> <em>20 </em>
                                    (1)
                                     <a href="https://doi.org/10.1186/s10194-019-0974-3" title="DOI URL">https://doi.org/10.1186/s10194-019-0974-3</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1186/s10194-019-0974-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1186%2Fs10194-019-0974-3%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Headache%2520and%2520Pain%26atitle%3DTherapeutic%252Bnovelties%252Bin%252Bmigraine%25253A%252Bnew%252Bdrugs%25252C%252Bnew%252Bhope%25253F%26aulast%3DDo%26aufirst%3DThien%2BPhu%26date%3D2019%26date%3D2019%26volume%3D20%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Robert  Croop</span>, <span class="hlFld-ContribAuthor ">Peter J  Goadsby</span>, <span class="hlFld-ContribAuthor ">David A  Stock</span>, <span class="hlFld-ContribAuthor ">Charles M  Conway</span>, <span class="hlFld-ContribAuthor ">Micaela  Forshaw</span>, <span class="hlFld-ContribAuthor ">Elyse G  Stock</span>, <span class="hlFld-ContribAuthor ">Vladimir  Coric</span>, <span class="hlFld-ContribAuthor ">Richard B  Lipton</span>. </span><span class="cited-content_cbyCitation_article-title">Efficacy, safety, and tolerability of rimegepant orally disintegrating tablet for the acute treatment of migraine: a randomised, phase 3, double-blind, placebo-controlled trial. </span><span class="cited-content_cbyCitation_journal-name">The Lancet</span><span> <strong>2019,</strong> <em>394 </em>
                                    (10200)
                                     , 737-745. <a href="https://doi.org/10.1016/S0140-6736(19)31606-X" title="DOI URL">https://doi.org/10.1016/S0140-6736(19)31606-X</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/S0140-6736(19)31606-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FS0140-6736%2819%2931606-X%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Lancet%26atitle%3DEfficacy%25252C%252Bsafety%25252C%252Band%252Btolerability%252Bof%252Brimegepant%252Borally%252Bdisintegrating%252Btablet%252Bfor%252Bthe%252Bacute%252Btreatment%252Bof%252Bmigraine%25253A%252Ba%252Brandomised%25252C%252Bphase%252B3%25252C%252Bdouble-blind%25252C%252Bplacebo-controlled%252Btrial%26aulast%3DCroop%26aufirst%3DRobert%26date%3D2019%26volume%3D394%26issue%3D10200%26spage%3D737%26epage%3D745" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Andrea  Negro</span>, <span class="hlFld-ContribAuthor ">Paolo  Martelletti</span>. </span><span class="cited-content_cbyCitation_article-title">Gepants for the treatment of migraine. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Investigational Drugs</span><span> <strong>2019,</strong> <em>28 </em>
                                    (6)
                                     , 555-567. <a href="https://doi.org/10.1080/13543784.2019.1618830" title="DOI URL">https://doi.org/10.1080/13543784.2019.1618830</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/13543784.2019.1618830&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F13543784.2019.1618830%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Investigational%2520Drugs%26atitle%3DGepants%252Bfor%252Bthe%252Btreatment%252Bof%252Bmigraine%26aulast%3DNegro%26aufirst%3DAndrea%26date%3D2019%26date%3D2019%26volume%3D28%26issue%3D6%26spage%3D555%26epage%3D567" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Roxana-Maria  Rujan</span>, <span class="hlFld-ContribAuthor ">Christopher A.  Reynolds</span>. </span><span class="cited-content_cbyCitation_article-title">Calcitonin Gene-Related Peptide Antagonists and Therapeutic Antibodies. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2018,</strong>,, 169-192. <a href="https://doi.org/10.1007/164_2018_173" title="DOI URL">https://doi.org/10.1007/164_2018_173</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/164_2018_173&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F164_2018_173%26sid%3Dliteratum%253Aachs%26atitle%3DCalcitonin%252BGene-Related%252BPeptide%252BAntagonists%252Band%252BTherapeutic%252BAntibodies%26aulast%3DRujan%26aufirst%3DRoxana-Maria%26date%3D2018%26date%3D2019%26spage%3D169%26epage%3D192%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DCalcitonin%252BGene-Related%252BPeptide%252B%252528CGRP%252529%252BMechanisms%26aulast%3DBrain%26aufirst%3DSusan%2BD.%26date%3D2019%26volume%3D255" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Majid  Sheykhzade</span>, <span class="hlFld-ContribAuthor ">Nilofar  Amandi</span>, <span class="hlFld-ContribAuthor ">Monica Vidal  Pla</span>, <span class="hlFld-ContribAuthor ">Bahareh  Abdolalizadeh</span>, <span class="hlFld-ContribAuthor ">Anette  Sams</span>, <span class="hlFld-ContribAuthor ">Karin  Warfvinge</span>, <span class="hlFld-ContribAuthor ">Lars  Edvinsson</span>, <span class="hlFld-ContribAuthor ">Darryl S.  Pickering</span>. </span><span class="cited-content_cbyCitation_article-title">Binding and functional pharmacological characteristics of gepant-type antagonists in rat brain and mesenteric arteries. </span><span class="cited-content_cbyCitation_journal-name">Vascular Pharmacology</span><span> <strong>2017,</strong> <em>90 </em>, 36-43. <a href="https://doi.org/10.1016/j.vph.2017.02.001" title="DOI URL">https://doi.org/10.1016/j.vph.2017.02.001</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.vph.2017.02.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.vph.2017.02.001%26sid%3Dliteratum%253Aachs%26jtitle%3DVascular%2520Pharmacology%26atitle%3DBinding%252Band%252Bfunctional%252Bpharmacological%252Bcharacteristics%252Bof%252Bgepant-type%252Bantagonists%252Bin%252Brat%252Bbrain%252Band%252Bmesenteric%252Barteries%26aulast%3DSheykhzade%26aufirst%3DMajid%26date%3D2017%26volume%3D90%26spage%3D36%26epage%3D43" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">G.M.  Dubowchik</span>, <span class="hlFld-ContribAuthor ">I.M.  Bell</span>. </span><span class="cited-content_cbyCitation_article-title">CGRP Receptor Antagonists for the Treatment of Migraine. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 176-224. <a href="https://doi.org/10.1016/B978-0-12-409547-2.12441-2" title="DOI URL">https://doi.org/10.1016/B978-0-12-409547-2.12441-2</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-409547-2.12441-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-409547-2.12441-2%26sid%3Dliteratum%253Aachs%26atitle%3DCGRP%252BReceptor%252BAntagonists%252Bfor%252Bthe%252BTreatment%252Bof%252BMigraine%26aulast%3DDubowchik%26aufirst%3DG.M.%26date%3D2017%26spage%3D176%26epage%3D224%26pub%3DElsevier%26atitle%3DComprehensive%252BMedicinal%252BChemistry%252BIII%26date%3D2017%26volume%3D346" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Naiyu  Zheng</span>, <span class="hlFld-ContribAuthor ">Jianing  Zeng</span>, <span class="hlFld-ContribAuthor ">Qin C.  Ji</span>, <span class="hlFld-ContribAuthor ">Aida  Angeles</span>, <span class="hlFld-ContribAuthor ">Anne-Francoise  Aubry</span>, <span class="hlFld-ContribAuthor ">Shenita  Basdeo</span>, <span class="hlFld-ContribAuthor ">Adela  Buzescu</span>, <span class="hlFld-ContribAuthor ">Ishani Savant  Landry</span>, <span class="hlFld-ContribAuthor ">Navin  Jariwala</span>, <span class="hlFld-ContribAuthor ">Wesley  Turley</span>, <span class="hlFld-ContribAuthor ">Richard  Burrell</span>, <span class="hlFld-ContribAuthor ">Mark E.  Arnold</span>. </span><span class="cited-content_cbyCitation_article-title">Bioanalysis of dried saliva spot (DSS) samples using detergent-assisted sample extraction with UHPLC-MS/MS detection. </span><span class="cited-content_cbyCitation_journal-name">Analytica Chimica Acta</span><span> <strong>2016,</strong> <em>934 </em>, 170-179. <a href="https://doi.org/10.1016/j.aca.2016.05.057" title="DOI URL">https://doi.org/10.1016/j.aca.2016.05.057</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.aca.2016.05.057&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.aca.2016.05.057%26sid%3Dliteratum%253Aachs%26jtitle%3DAnalytica%2520Chimica%2520Acta%26atitle%3DBioanalysis%252Bof%252Bdried%252Bsaliva%252Bspot%252B%252528DSS%252529%252Bsamples%252Busing%252Bdetergent-assisted%252Bsample%252Bextraction%252Bwith%252BUHPLC-MS%25252FMS%252Bdetection%26aulast%3DZheng%26aufirst%3DNaiyu%26date%3D2016%26volume%3D934%26spage%3D170%26epage%3D179" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hans-Christoph  Diener</span>, <span class="hlFld-ContribAuthor ">Andrew  Charles</span>, <span class="hlFld-ContribAuthor ">Peter J  Goadsby</span>, <span class="hlFld-ContribAuthor ">Dagny  Holle</span>. </span><span class="cited-content_cbyCitation_article-title">New therapeutic approaches for the prevention and treatment of migraine. </span><span class="cited-content_cbyCitation_journal-name">The Lancet Neurology</span><span> <strong>2015,</strong> <em>14 </em>
                                    (10)
                                     , 1010-1022. <a href="https://doi.org/10.1016/S1474-4422(15)00198-2" title="DOI URL">https://doi.org/10.1016/S1474-4422(15)00198-2</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/S1474-4422(15)00198-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FS1474-4422%2815%2900198-2%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Lancet%2520Neurology%26atitle%3DNew%252Btherapeutic%252Bapproaches%252Bfor%252Bthe%252Bprevention%252Band%252Btreatment%252Bof%252Bmigraine%26aulast%3DDiener%26aufirst%3DHans-Christoph%26date%3D2015%26volume%3D14%26issue%3D10%26spage%3D1010%26epage%3D1022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">László  Vécsei</span>, <span class="hlFld-ContribAuthor ">Délia  Szok</span>, <span class="hlFld-ContribAuthor ">Anett  Csáti</span>, <span class="hlFld-ContribAuthor ">János  Tajti</span>. </span><span class="cited-content_cbyCitation_article-title">CGRP antagonists and antibodies for the treatment of migraine. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Investigational Drugs</span><span> <strong>2015,</strong> <em>24 </em>
                                    (1)
                                     , 31-41. <a href="https://doi.org/10.1517/13543784.2015.960921" title="DOI URL">https://doi.org/10.1517/13543784.2015.960921</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1517/13543784.2015.960921&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1517%2F13543784.2015.960921%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Investigational%2520Drugs%26atitle%3DCGRP%252Bantagonists%252Band%252Bantibodies%252Bfor%252Bthe%252Btreatment%252Bof%252Bmigraine%26aulast%3DV%25C3%25A9csei%26aufirst%3DL%25C3%25A1szl%25C3%25B3%26date%3D2015%26date%3D2014%26volume%3D24%26issue%3D1%26spage%3D31%26epage%3D41" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">F. A.  Russell</span>, <span class="hlFld-ContribAuthor ">R.  King</span>, <span class="hlFld-ContribAuthor ">S.-J.  Smillie</span>, <span class="hlFld-ContribAuthor ">X.  Kodji</span>, <span class="hlFld-ContribAuthor ">S. D.  Brain</span>. </span><span class="cited-content_cbyCitation_article-title">Calcitonin Gene-Related Peptide: Physiology and Pathophysiology. </span><span class="cited-content_cbyCitation_journal-name">Physiological Reviews</span><span> <strong>2014,</strong> <em>94 </em>
                                    (4)
                                     , 1099-1142. <a href="https://doi.org/10.1152/physrev.00034.2013" title="DOI URL">https://doi.org/10.1152/physrev.00034.2013</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1152/physrev.00034.2013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1152%2Fphysrev.00034.2013%26sid%3Dliteratum%253Aachs%26jtitle%3DPhysiological%2520Reviews%26atitle%3DCalcitonin%252BGene-Related%252BPeptide%25253A%252BPhysiology%252Band%252BPathophysiology%26aulast%3DRussell%26aufirst%3DF.%2BA.%26date%3D2014%26volume%3D94%26issue%3D4%26spage%3D1099%26epage%3D1142" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bireshwar  Dasgupta</span>, <span class="hlFld-ContribAuthor ">Edward  Kozlowski</span>, <span class="hlFld-ContribAuthor ">Daniel R.  Schroeder</span>, <span class="hlFld-ContribAuthor ">John R.  Torrente</span>, <span class="hlFld-ContribAuthor ">Cen  Xu</span>, <span class="hlFld-ContribAuthor ">Sokhom  Pin</span>, <span class="hlFld-ContribAuthor ">Charlie M.  Conway</span>, <span class="hlFld-ContribAuthor ">Gene M.  Dubowchik</span>, <span class="hlFld-ContribAuthor ">John E.  Macor</span>, <span class="hlFld-ContribAuthor ">Vivekananda M.  Vrudhula</span>. </span><span class="cited-content_cbyCitation_article-title">Serendipitous oxidation product of BIBN4096BS: A potent CGRP receptor antagonist. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2014,</strong> <em>24 </em>
                                    (12)
                                     , 2744-2748. <a href="https://doi.org/10.1016/j.bmcl.2014.04.033" title="DOI URL">https://doi.org/10.1016/j.bmcl.2014.04.033</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2014.04.033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2014.04.033%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DSerendipitous%252Boxidation%252Bproduct%252Bof%252BBIBN4096BS%25253A%252BA%252Bpotent%252BCGRP%252Breceptor%252Bantagonist%26aulast%3DDasgupta%26aufirst%3DBireshwar%26date%3D2014%26volume%3D24%26issue%3D12%26spage%3D2744%26epage%3D2748" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">S  Benemei</span>, <span class="hlFld-ContribAuthor ">C  Fusi</span>, <span class="hlFld-ContribAuthor ">Gabriela  Trevisan</span>, <span class="hlFld-ContribAuthor ">Pierangelo  Geppetti</span>. </span><span class="cited-content_cbyCitation_article-title">The TRPA1 channel in migraine mechanism and treatment. </span><span class="cited-content_cbyCitation_journal-name">British Journal of Pharmacology</span><span> <strong>2014,</strong> <em>171 </em>
                                    (10)
                                     , 2552-2567. <a href="https://doi.org/10.1111/bph.12512" title="DOI URL">https://doi.org/10.1111/bph.12512</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/bph.12512&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fbph.12512%26sid%3Dliteratum%253Aachs%26jtitle%3DBritish%2520Journal%2520of%2520Pharmacology%26atitle%3DThe%252BTRPA1%252Bchannel%252Bin%252Bmigraine%252Bmechanism%252Band%252Btreatment%26aulast%3DBenemei%26aufirst%3DS%26date%3D2014%26date%3D2014%26volume%3D171%26issue%3D10%26spage%3D2552%26epage%3D2567" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Naiyu  Zheng</span>, <span class="hlFld-ContribAuthor ">Jianing  Zeng</span>, <span class="hlFld-ContribAuthor ">Qin C.  Ji</span>, <span class="hlFld-ContribAuthor ">Aida  Angeles</span>, <span class="hlFld-ContribAuthor ">Adela  Buzescu</span>, <span class="hlFld-ContribAuthor ">Shenita  Basdeo</span>, <span class="hlFld-ContribAuthor ">Anne-Françoise  Aubry</span>, <span class="hlFld-ContribAuthor ">Kevin  Trouba</span>, <span class="hlFld-ContribAuthor ">Laura M.  Patrone</span>, <span class="hlFld-ContribAuthor ">Qianping  Peng</span>, <span class="hlFld-ContribAuthor ">Mark E.  Arnold</span>. </span><span class="cited-content_cbyCitation_article-title">Improved liquid–liquid extraction with inter-well volume replacement dilution workflow and its application to quantify BMS-927711 in rat dried blood spots by UHPLC–MS/MS. </span><span class="cited-content_cbyCitation_journal-name">Journal of Pharmaceutical and Biomedical Analysis</span><span> <strong>2014,</strong> <em>89 </em>, 240-250. <a href="https://doi.org/10.1016/j.jpba.2013.11.017" title="DOI URL">https://doi.org/10.1016/j.jpba.2013.11.017</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jpba.2013.11.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jpba.2013.11.017%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Pharmaceutical%2520and%2520Biomedical%2520Analysis%26atitle%3DImproved%252Bliquid%2525E2%252580%252593liquid%252Bextraction%252Bwith%252Binter-well%252Bvolume%252Breplacement%252Bdilution%252Bworkflow%252Band%252Bits%252Bapplication%252Bto%252Bquantify%252BBMS-927711%252Bin%252Brat%252Bdried%252Bblood%252Bspots%252Bby%252BUHPLC%2525E2%252580%252593MS%25252FMS%26aulast%3DZheng%26aufirst%3DNaiyu%26date%3D2014%26volume%3D89%26spage%3D240%26epage%3D250" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ronald  Marcus</span>, <span class="hlFld-ContribAuthor ">Peter J  Goadsby</span>, <span class="hlFld-ContribAuthor ">David  Dodick</span>, <span class="hlFld-ContribAuthor ">David  Stock</span>, <span class="hlFld-ContribAuthor ">George  Manos</span>, <span class="hlFld-ContribAuthor ">Tanya Z  Fischer</span>. </span><span class="cited-content_cbyCitation_article-title">BMS-927711 for the acute treatment of migraine: A double-blind, randomized, placebo controlled, dose-ranging trial. </span><span class="cited-content_cbyCitation_journal-name">Cephalalgia</span><span> <strong>2014,</strong> <em>34 </em>
                                    (2)
                                     , 114-125. <a href="https://doi.org/10.1177/0333102413500727" title="DOI URL">https://doi.org/10.1177/0333102413500727</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1177/0333102413500727&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1177%2F0333102413500727%26sid%3Dliteratum%253Aachs%26jtitle%3DCephalalgia%26atitle%3DBMS-927711%252Bfor%252Bthe%252Bacute%252Btreatment%252Bof%252Bmigraine%25253A%252BA%252Bdouble-blind%25252C%252Brandomized%25252C%252Bplacebo%252Bcontrolled%25252C%252Bdose-ranging%252Btrial%26aulast%3DMarcus%26aufirst%3DRonald%26date%3D2014%26date%3D2013%26volume%3D34%26issue%3D2%26spage%3D114%26epage%3D125" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">C S  Walker</span>, <span class="hlFld-ContribAuthor ">D L  Hay</span>. </span><span class="cited-content_cbyCitation_article-title">CGRP in the trigeminovascular system: a role for CGRP, adrenomedullin and amylin receptors?. </span><span class="cited-content_cbyCitation_journal-name">British Journal of Pharmacology</span><span> <strong>2013,</strong> <em>170 </em>
                                    (7)
                                     , 1293-1307. <a href="https://doi.org/10.1111/bph.12129" title="DOI URL">https://doi.org/10.1111/bph.12129</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/bph.12129&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fbph.12129%26sid%3Dliteratum%253Aachs%26jtitle%3DBritish%2520Journal%2520of%2520Pharmacology%26atitle%3DCGRP%252Bin%252Bthe%252Btrigeminovascular%252Bsystem%25253A%252Ba%252Brole%252Bfor%252BCGRP%25252C%252Badrenomedullin%252Band%252Bamylin%252Breceptors%25253F%26aulast%3DWalker%26aufirst%3DC%2BS%26date%3D2013%26date%3D2013%26volume%3D170%26issue%3D7%26spage%3D1293%26epage%3D1307" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Stephen L.  Garland</span>. </span><span class="cited-content_cbyCitation_article-title">Are GPCRs Still a Source of New Targets?. </span><span class="cited-content_cbyCitation_journal-name">Journal of Biomolecular Screening</span><span> <strong>2013,</strong> <em>18 </em>
                                    (9)
                                     , 947-966. <a href="https://doi.org/10.1177/1087057113498418" title="DOI URL">https://doi.org/10.1177/1087057113498418</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1177/1087057113498418&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1177%2F1087057113498418%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Biomolecular%2520Screening%26atitle%3DAre%252BGPCRs%252BStill%252Ba%252BSource%252Bof%252BNew%252BTargets%25253F%26aulast%3DGarland%26aufirst%3DStephen%2BL.%26date%3D2013%26date%3D2013%26volume%3D18%26issue%3D9%26spage%3D947%26epage%3D966" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Naiyu  Zheng</span>, <span class="hlFld-ContribAuthor ">Jianing  Zeng</span>, <span class="hlFld-ContribAuthor ">Billy  Akinsanya</span>, <span class="hlFld-ContribAuthor ">Adela  Buzescu</span>, <span class="hlFld-ContribAuthor ">Yuan-Qing  Xia</span>, <span class="hlFld-ContribAuthor ">Van  Ly</span>, <span class="hlFld-ContribAuthor ">Kevin  Trouba</span>, <span class="hlFld-ContribAuthor ">Qianping  Peng</span>, <span class="hlFld-ContribAuthor ">Anne-Françoise  Aubry</span>, <span class="hlFld-ContribAuthor ">Mark E.  Arnold</span>. </span><span class="cited-content_cbyCitation_article-title">A rapid, accurate and robust UHPLC–MS/MS method for quantitative determination of BMS-927711, a CGRP receptor antagonist, in plasma in support of non-clinical toxicokinetic studies. </span><span class="cited-content_cbyCitation_journal-name">Journal of Pharmaceutical and Biomedical Analysis</span><span> <strong>2013,</strong> <em>83 </em>, 237-248. <a href="https://doi.org/10.1016/j.jpba.2013.05.019" title="DOI URL">https://doi.org/10.1016/j.jpba.2013.05.019</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jpba.2013.05.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jpba.2013.05.019%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Pharmaceutical%2520and%2520Biomedical%2520Analysis%26atitle%3DA%252Brapid%25252C%252Baccurate%252Band%252Brobust%252BUHPLC%2525E2%252580%252593MS%25252FMS%252Bmethod%252Bfor%252Bquantitative%252Bdetermination%252Bof%252BBMS-927711%25252C%252Ba%252BCGRP%252Breceptor%252Bantagonist%25252C%252Bin%252Bplasma%252Bin%252Bsupport%252Bof%252Bnon-clinical%252Btoxicokinetic%252Bstudies%26aulast%3DZheng%26aufirst%3DNaiyu%26date%3D2013%26volume%3D83%26spage%3D237%26epage%3D248" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Thomas P  Bravo</span>, <span class="hlFld-ContribAuthor ">Bert B  Vargas</span>, <span class="hlFld-ContribAuthor ">Rashmi B  Halker</span>. </span><span class="cited-content_cbyCitation_article-title">Calcitonin gene-related peptide receptor antagonists. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2013,</strong>,, 22-35. <a href="https://doi.org/10.2217/ebo.13.261" title="DOI URL">https://doi.org/10.2217/ebo.13.261</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2217/ebo.13.261&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2217%2Febo.13.261%26sid%3Dliteratum%253Aachs%26atitle%3DCalcitonin%252Bgene-related%252Bpeptide%252Breceptor%252Bantagonists%26aulast%3DBravo%26aufirst%3DThomas%2BP%26date%3D2013%26date%3D2013%26spage%3D22%26epage%3D35%26pub%3DFuture%2520Medicine%2520Ltd%26atitle%3DNovel%252BApproaches%252Bin%252BMigraine%252BTreatment%26aulast%3DDiener%26aufirst%3DHans-Christoph%26date%3D2013%26date%3D2013%26volume%3D346" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">M.  Lanteri-Minet</span>. </span><span class="cited-content_cbyCitation_article-title">What's new in the migraine attack treatment. </span><span class="cited-content_cbyCitation_journal-name">Revue Neurologique</span><span> <strong>2013,</strong> <em>169 </em>
                                    (5)
                                     , 436-441. <a href="https://doi.org/10.1016/j.neurol.2013.03.006" title="DOI URL">https://doi.org/10.1016/j.neurol.2013.03.006</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.neurol.2013.03.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.neurol.2013.03.006%26sid%3Dliteratum%253Aachs%26jtitle%3DRevue%2520Neurologique%26atitle%3DWhat%252527s%252Bnew%252Bin%252Bthe%252Bmigraine%252Battack%252Btreatment%26aulast%3DLanteri-Minet%26aufirst%3DM.%26date%3D2013%26volume%3D169%26issue%3D5%26spage%3D436%26epage%3D441" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-23/jm3013147/production/images/medium/jm-2012-013147_0008.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-23/jm3013147/production/images/large/jm-2012-013147_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3013147&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-23/jm3013147/production/images/medium/jm-2012-013147_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-23/jm3013147/production/images/large/jm-2012-013147_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Selected CGRP receptor antagonists.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-23/jm3013147/production/images/large/jm-2012-013147_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3013147&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-23/jm3013147/production/images/medium/jm-2012-013147_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-23/jm3013147/production/images/large/jm-2012-013147_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Proposed target CGRP receptor antagonists <b>6</b>, <b>7</b>, and <b>8</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-23/jm3013147/production/images/large/jm-2012-013147_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3013147&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-23/jm3013147/production/images/medium/jm-2012-013147_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-23/jm3013147/production/images/large/jm-2012-013147_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Alcohols <b>6</b> and <b>7</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-23/jm3013147/production/images/large/jm-2012-013147_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3013147&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) THF, TBAF, −15 °C, 1 h (62%); (b) DMF, NaHMDS, −15 to −5 °C, 1.5 h (29%); (c) MeOH, NaBH<sub>4</sub>, rt, 30 min, <b>6</b> (14%), <b>7</b> (12%), <b>13</b> (6%).</p></p></figure><figure data-id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-23/jm3013147/production/images/medium/jm-2012-013147_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-23/jm3013147/production/images/large/jm-2012-013147_0005.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Absolute Stereochemistry of Diols <b>15</b> and <b>18</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-23/jm3013147/production/images/large/jm-2012-013147_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3013147&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) MeOH, NaBH<sub>4</sub>, rt, 1 h (96%); (b) THF, TBAF, rt, 2 h, <b>15</b> (65%), <b>16</b> (17%), <b>17</b> (12%); (c) THF, TBAF (2.5 equiv), 50 °C, 18 h, (94%).</p></p></figure><figure data-id="sch3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-23/jm3013147/production/images/medium/jm-2012-013147_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-23/jm3013147/production/images/large/jm-2012-013147_0006.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. The Stereospecific Synthesis of <b>6</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-23/jm3013147/production/images/large/jm-2012-013147_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3013147&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) CH<sub>2</sub>Cl<sub>2</sub>, Ac<sub>2</sub>O, Et<sub>3</sub>N, DMAP, rt, 2 h; (b) THF, TBAF, rt, 2h (87% for 2 steps); (c) <b>11</b>, DMF, NaHMDS, −15 to 0 °C, 2 h (30% + 13% of <b>6</b>); (d) MeOH, K<sub>2</sub>CO<sub>3</sub>, rt, 1 h (56%).</p></p></figure><figure data-id="sch4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-23/jm3013147/production/images/medium/jm-2012-013147_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-23/jm3013147/production/images/large/jm-2012-013147_0007.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. The Stereospecific Synthesis of <b>8</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-23/jm3013147/production/images/large/jm-2012-013147_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3013147&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) NCS, Ph<sub>3</sub>P, THF, rt, 5 h (83%); (b) NaN<sub>3</sub>, DMF, 50 °C, 15 h; (c) TBAF, THF, rt, 1.5 h; (d) <b>11</b>, DMF, NaHMDS, −15 °C to rt, 4 h (73% for 3 steps); (e) PMe<sub>3</sub>, THF, H<sub>2</sub>O, rt, 5 h (85%).</p></p></figure><figure data-id="fig2a" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-23/jm3013147/production/images/medium/jm-2012-013147_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-23/jm3013147/production/images/large/jm-2012-013147_0003.jpeg" id="rightTab-GRAPHIC-d1677e1115-autogenerated" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Marmoset facial blood flow at 7 mg/kg, SC: 30 min represents the increased facial blood flow caused for hCGRP (10 μg/kg IV); 7 mg/kg <b>8</b> (SC) delivered at time = 0 min. At 15, 60, and 105 min, hCGRP challenge (10 μg/kg IV) was administered and reduction of facial blood flow and plasma levels of <b>8</b> were measured.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-23/jm3013147/production/images/large/jm-2012-013147_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3013147&amp;id=fig2a"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i31">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_44044" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_44044" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 22 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Hu, X. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Markson, L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lipton, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stewart., W. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berger, M. L.</span><span> </span><span class="NLM_article-title">Burden of Migraine in the United States: Disability and Economic Costs</span> <span class="citation_source-journal">Arch. Intern. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">159</span><span class="NLM_x">, </span> <span class="NLM_fpage">813</span><span class="NLM_x">–</span> <span class="NLM_lpage">818</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm3013147&amp;key=10.1001%2Farchinte.159.8.813" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm3013147&amp;key=10219926" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm3013147&amp;key=1%3ACAS%3A280%3ADyaK1M3jsFegsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=159&publication_year=1999&pages=813-818&author=X.+H.+Huauthor=L.+E.+Marksonauthor=R.+B.+Liptonauthor=W.+F.+Stewart.author=M.+L.+Berger&title=Burden+of+Migraine+in+the+United+States%3A+Disability+and+Economic+Costs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Burden of migraine in the United States: disability and economic costs</span></div><div class="casAuthors">Hu X H; Markson L E; Lipton R B; Stewart W F; Berger M L</div><div class="citationInfo"><span class="NLM_cas:title">Archives of internal medicine</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">159</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">813-8</span>
        ISSN:<span class="NLM_cas:issn">0003-9926</span>.
    </div><div class="casAbstract">BACKGROUND:  Migraine is a common disabling disease but its economic burden has not been adequately quantified.  OBJECTIVE:  To estimate the burden of migraine in the United States with respect to disability and economic costs.  METHODS:  The following data sources were used: published data, the Baltimore County Migraine Study, MEDSTAT's MarketScan medical claims data set, and statistics from the Census Bureau and the Bureau of Labor Statistics.  Disability was expressed as bedridden days.  Charges for migraine-related treatment were used as direct cost inputs.  The human capital approach was used in the estimation of indirect costs.  RESULTS:  Migraineurs required 3.8 bed rest days for men and 5.6 days for women each year, resulting in a total of 112 million bedridden days.  Migraine costs American employers about $13 billion a year because of missed workdays and impaired work function; close to $8 billion was directly due to missed workdays.  Patients of both sexes aged 30 to 49 years incurred higher indirect costs compared with younger or older employed patients.  Annual direct medical costs for migraine care were about $1 billion and about $100 was spent per diagnosed patient.  Physician office visits accounted for about 60% of all costs; in contrast, emergency department visits contributed less than 1% of the direct costs.  CONCLUSIONS:  The economic burden of migraine predominantly falls on patients and their employers in the form of bedridden days and lost productivity.  Various screening and treatment regimens should be evaluated to identify opportunities to reduce the disease burden.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTrOdrohggHIzUE-swuRqsHfW6udTcc2eZiCT4VrYRpeLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK1M3jsFegsA%253D%253D&md5=0def3c32ae10cac85a007cb62c6343c6</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1001%2Farchinte.159.8.813&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1001%252Farchinte.159.8.813%26sid%3Dliteratum%253Aachs%26aulast%3DHu%26aufirst%3DX.%2BH.%26aulast%3DMarkson%26aufirst%3DL.%2BE.%26aulast%3DLipton%26aufirst%3DR.%2BB.%26aulast%3DStewart.%26aufirst%3DW.%2BF.%26aulast%3DBerger%26aufirst%3DM.%2BL.%26atitle%3DBurden%2520of%2520Migraine%2520in%2520the%2520United%2520States%253A%2520Disability%2520and%2520Economic%2520Costs%26jtitle%3DArch.%2520Intern.%2520Med.%26date%3D1999%26volume%3D159%26spage%3D813%26epage%3D818" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Graham, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolff, H. G.</span><span> </span><span class="NLM_article-title">Mechanism of migraine headache and the action of ergotamine tartrate</span> <span class="citation_source-journal">Arch. Neurol. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1938</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">737</span><span class="NLM_x">–</span> <span class="NLM_lpage">763</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm3013147&amp;key=10.1001%2Farchneurpsyc.1938.02270040093005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm3013147&amp;key=1%3ACAS%3A528%3ADyaA1cXkvVCjtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=1938&pages=737-763&author=J.+P.+Grahamauthor=H.+G.+Wolff&title=Mechanism+of+migraine+headache+and+the+action+of+ergotamine+tartrate"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanism of migraine headache and action of ergotamine tartrate</span></div><div class="casAuthors">Graham, J. R.; Wolff, H. G.</div><div class="citationInfo"><span class="NLM_cas:title">Archives of Neurology and Psychiatry</span>
        (<span class="NLM_cas:date">1938</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">737-63</span>CODEN:
                <span class="NLM_cas:coden">ANPSAI</span>;
        ISSN:<span class="NLM_cas:issn">0096-6754</span>.
    </div><div class="casAbstract">See C. A. 32, 3824.6.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqM0aZpru8Z2rVg90H21EOLACvtfcHk0liekQdOFLZDqQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaA1cXkvVCjtQ%253D%253D&md5=e30731ad6d779369a228cc783d930089</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1001%2Farchneurpsyc.1938.02270040093005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1001%252Farchneurpsyc.1938.02270040093005%26sid%3Dliteratum%253Aachs%26aulast%3DGraham%26aufirst%3DJ.%2BP.%26aulast%3DWolff%26aufirst%3DH.%2BG.%26atitle%3DMechanism%2520of%2520migraine%2520headache%2520and%2520the%2520action%2520of%2520ergotamine%2520tartrate%26jtitle%3DArch.%2520Neurol.%2520Psychiatry%26date%3D1938%26volume%3D39%26spage%3D737%26epage%3D763" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Olesen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burstein, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ashina, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tfelt-Hansen, P.</span><span> </span><span class="NLM_article-title">Origin of pain in migraine: evidence for peripheral sensitisation</span> <span class="citation_source-journal">Lancet Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">679</span><span class="NLM_x">–</span> <span class="NLM_lpage">690</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm3013147&amp;key=10.1016%2FS1474-4422%2809%2970090-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm3013147&amp;key=19539239" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm3013147&amp;key=1%3ACAS%3A280%3ADC%252BD1Mvjt1ynsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2009&pages=679-690&author=J.+Olesenauthor=R.+Bursteinauthor=M.+Ashinaauthor=P.+Tfelt-Hansen&title=Origin+of+pain+in+migraine%3A+evidence+for+peripheral+sensitisation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Origin of pain in migraine: evidence for peripheral sensitisation</span></div><div class="casAuthors">Olesen Jes; Burstein Rami; Ashina Messoud; Tfelt-Hansen Peer</div><div class="citationInfo"><span class="NLM_cas:title">The Lancet. Neurology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">679-90</span>
        ISSN:<span class="NLM_cas:issn">1474-4422</span>.
    </div><div class="casAbstract">Migraine is the most common neurological disorder, and much has been learned about its mechanisms in recent years.  However, the origin of painful impulses in the trigeminal nerve is still uncertain.  Despite the attention paid recently to the role of central sensitisation in migraine pathophysiology, in our view, neuronal hyperexcitability depends on activation of peripheral nociceptors.  Although the onset of a migraine attack might take place in deep-brain structures, some evidence indicates that the headache phase depends on nociceptive input from perivascular sensory nerve terminals.  The input from arteries is probably more important than the input from veins.  Several studies provide evidence for input from extracranial, dural, and pial arteries but, likewise, there is also evidence against all three of these locations.  On balance, afferents are most probably excited in all three territories or the importance of individual territories varies from patient to patient.  We suggest that migraine can be explained to patients as a disorder of the brain, and that the headache originates in the sensory fibres that convey pain signals from intracranial and extracranial blood vessels.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcThAEQji8-P8_h3YQQtAhNufW6udTcc2eb66JAAAeP8p7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1Mvjt1ynsQ%253D%253D&md5=a3bddb8ef7e49bdbcad68339552e00eb</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2FS1474-4422%2809%2970090-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1474-4422%252809%252970090-0%26sid%3Dliteratum%253Aachs%26aulast%3DOlesen%26aufirst%3DJ.%26aulast%3DBurstein%26aufirst%3DR.%26aulast%3DAshina%26aufirst%3DM.%26aulast%3DTfelt-Hansen%26aufirst%3DP.%26atitle%3DOrigin%2520of%2520pain%2520in%2520migraine%253A%2520evidence%2520for%2520peripheral%2520sensitisation%26jtitle%3DLancet%2520Neurol.%26date%3D2009%26volume%3D8%26spage%3D679%26epage%3D690" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Goadsby, P. J</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Charbit, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andreou, A. P</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akerman, S</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holland, P. R.</span><span> </span><span class="NLM_article-title">Neurobiology of migraine</span> <span class="citation_source-journal">Neuroscience</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">161</span><span class="NLM_x">, </span> <span class="NLM_fpage">327</span><span class="NLM_x">–</span> <span class="NLM_lpage">341</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=161&publication_year=2009&pages=327-341&author=P.+J+Goadsbyauthor=A.+R.+Charbitauthor=A.+P+Andreouauthor=S+Akermanauthor=P.+R.+Holland&title=Neurobiology+of+migraine"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGoadsby%26aufirst%3DP.%2BJ%26aulast%3DCharbit%26aufirst%3DA.%2BR.%26aulast%3DAndreou%26aufirst%3DA.%2BP%26aulast%3DAkerman%26aufirst%3DS%26aulast%3DHolland%26aufirst%3DP.%2BR.%26atitle%3DNeurobiology%2520of%2520migraine%26jtitle%3DNeuroscience%26date%3D2009%26volume%3D161%26spage%3D327%26epage%3D341" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">van Rossum, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanisch, U. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quirion, R.</span><span> </span><span class="NLM_article-title">Neuroanatomical localization, pharmacological characterization and functions of CGRP, related peptides and their receptors</span> <span class="citation_source-journal">Neurosci. Biobehav. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">649</span><span class="NLM_x">–</span> <span class="NLM_lpage">678</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=1997&pages=649-678&author=D.+van+Rossumauthor=U.+K.+Hanischauthor=R.+Quirion&title=Neuroanatomical+localization%2C+pharmacological+characterization+and+functions+of+CGRP%2C+related+peptides+and+their+receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3Dvan%2BRossum%26aufirst%3DD.%26aulast%3DHanisch%26aufirst%3DU.%2BK.%26aulast%3DQuirion%26aufirst%3DR.%26atitle%3DNeuroanatomical%2520localization%252C%2520pharmacological%2520characterization%2520and%2520functions%2520of%2520CGRP%252C%2520related%2520peptides%2520and%2520their%2520receptors%26jtitle%3DNeurosci.%2520Biobehav.%2520Rev.%26date%3D1997%26volume%3D21%26spage%3D649%26epage%3D678" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Goadsby, P. J.</span><span> </span><span class="NLM_article-title">Calcitonin gene-related peptide antagonists as treatments of migraine and other primary headaches</span> <span class="citation_source-journal">Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">65</span><span class="NLM_x">, </span> <span class="NLM_fpage">2557</span><span class="NLM_x">–</span> <span class="NLM_lpage">2567</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2005&pages=2557-2567&author=P.+J.+Goadsby&title=Calcitonin+gene-related+peptide+antagonists+as+treatments+of+migraine+and+other+primary+headaches"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGoadsby%26aufirst%3DP.%2BJ.%26atitle%3DCalcitonin%2520gene-related%2520peptide%2520antagonists%2520as%2520treatments%2520of%2520migraine%2520and%2520other%2520primary%2520headaches%26jtitle%3DDrugs%26date%3D2005%26volume%3D65%26spage%3D2557%26epage%3D2567" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit6b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Edvinsson, L.</span><span> </span><span class="NLM_article-title">Blockade of CGRP receptors in the intracranial vasculature: a new target in the treatment of headache</span> <span class="citation_source-journal">Cephalalgia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">611</span><span class="NLM_x">–</span> <span class="NLM_lpage">622</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2004&pages=611-622&author=L.+Edvinsson&title=Blockade+of+CGRP+receptors+in+the+intracranial+vasculature%3A+a+new+target+in+the+treatment+of+headache"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEdvinsson%26aufirst%3DL.%26atitle%3DBlockade%2520of%2520CGRP%2520receptors%2520in%2520the%2520intracranial%2520vasculature%253A%2520a%2520new%2520target%2520in%2520the%2520treatment%2520of%2520headache%26jtitle%3DCephalalgia%26date%3D2004%26volume%3D24%26spage%3D611%26epage%3D622" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit6c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Williamson, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hargreaves, R. J.</span><span> </span><span class="NLM_article-title">Neurogenic inflammation in the context of migraine</span> <span class="citation_source-journal">Microsc. Res. Tech.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">167</span><span class="NLM_x">–</span> <span class="NLM_lpage">178</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6c&amp;dbid=16&amp;doi=10.1021%2Fjm3013147&amp;key=10.1002%2Fjemt.1081" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6c&amp;dbid=8&amp;doi=10.1021%2Fjm3013147&amp;key=11301492" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6c&amp;dbid=32&amp;doi=10.1021%2Fjm3013147&amp;key=1%3ACAS%3A528%3ADC%252BD3MXjvVKrur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2001&pages=167-178&author=D.+J.+Williamsonauthor=R.+J.+Hargreaves&title=Neurogenic+inflammation+in+the+context+of+migraine"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6cR"><div class="casContent"><span class="casTitleNuber">6c</span><div class="casTitle"><span class="NLM_cas:atitle">Neurogenic inflammation in the context of migraine</span></div><div class="casAuthors">Williamson, David J.; Hargreaves, Richard J.</div><div class="citationInfo"><span class="NLM_cas:title">Microscopy Research and Technique</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">167-178</span>CODEN:
                <span class="NLM_cas:coden">MRTEEO</span>;
        ISSN:<span class="NLM_cas:issn">1059-910X</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">A review with refs.  Despite considerable research into the pathogenesis of idiopathic headaches, such as migraine, the pathophysiol. mechanisms underlying them remain poorly understood.  Although it is well established that the trigeminal nerve becomes activated during migraine, the consequences of this activation remain controversial.  One theory, based on preclin. observations, is that activation of trigeminal sensory fibers leads to a painful neurogenic inflammation within the meningeal (dural) vasculature mediated by neuropeptide release from trigeminal sensory fibers and characterized by plasma protein extravasation, vasodilation, and mast cell degranulation.  Effective antimigraine agents such as ergots, triptans, opioids, and valproate inhibit preclin. neurogenic dural extravasation, suggesting that this activity may be a predictor of potential clin. efficacy of novel agents.  However, several clin. trials with other agents that inhibit this process preclinically have failed to show efficacy in the acute treatment of migraine in man.  Alternatively, it has been proposed that painful neurogenic vasodilation of meningeal blood vessels could be a key component of the inflammatory process during migraine headache.  This view is supported by the observation that jugular plasma levels of the potent vasodilator, calcitonin gene-related peptide (CGRP) are elevated during the headache and normalized by successful sumatriptan treatment.  Preclinically, activation of trigeminal sensory fibers evokes a CGRP-mediated neurogenic dural vasodilation, which is blocked by dihydroergotamine, triptans, and opioids but unaffected by NK1 receptor antagonists that failed in clin. trials.  These observations suggest that CGRP release with assocd. neurogenic dural vasodilation may be important in the generation of migraine pain, a theory that would ultimately be tested by the clin. testing of a CGRP receptor antagonist.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoEGuy5ewVpVbVg90H21EOLACvtfcHk0litFSyD_wiI7w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXjvVKrur0%253D&md5=a2639c17392a170b3a9499bdfbdd2247</span></div><a href="/servlet/linkout?suffix=cit6c&amp;dbid=16384&amp;doi=10.1002%2Fjemt.1081&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjemt.1081%26sid%3Dliteratum%253Aachs%26aulast%3DWilliamson%26aufirst%3DD.%2BJ.%26aulast%3DHargreaves%26aufirst%3DR.%2BJ.%26atitle%3DNeurogenic%2520inflammation%2520in%2520the%2520context%2520of%2520migraine%26jtitle%3DMicrosc.%2520Res.%2520Tech.%26date%3D2001%26volume%3D53%26spage%3D167%26epage%3D178" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Recober, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Russo, A. F.</span><span> </span><span class="NLM_article-title">Calcitonin gene-related peptide: an update on the biology</span> <span class="citation_source-journal">Curr. Opin. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">241</span><span class="NLM_x">–</span> <span class="NLM_lpage">246</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm3013147&amp;key=10.1097%2FWCO.0b013e32832b2427" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm3013147&amp;key=19434786" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm3013147&amp;key=1%3ACAS%3A528%3ADC%252BD1MXlsVeqsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2009&pages=241-246&author=A.+Recoberauthor=A.+F.+Russo&title=Calcitonin+gene-related+peptide%3A+an+update+on+the+biology"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Calcitonin gene-related peptide: an update on the biology</span></div><div class="casAuthors">Recober, Ana; Russo, Andrew F.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Neurology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">241-246</span>CODEN:
                <span class="NLM_cas:coden">CONEEX</span>;
        ISSN:<span class="NLM_cas:issn">1350-7540</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Purpose of review: This review includes the most relevant and recent studies on the biol. of calcitonin gene-related peptide (CGRP) as it pertains to primary headaches and particularly to migraine.  Especial attention was given to those published within the last year.  Recent findings: The development of CGRP receptor antagonists is discussed in detail, as well as recent advances in our understanding of CGRP actions in migraine.  Finally, other important functions of CGRP outside of the nervous system are briefly discussed.  Summary: The advent of CGRP receptor antagonists as a novel therapy for migraine attacks may represent a new era in the acute management of migraine.  More than a simple addn. to the currently available treatments, this group of drugs may become an outstanding option for patients with cardiovascular disease, given the lack of assocd. vasoconstriction.  Furthermore, nonpeptide CGRP receptor antagonists, CGRP antibodies and CGRP-binding RNA-Spiegelmer are valuable research tools that will further advance our understanding of migraine pathophysiol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo2sEn4kbfdM7Vg90H21EOLACvtfcHk0lii5rd5WoajJw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXlsVeqsLs%253D&md5=a202b91719ad347b88efd0d1371e61f2</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1097%2FWCO.0b013e32832b2427&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FWCO.0b013e32832b2427%26sid%3Dliteratum%253Aachs%26aulast%3DRecober%26aufirst%3DA.%26aulast%3DRusso%26aufirst%3DA.%2BF.%26atitle%3DCalcitonin%2520gene-related%2520peptide%253A%2520an%2520update%2520on%2520the%2520biology%26jtitle%3DCurr.%2520Opin.%2520Neurol.%26date%3D2009%26volume%3D22%26spage%3D241%26epage%3D246" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Olesen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diener, H. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Husstedt, I. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goadsby, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hall, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meier, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pollentier, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lesko, L. M.</span><span> </span><span class="NLM_article-title">Calcitonin gene related peptide receptor antagonist BIBN 4096 BS for the acute treatment of migraine</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">350</span><span class="NLM_x">, </span> <span class="NLM_fpage">1104</span><span class="NLM_x">–</span> <span class="NLM_lpage">1110</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm3013147&amp;key=10.1056%2FNEJMoa030505" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm3013147&amp;key=15014183" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm3013147&amp;key=1%3ACAS%3A528%3ADC%252BD2cXitV2qur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=350&publication_year=2004&pages=1104-1110&author=J.+Olesenauthor=H.+C.+Dienerauthor=I.+W.+Husstedtauthor=P.+J.+Goadsbyauthor=D.+Hallauthor=U.+Meierauthor=S.+Pollentierauthor=L.+M.+Lesko&title=Calcitonin+gene+related+peptide+receptor+antagonist+BIBN+4096+BS+for+the+acute+treatment+of+migraine"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Calcitonin gene-related peptide receptor antagonist BIBN 4096 BS for the acute treatment of migraine</span></div><div class="casAuthors">Olesen, Jes; Diener, Hans-Christoph; Husstedt, Ingo W.; Goadsby, Peter J.; Hall, David; Meier, Ulrich; Pollentier, Stephane; Lesko, Lynna M.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">350</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1104-1110</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">BACKGROUND: Calcitonin gene-related peptide (CGRP) may have a causative role in migraine.  We therefore hypothesized that a CGRP-receptor antagonist might be effective in the treatment of migraine attacks.  METHODS: In an international, multicenter, double-blind, randomized clin. trial of BIBN 4096 BS, a highly specific and potent nonpeptide CGRP-receptor antagonist, 126 patients with migraine received one of the following: placebo or 0.25, 0.5, 1, 2.5, 5, or 10 mg of BIBN 4096 BS i.v. over a period of 10 min.  A group-sequential adaptive treatment-assignment design was used to minimize the no. of patients exposed.  RESULTS: The 2.5-mg dose was selected, with a response rite of 66 %, as compared with 27 % for placebo (P = 0.001).  The BIBN 4096 BS group as a whole had a response rate of 60 %.  Significant superiority over placebo was also obsd. with respect to most secondary end points: the pain-free rate at 2 h; the rate of sustained response over a period of 24 h; the rate of recurrence of headache; improvement in nausea, photophobia, phonophobia, and functional capacity; and the time to meaningful relief.  An effect was apparent after 30 min and increased over the next few hours.  The overall rate of adverse events was 25 % after the 2.5-mg dose of the drug and 20 % for the BIBN 4096 BS group as a whole, as compared with 12 % for placebo.  The most frequent side effect was paresthesia.  There were no serious adverse events.  CONCLUSIONS: The CGRP antagonist BIBN 4096 BS was effective in treating acute attacks of migraine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpsmM0pM13jFLVg90H21EOLACvtfcHk0lii5rd5WoajJw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXitV2qur0%253D&md5=5eaed0182c6d0232507467ef7120515b</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa030505&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa030505%26sid%3Dliteratum%253Aachs%26aulast%3DOlesen%26aufirst%3DJ.%26aulast%3DDiener%26aufirst%3DH.%2BC.%26aulast%3DHusstedt%26aufirst%3DI.%2BW.%26aulast%3DGoadsby%26aufirst%3DP.%2BJ.%26aulast%3DHall%26aufirst%3DD.%26aulast%3DMeier%26aufirst%3DU.%26aulast%3DPollentier%26aufirst%3DS.%26aulast%3DLesko%26aufirst%3DL.%2BM.%26atitle%3DCalcitonin%2520gene%2520related%2520peptide%2520receptor%2520antagonist%2520BIBN%25204096%2520BS%2520for%2520the%2520acute%2520treatment%2520of%2520migraine%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2004%26volume%3D350%26spage%3D1104%26epage%3D1110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="note"><p class="first last">IDDB, Thomson Scientific reports that development of BIBN4096BS has been discontinued.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Paone, D. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaw, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, D. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burgey, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deng, J. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kane, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koblan, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salvatore, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mosser, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnston, V. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, B. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller-Stein, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hershey, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graham, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vacca, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, T. M.</span><span> </span><span class="NLM_article-title">Potent, Orally Bioavailable Calcitonin Gene-Related Peptide Receptor Antagonists for the Treatment of Migraine: Discovery of <i>N</i>-[(3<i>R</i>,6<i>S</i>)-6-(2,3-Difluorophenyl)-2-oxo-1- (2,2,2-trifluoroethyl)azepan-3-yl]-4-(2-oxo-2,3-dihydro-1<i>H</i>-imidazo[4,5-<i>b</i>]pyridin- 1-yl)piperidine-1-carboxamide (MK-0974)</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">5564</span><span class="NLM_x">–</span> <span class="NLM_lpage">5567</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm070668p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=5564-5567&author=D.+V.+Paoneauthor=A.+W.+Shawauthor=D.+N.+Nguyenauthor=C.+S.+Burgeyauthor=J.+Z.+Dengauthor=S.+A.+Kaneauthor=K.+S.+Koblanauthor=C.+A.+Salvatoreauthor=S.+D.+Mosserauthor=V.+K.+Johnstonauthor=B.+K.+Wongauthor=C.+M.+Miller-Steinauthor=J.+C.+Hersheyauthor=S.+L.+Grahamauthor=J.+P.+Vaccaauthor=T.+M.+Williams&title=Potent%2C+Orally+Bioavailable+Calcitonin+Gene-Related+Peptide+Receptor+Antagonists+for+the+Treatment+of+Migraine%3A+Discovery+of+N-%5B%283R%2C6S%29-6-%282%2C3-Difluorophenyl%29-2-oxo-1-+%282%2C2%2C2-trifluoroethyl%29azepan-3-yl%5D-4-%282-oxo-2%2C3-dihydro-1H-imidazo%5B4%2C5-b%5Dpyridin-+1-yl%29piperidine-1-carboxamide+%28MK-0974%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1021%2Fjm070668p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm070668p%26sid%3Dliteratum%253Aachs%26aulast%3DPaone%26aufirst%3DD.%2BV.%26aulast%3DShaw%26aufirst%3DA.%2BW.%26aulast%3DNguyen%26aufirst%3DD.%2BN.%26aulast%3DBurgey%26aufirst%3DC.%2BS.%26aulast%3DDeng%26aufirst%3DJ.%2BZ.%26aulast%3DKane%26aufirst%3DS.%2BA.%26aulast%3DKoblan%26aufirst%3DK.%2BS.%26aulast%3DSalvatore%26aufirst%3DC.%2BA.%26aulast%3DMosser%26aufirst%3DS.%2BD.%26aulast%3DJohnston%26aufirst%3DV.%2BK.%26aulast%3DWong%26aufirst%3DB.%2BK.%26aulast%3DMiller-Stein%26aufirst%3DC.%2BM.%26aulast%3DHershey%26aufirst%3DJ.%2BC.%26aulast%3DGraham%26aufirst%3DS.%2BL.%26aulast%3DVacca%26aufirst%3DJ.%2BP.%26aulast%3DWilliams%26aufirst%3DT.%2BM.%26atitle%3DPotent%252C%2520Orally%2520Bioavailable%2520Calcitonin%2520Gene-Related%2520Peptide%2520Receptor%2520Antagonists%2520for%2520the%2520Treatment%2520of%2520Migraine%253A%2520Discovery%2520of%2520N-%255B%25283R%252C6S%2529-6-%25282%252C3-Difluorophenyl%2529-2-oxo-1-%2520%25282%252C2%252C2-trifluoroethyl%2529azepan-3-yl%255D-4-%25282-oxo-2%252C3-dihydro-1H-imidazo%255B4%252C5-b%255Dpyridin-%25201-yl%2529piperidine-1-carboxamide%2520%2528MK-0974%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D5564%26epage%3D5567" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Hewitt, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lipton, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brandes, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ceesay, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gottwald, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schaefer, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lines, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ho, T. W.</span><span> </span><span class="NLM_article-title">Randomized Controlled Study of Telcagepant Plus Ibuprofen or Acetaminophen in Migraine</span> <span class="citation_source-journal">Headache</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">533</span><span class="NLM_x">–</span> <span class="NLM_lpage">543</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2011&pages=533-543&author=D.+J.+Hewittauthor=V.+Martinauthor=R.+B.+Liptonauthor=J.+Brandesauthor=P.+Ceesayauthor=R.+Gottwaldauthor=E.+Schaeferauthor=C.+Linesauthor=T.+W.+Ho&title=Randomized+Controlled+Study+of+Telcagepant+Plus+Ibuprofen+or+Acetaminophen+in+Migraine"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHewitt%26aufirst%3DD.%2BJ.%26aulast%3DMartin%26aufirst%3DV.%26aulast%3DLipton%26aufirst%3DR.%2BB.%26aulast%3DBrandes%26aufirst%3DJ.%26aulast%3DCeesay%26aufirst%3DP.%26aulast%3DGottwald%26aufirst%3DR.%26aulast%3DSchaefer%26aufirst%3DE.%26aulast%3DLines%26aufirst%3DC.%26aulast%3DHo%26aufirst%3DT.%2BW.%26atitle%3DRandomized%2520Controlled%2520Study%2520of%2520Telcagepant%2520Plus%2520Ibuprofen%2520or%2520Acetaminophen%2520in%2520Migraine%26jtitle%3DHeadache%26date%3D2011%26volume%3D51%26spage%3D533%26epage%3D543" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit11b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Tfelt-Hansen, P.</span><span> </span><span class="NLM_article-title">Excellent Tolerability but Relatively Low Initial Clinical Efficacy of Telcagepant in Migraine Headache</span> <span class="citation_source-journal">Headache</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">118</span><span class="NLM_x">–</span> <span class="NLM_lpage">123</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2011&pages=118-123&author=P.+Tfelt-Hansen&title=Excellent+Tolerability+but+Relatively+Low+Initial+Clinical+Efficacy+of+Telcagepant+in+Migraine+Headache"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTfelt-Hansen%26aufirst%3DP.%26atitle%3DExcellent%2520Tolerability%2520but%2520Relatively%2520Low%2520Initial%2520Clinical%2520Efficacy%2520of%2520Telcagepant%2520in%2520Migraine%2520Headache%26jtitle%3DHeadache%26date%3D2011%26volume%3D51%26spage%3D118%26epage%3D123" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit11c"><span><span class="NLM_label">(c) </span><div class="note"><p class="first last">Merck recently discontinued the development of telcagepant.</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Merck+recently+discontinued+the+development+of+telcagepant."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Bell, I. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallicchio, S. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quigley, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Craig, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stump, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">C. Blair Zartman, C. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fay, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, C.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lynch, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moore, E. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mosser, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prueksaritanont, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Regan, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roller, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salvatore, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kane, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vacca, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selnick, H. G.</span><span> </span><span class="NLM_article-title">Discovery of MK-3207: A Highly Potent, Orally Bioavailable CGRP Receptor Antagonist</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">24</span><span class="NLM_x">–</span> <span class="NLM_lpage">29</span></span><div class="citationLinks">[<a href="/doi/10.1021/ml900016y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm3013147&amp;key=1%3ACAS%3A528%3ADC%252BC3cXksFegsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2010&pages=24-29&author=I.+M.+Bellauthor=S.+N.+Gallicchioauthor=M.+R.+Woodauthor=A.+G.+Quigleyauthor=A.+Craigauthor=C.+A.+Stumpauthor=C.+B.+C.+Blair+Zartmanauthor=J.+F.+Fayauthor=C.-C.+Liauthor=J.+J.+Lynchauthor=E.+L.+Mooreauthor=S.+D.+Mosserauthor=T.+Prueksaritanontauthor=C.+P.+Reganauthor=S.+Rollerauthor=C.+A.+Salvatoreauthor=S.+A.+Kaneauthor=J.+P.+Vaccaauthor=H.+G.+Selnick&title=Discovery+of+MK-3207%3A+A+Highly+Potent%2C+Orally+Bioavailable+CGRP+Receptor+Antagonist"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of MK-3207: A Highly Potent, Orally Bioavailable CGRP Receptor Antagonist</span></div><div class="casAuthors">Bell, Ian M.; Gallicchio, Steven N.; Wood, Michael R.; Quigley, Amy G.; Stump, Craig A.; Zartman, C. Blair; Fay, John F.; Li, Chi-Chung; Lynch, Joseph J.; Moore, Eric L.; Mosser, Scott D.; Prueksaritanont, Thomayant; Regan, Christopher P.; Roller, Shane; Salvatore, Christopher A.; Kane, Stefanie A.; Vacca, Joseph P.; Selnick, Harold G.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">24-29</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Incorporation of polar functionality into a series of highly potent calcitonin gene-related peptide (CGRP) receptor antagonists was explored in an effort to improve pharmacokinetics.  This strategy identified piperazinone analogs that possessed improved soly. at acidic pH and increased oral bioavailability in monkeys.  Further optimization led to the discovery of the clin. candidate 2-[(8R)-8-(3,5-difluorophenyl)-10-oxo-6,9-diazaspiro[4.5]dec-9-yl]-N-[(2R)-2'-oxo-1,1',2',3-tetrahydrospiro[indene-2,3'-pyrrolo[2,3-b]pyridin]-5-yl]acetamide (MK-3207) (4), the most potent orally active CGRP receptor antagonist described to date.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoIThxRCo8aD7Vg90H21EOLACvtfcHk0lhunlQRXZoVJA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXksFegsQ%253D%253D&md5=2060a1762781cce87db2263731e9d85a</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1021%2Fml900016y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml900016y%26sid%3Dliteratum%253Aachs%26aulast%3DBell%26aufirst%3DI.%2BM.%26aulast%3DGallicchio%26aufirst%3DS.%2BN.%26aulast%3DWood%26aufirst%3DM.%2BR.%26aulast%3DQuigley%26aufirst%3DA.%2BG.%26aulast%3DCraig%26aufirst%3DA.%26aulast%3DStump%26aufirst%3DC.%2BA.%26aulast%3DC.%2BBlair%2BZartman%26aufirst%3DC.%2BB.%26aulast%3DFay%26aufirst%3DJ.%2BF.%26aulast%3DLi%26aufirst%3DC.-C.%26aulast%3DLynch%26aufirst%3DJ.%2BJ.%26aulast%3DMoore%26aufirst%3DE.%2BL.%26aulast%3DMosser%26aufirst%3DS.%2BD.%26aulast%3DPrueksaritanont%26aufirst%3DT.%26aulast%3DRegan%26aufirst%3DC.%2BP.%26aulast%3DRoller%26aufirst%3DS.%26aulast%3DSalvatore%26aufirst%3DC.%2BA.%26aulast%3DKane%26aufirst%3DS.%2BA.%26aulast%3DVacca%26aufirst%3DJ.%2BP.%26aulast%3DSelnick%26aufirst%3DH.%2BG.%26atitle%3DDiscovery%2520of%2520MK-3207%253A%2520A%2520Highly%2520Potent%252C%2520Orally%2520Bioavailable%2520CGRP%2520Receptor%2520Antagonist%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D1%26spage%3D24%26epage%3D29" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Diener, H.-C</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barbanti, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dahlöf, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reuter, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Habeck, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Podhorna, J.</span><span> </span><span class="NLM_article-title">BI 44370 TA, an oral CGRP antagonist for the treatment of acute migraine attacks: results from a phase II study</span> <span class="citation_source-journal">Cephalalgia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">573</span><span class="NLM_x">–</span> <span class="NLM_lpage">584</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2011&pages=573-584&author=H.-C+Dienerauthor=P.+Barbantiauthor=C.+Dahl%C3%B6fauthor=U.+Reuterauthor=J.+Habeckauthor=J.+Podhorna&title=BI+44370+TA%2C+an+oral+CGRP+antagonist+for+the+treatment+of+acute+migraine+attacks%3A+results+from+a+phase+II+study"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDiener%26aufirst%3DH.-C%26aulast%3DBarbanti%26aufirst%3DP.%26aulast%3DDahl%25C3%25B6f%26aufirst%3DC.%26aulast%3DReuter%26aufirst%3DU.%26aulast%3DHabeck%26aufirst%3DJ.%26aulast%3DPodhorna%26aufirst%3DJ.%26atitle%3DBI%252044370%2520TA%252C%2520an%2520oral%2520CGRP%2520antagonist%2520for%2520the%2520treatment%2520of%2520acute%2520migraine%2520attacks%253A%2520results%2520from%2520a%2520phase%2520II%2520study%26jtitle%3DCephalalgia%26date%3D2011%26volume%3D31%26spage%3D573%26epage%3D584" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="note"><p class="first last">Merck publicly anounced the discontinuation of MK-3207 due to toxicity, while there was no further public news about BI 44370.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Luo, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conway, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keavy, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denton, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kostich, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mercer, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schartman, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Signor, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lentz, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Browning, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macor, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dubowchik, G. M.</span><span> </span><span class="NLM_article-title">Discovery of BMS-846372, a Potent and Orally Active Human CGRP Receptor Antagonist for the Treatment of Migraine</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">337</span><span class="NLM_x">–</span> <span class="NLM_lpage">341</span></span><div class="citationLinks">[<a href="/doi/10.1021/ml300021s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm3013147&amp;key=1%3ACAS%3A528%3ADC%252BC38XivVCmtL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=337-341&author=G.+Luoauthor=L.+Chenauthor=C.+M.+Conwayauthor=D.+Keavyauthor=R.+Dentonauthor=W.+Kostichauthor=S.+Mercerauthor=R.+Schartmanauthor=L.+Signorauthor=K.+Lentzauthor=M.+Browningauthor=J.+E.+Macorauthor=G.+M.+Dubowchik&title=Discovery+of+BMS-846372%2C+a+Potent+and+Orally+Active+Human+CGRP+Receptor+Antagonist+for+the+Treatment+of+Migraine"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of BMS-846372, a Potent and Orally Active Human CGRP Receptor Antagonist for the Treatment of Migraine</span></div><div class="casAuthors">Luo, Guanglin; Chen, Ling; Conway, Charles M.; Denton, Rex; Keavy, Deborah; Gulianello, Michael; Huang, Yanling; Kostich, Walter; Lentz, Kimberley A.; Mercer, Stephen E.; Schartman, Richard; Signor, Laura; Browning, Marc; Macor, John E.; Dubowchik, Gene M.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">337-341</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Calcitonin gene-related peptide (CGRP) receptor antagonists have been clin. shown to be effective in the treatment of migraine, but identification of potent and orally bioavailable compds. has been challenging.  Herein, we describe the conceptualization, synthesis, and preclin. characterization of a potent, orally active CGRP receptor antagonist 5 (BMS-846372, I).  Compd. 5 has good oral bioavailability in rat, dog, and cynomolgus monkeys and overall attractive preclin. properties including strong (>50% inhibition) exposure-dependent in vivo efficacy in a marmoset migraine model.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTLc4IaUEHT7Vg90H21EOLACvtfcHk0lhunlQRXZoVJA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XivVCmtL4%253D&md5=23c9624b0835dd459bdf4348fc66f623</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1021%2Fml300021s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml300021s%26sid%3Dliteratum%253Aachs%26aulast%3DLuo%26aufirst%3DG.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DConway%26aufirst%3DC.%2BM.%26aulast%3DKeavy%26aufirst%3DD.%26aulast%3DDenton%26aufirst%3DR.%26aulast%3DKostich%26aufirst%3DW.%26aulast%3DMercer%26aufirst%3DS.%26aulast%3DSchartman%26aufirst%3DR.%26aulast%3DSignor%26aufirst%3DL.%26aulast%3DLentz%26aufirst%3DK.%26aulast%3DBrowning%26aufirst%3DM.%26aulast%3DMacor%26aufirst%3DJ.%2BE.%26aulast%3DDubowchik%26aufirst%3DG.%2BM.%26atitle%3DDiscovery%2520of%2520BMS-846372%252C%2520a%2520Potent%2520and%2520Orally%2520Active%2520Human%2520CGRP%2520Receptor%2520Antagonist%2520for%2520the%2520Treatment%2520of%2520Migraine%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D3%26spage%3D337%26epage%3D341" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Luo, G.; Conway, C. M.; Everlof, G.; Lentz, K. A.; Schartman, R.; Macor, J. E.; Dubowchik, G. M.</span><div class="note"><p class="first last">Unpublished results</p></div>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Luo%2C+G.%3B+Conway%2C+C.+M.%3B+Everlof%2C+G.%3B+Lentz%2C+K.+A.%3B+Schartman%2C+R.%3B+Macor%2C+J.+E.%3B+Dubowchik%2C+G.+M.Unpublished+results."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dunpublished%26sid%3Dliteratum%253Aachs%26aulast%3DLuo%26aufirst%3DG." title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Leahy, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fan, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Desai, L. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanson, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sugiyama, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosner, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cuniere, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, Q.</span><span> </span><span class="NLM_article-title">Efficient and Scalable Enantioselective Synthesis of a CGRP antagonist</span> <span class="citation_source-journal">Org. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">4938</span><span class="NLM_x">–</span> <span class="NLM_lpage">4941</span></span><div class="citationLinks">[<a href="/doi/10.1021/ol302262q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm3013147&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhtlaju7bE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2012&pages=4938-4941&author=D.+K.+Leahyauthor=Y.+Fanauthor=L.+V.+Desaiauthor=C.+Chanauthor=J.+Zhuauthor=G.+Luoauthor=L.+Chenauthor=R.+L.+Hansonauthor=M.+Sugiyamaauthor=T.+Rosnerauthor=N.+Cuniereauthor=Z.+Guoauthor=Q.+Gao&title=Efficient+and+Scalable+Enantioselective+Synthesis+of+a+CGRP+antagonist"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Efficient and Scalable Enantioselective Synthesis of a CGRP Antagonist</span></div><div class="casAuthors">Leahy, David K.; Fan, Yu; Desai, Lopa V.; Chan, Collin; Zhu, Jason; Luo, Guanglin; Chen, Ling; Hanson, Ronald L.; Sugiyama, Masano; Rosner, Thorsten; Cuniere, Nicolas; Guo, Zhiwei; Hsiao, Yi; Gao, Qi</div><div class="citationInfo"><span class="NLM_cas:title">Organic Letters</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">4938-4941</span>CODEN:
                <span class="NLM_cas:coden">ORLEF7</span>;
        ISSN:<span class="NLM_cas:issn">1523-7052</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">An enantioselective synthesis of the CGRP antagonist BMS-846372, amenable to large scale prepn., is presented.  This new synthesis showcases a chemo- and enantioselective redn. of a cyclohepta[b]pyridine-5,9-dione as well as a Pd-catalyzed alpha-arylation reaction to form the key carbon-carbon bond and set the abs. and relative stereochem.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGod3XsfrjjvsrVg90H21EOLACvtfcHk0ljq_Das8TTaZA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhtlaju7bE&md5=e3e51b78cfb9dc615d414fcdf99267f5</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1021%2Fol302262q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol302262q%26sid%3Dliteratum%253Aachs%26aulast%3DLeahy%26aufirst%3DD.%2BK.%26aulast%3DFan%26aufirst%3DY.%26aulast%3DDesai%26aufirst%3DL.%2BV.%26aulast%3DChan%26aufirst%3DC.%26aulast%3DZhu%26aufirst%3DJ.%26aulast%3DLuo%26aufirst%3DG.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DHanson%26aufirst%3DR.%2BL.%26aulast%3DSugiyama%26aufirst%3DM.%26aulast%3DRosner%26aufirst%3DT.%26aulast%3DCuniere%26aufirst%3DN.%26aulast%3DGuo%26aufirst%3DZ.%26aulast%3DGao%26aufirst%3DQ.%26atitle%3DEfficient%2520and%2520Scalable%2520Enantioselective%2520Synthesis%2520of%2520a%2520CGRP%2520antagonist%26jtitle%3DOrg.%2520Lett.%26date%3D2012%26volume%3D14%26spage%3D4938%26epage%3D4941" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Luo, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Civiello, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pin, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kostich, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelley, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conway, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macor, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dubowchik, G. M.</span><span> </span><span class="NLM_article-title">Calcitonin Gene-related Peptide (CGRP) Receptor Antagonists: Pyridine as a Replacement for a Core Amide Group</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">2917</span><span class="NLM_x">–</span> <span class="NLM_lpage">2921</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Fjm3013147&amp;key=10.1016%2Fj.bmcl.2012.02.065" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Fjm3013147&amp;key=22429470" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Fjm3013147&amp;key=1%3ACAS%3A528%3ADC%252BC38XktFSju7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=2917-2921&author=G.+Luoauthor=L.+Chenauthor=R.+Civielloauthor=S.+S.+Pinauthor=C.+Xuauthor=W.+Kostichauthor=M.+Kelleyauthor=C.+M.+Conwayauthor=J.+E.+Macorauthor=G.+M.+Dubowchik&title=Calcitonin+Gene-related+Peptide+%28CGRP%29+Receptor+Antagonists%3A+Pyridine+as+a+Replacement+for+a+Core+Amide+Group"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Calcitonin gene-related peptide (CGRP) receptor antagonists: Pyridine as a replacement for a core amide group</span></div><div class="casAuthors">Luo, Guanglin; Chen, Ling; Civiello, Rita; Pin, Sokhom S.; Xu, Cen; Kostich, Walter; Kelley, Michelle; Conway, Charles M.; Macor, John E.; Dubowchik, Gene M.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2917-2921</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">In our continuing efforts to identify CGRP receptor antagonists that can be dosed orally for the treatment of migraine headache, we have investigated a pyridine bioisosteric replacement of a polar amide portion of a previous lead compd., BMS-694153.  Pyridine derivs. were discovered and their SAR was studied.  Some of them showed excellent binding potency.  However, oral bioavailability was low, even for compds. with good Caco-2 cell permeability.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq0OTIfcyLurbVg90H21EOLACvtfcHk0ljq_Das8TTaZA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XktFSju7o%253D&md5=d3746bdccb98d8b3a03e162f01c620bd</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2012.02.065&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2012.02.065%26sid%3Dliteratum%253Aachs%26aulast%3DLuo%26aufirst%3DG.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DCiviello%26aufirst%3DR.%26aulast%3DPin%26aufirst%3DS.%2BS.%26aulast%3DXu%26aufirst%3DC.%26aulast%3DKostich%26aufirst%3DW.%26aulast%3DKelley%26aufirst%3DM.%26aulast%3DConway%26aufirst%3DC.%2BM.%26aulast%3DMacor%26aufirst%3DJ.%2BE.%26aulast%3DDubowchik%26aufirst%3DG.%2BM.%26atitle%3DCalcitonin%2520Gene-related%2520Peptide%2520%2528CGRP%2529%2520Receptor%2520Antagonists%253A%2520Pyridine%2520as%2520a%2520Replacement%2520for%2520a%2520Core%2520Amide%2520Group%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D2917%26epage%3D2921" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="note"><p class="first last">See <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a> for details.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><div class="note"><p class="first last">The relative stereochemistry of <b>17</b> and <b>13</b> were not rigorously established. The absolute stereochemistry of <b>8</b> was established through extensive X-ray analysis of <b>8</b> and intermediate <b>23</b></p></div>: <span class="NLM_contrib-group">Qi, G. </span><div class="note"><p class="first last">Unpublished results</p></div>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=The+relative+stereochemistry+of+17+and+13+were+not+rigorously+established.+The+absolute+stereochemistry+of+8+was+established+through+extensive+X-ray+analysis+of+8+and+intermediate+23%3A+Qi%2C+G.+Unpublished+results."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dunpublished%26sid%3Dliteratum%253Aachs%26aulast%3DQi%26aufirst%3DG." title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><div class="note"><p class="first last">Compound <b>8</b> had marmoset CGRP receptor <i>K</i><sub>i</sub> of 0.0921 ± 1.5 nM (<i>n</i> = 2). For the description of all biologic assays, see also:</p></div><span class="NLM_contrib-group">Degnan, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaturvedula, P. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conway, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cook, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denton, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macci, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathias, N. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moench, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pin, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ren, S. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schartman, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Signor, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thalody, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Widmann, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macor, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dubowchik, G. M.</span><span> </span><span class="NLM_article-title">Discovery of (<i>R</i>)-4-(8-Fluoro-2-oxo-1,2-dihydroquinazolin-3(4<i>H</i>)-yl)-<i>N</i>-(3-(7-methyl-1<i>H</i>-indazol-5-yl)-1-oxo-1-(4-(piperidin-1-yl)piperidin-1-yl)propan-2-yl)piperidine-1-carboxamide (BMS-694153): A Potent Antagonist of the Human Calcitonin Gene-Related Peptide Receptor for Migraine with Rapid and Efficient Intranasal Exposure</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">4858</span><span class="NLM_x">–</span> <span class="NLM_lpage">4861</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm800546t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=4858-4861&author=A.+P.+Degnanauthor=P.+V.+Chaturvedulaauthor=C.+M.+Conwayauthor=D.+Cookauthor=C.+D.+Davisauthor=R.+Dentonauthor=X.+Hanauthor=R.+Macciauthor=N.+R.+Mathiasauthor=P.+Moenchauthor=S.+S.+Pinauthor=S.+X.+Renauthor=R.+Schartmanauthor=L.+Signorauthor=G.+Thalodyauthor=K.+A.+Widmannauthor=C.+Xuauthor=J.+E.+Macorauthor=G.+M.+Dubowchik&title=Discovery+of+%28R%29-4-%288-Fluoro-2-oxo-1%2C2-dihydroquinazolin-3%284H%29-yl%29-N-%283-%287-methyl-1H-indazol-5-yl%29-1-oxo-1-%284-%28piperidin-1-yl%29piperidin-1-yl%29propan-2-yl%29piperidine-1-carboxamide+%28BMS-694153%29%3A+A+Potent+Antagonist+of+the+Human+Calcitonin+Gene-Related+Peptide+Receptor+for+Migraine+with+Rapid+and+Efficient+Intranasal+Exposure"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Fjm800546t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm800546t%26sid%3Dliteratum%253Aachs%26aulast%3DDegnan%26aufirst%3DA.%2BP.%26aulast%3DChaturvedula%26aufirst%3DP.%2BV.%26aulast%3DConway%26aufirst%3DC.%2BM.%26aulast%3DCook%26aufirst%3DD.%26aulast%3DDavis%26aufirst%3DC.%2BD.%26aulast%3DDenton%26aufirst%3DR.%26aulast%3DHan%26aufirst%3DX.%26aulast%3DMacci%26aufirst%3DR.%26aulast%3DMathias%26aufirst%3DN.%2BR.%26aulast%3DMoench%26aufirst%3DP.%26aulast%3DPin%26aufirst%3DS.%2BS.%26aulast%3DRen%26aufirst%3DS.%2BX.%26aulast%3DSchartman%26aufirst%3DR.%26aulast%3DSignor%26aufirst%3DL.%26aulast%3DThalody%26aufirst%3DG.%26aulast%3DWidmann%26aufirst%3DK.%2BA.%26aulast%3DXu%26aufirst%3DC.%26aulast%3DMacor%26aufirst%3DJ.%2BE.%26aulast%3DDubowchik%26aufirst%3DG.%2BM.%26atitle%3DDiscovery%2520of%2520%2528R%2529-4-%25288-Fluoro-2-oxo-1%252C2-dihydroquinazolin-3%25284H%2529-yl%2529-N-%25283-%25287-methyl-1H-indazol-5-yl%2529-1-oxo-1-%25284-%2528piperidin-1-yl%2529piperidin-1-yl%2529propan-2-yl%2529piperidine-1-carboxamide%2520%2528BMS-694153%2529%253A%2520A%2520Potent%2520Antagonist%2520of%2520the%2520Human%2520Calcitonin%2520Gene-Related%2520Peptide%2520Receptor%2520for%2520Migraine%2520with%2520Rapid%2520and%2520Efficient%2520Intranasal%2520Exposure%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D4858%26epage%3D4861" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Conway, C. M.; Dubowchik, G. M.; Cook, D. A.; Signor, L. J.; Thalody, G.; Kostich, W. A.; Gulianello, M.; Huang, Y.; Denton, R.; Lentz, K. A.; Schartman, R.; Johnson, B. M.; Browning, M.; Luo, G.; Chen, L.; Macor, J. E.</span><div class="note"><p class="first last">Unpublished results</p></div>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Conway%2C+C.+M.%3B+Dubowchik%2C+G.+M.%3B+Cook%2C+D.+A.%3B+Signor%2C+L.+J.%3B+Thalody%2C+G.%3B+Kostich%2C+W.+A.%3B+Gulianello%2C+M.%3B+Huang%2C+Y.%3B+Denton%2C+R.%3B+Lentz%2C+K.+A.%3B+Schartman%2C+R.%3B+Johnson%2C+B.+M.%3B+Browning%2C+M.%3B+Luo%2C+G.%3B+Chen%2C+L.%3B+Macor%2C+J.+E.Unpublished+results."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dunpublished%26sid%3Dliteratum%253Aachs%26aulast%3DConway%26aufirst%3DC.%2BM." title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i27"><a href="/doi/suppl/10.1021/jm3013147">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_70026"></div></div></div></div></div><hr /></hr><p class="last">X-ray structures of intermediates <b>15</b> and <b>18</b> and biology experimental. This material is available free of charge via the Internet at <a class="extLink" href="http://pubs.acs.org">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm3013147/suppl_file/jm3013147_si_001.pdf">jm3013147_si_001.pdf (312.84 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm3013147&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2012.55.issue-23%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3Barticle%3Aarticle%3A10.1021%2Fjm3013147%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm3013147" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                671KB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"67996f5afbc022a8","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
